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Abstract 
Aurora A is an important mitotic regulator that has been found to be up-regulated in a variety of 
tumours provoking a great deal of attention and the development of a number of small molecule 
Aurora kinase inhibitors. Most of these inhibitors though have predominantly targeted Aurora B, 
meaning that our understanding of the role of the kinase activity of Aurora A is comparatively less 
well developed.  
MLN8054 however, is a small molecule inhibitor that has been reported in vitro to have a high 
degree of specificity towards Aurora A activity. In this thesis, I show in vivo that MLN8054 can be 
used to specifically inhibit Aurora A activity, and exploit this quality to probe the role of Aurora A 
activity in human cells. I was consequently able to show that Aurora A activity not only has a clear 
role in spindle formation, where it is required for the determination of K-fibre length and in the 
degree of centrosome separation, but also in the regulation of microtubule organisation. Despite the 
spindle deformities seen after inhibiting Aurora A activity, the majority of HeLa and DLD-1 cells 
were still able to form bipolar spindles capable of attaching to kinetochores. These spindle 
structures did not however, assert normal levels of force through the kinetochores, and cells were 
consequently unable to efficiently align their chromosomes, causing significant delays to mitotic 
progression. Cells were still able to divide in the absence of Aurora A activity, although the 
detection of segregation defects and aneuploid progeny indicates a role for Aurora A activity in the 
faithful segregation of the genetic material. Importantly however, Aurora A activity was not found 
to have a prominent role in the spindle assembly checkpoint.  
Increasing the potency of Aurora A inhibition by using a drug-resistant cell line confirmed the 
observations made in HeLa and DLD-1 cells, emphasising that although Aurora A activity is 
required for spindle assembly, cells can still activate the spindle checkpoint and divide in its 
absence. I therefore propose that Aurora A activity is required for the formation of normal spindle 
structures capable of efficiently aligning and evenly dividing chromosomes during cell division. 
These roles were attributed in part to the kinase activity of Aurora A in the regulation of TACC3 
and chTOG localisation on the spindle and centrosomes. 
Interestingly however, Aurora A activity did not appear to be required for spindle assembly in non-
transformed cells, which were able to more efficiently align their chromosomes and divide 
following Aurora A inhibition than the cancer cell lines. Furthermore, the non-transformed cells 
accumulated with 2N DNA after longer-term Aurora A inhibition, as opposed to the cancer cell 
lines, which exhibited profound aneuploidy following the equivalent treatment. This finding is 
encouraging, as consistent with recently published reports, it indicates that Aurora A inhibition 
may be successfully used in order to specifically target cancer cells.  
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1 Introduction 
1.1 Historical developments in the understanding of cell division 
1.1.1 The birth of Cell Theory 
The notion that living organisms are made up of individual units or ‘cells’ which are formed by the 
division of a mother cell, was both conceptually and technically difficult to develop. The ancient 
Greeks were the first to theorise that living things were made out of more simple components, with 
Aristotle hypothesising that life was the result of a ‘vital force’ which served to activate basic units. 
Advances to this theory were however speculative, until the development of microscopic 
techniques, which enabled the detailed observation of organisms. These techniques, together with a 
succession of meticulous studies by prolific scientific thinkers, would come to completely change 
our understanding of the living world. 
After the development of early microscopes in the late 16th century, a number of scientists were 
able to examine the intricate construction of various tissues, however it was not until the first half 
of the 19th century that the Cell Theory was developed. This important theory was the product of 
two scientists called Schlieden (Schlieden, 1838) and Shwann (Shwann, 1839), who described all 
living things as being made out of individual units called cells. This theory was further developed 
by the observation that cells were not formed de novo, but instead were created by the formation of 
a partition in the parental cell, resulting in the production of two daughter cells (Amos, 2000, von 
Mohl, 1835). The observation in the 1840s and early 1850s that nuclear division preceded cell 
division brought the understanding of cell reproduction still further, however the step to 
understanding the relevance of chromosomes was more challenging. When analysing salamander 
cells, Flemming observed the strand-like entities of chromosomes and witnessed their longitudinal 
splitting at anaphase (Flemming, 1882) (Figure 1.1). This process was consequently named 
‘mitosis’, from the Greek word for thread. Flemming’s investigations also indicated the presence of 
a network of fibres, which would later be described as the ‘spindle’ (Flemming, 1882). These 
revolutionary steps in the understanding of cell division prompted a torrent of investigations which 
shed further light on the intricacies of the process.  
 
 
Figure 1.1 Early illustrations of the spindle and chromosomes from Flemming‘s book
Zellsubstanz, Kern und Zelltheilung, published in 1882 (image taken from (Paweletz,
2001)).
17
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1.1.2 The importance of nuclear material 
Many leading thinkers in the field considered the nuclear factors of a cell to be of eminent 
importance in determining the character of the cell, however experimental challenges made this 
theory difficult to prove. In 1889 however, Boveri succeeded in fertilising an enucleate sea urchin 
egg with the sperm of another species to produce a distinguishably different embryo (Boveri, 
1889). This appeared to be clear evidence of the nuclear rather than cytoplasmic control over 
cellular development. Further advances in the area also revealed that each chromosome played a 
distinct role in cell development, and that a complete chromosome set was required for normal 
development.  
1.1.3 The characterisation of the spindle 
The improvement of experimental techniques such as live-cell imaging and advanced microscopy 
between 1920 and 1950 enabled better observation and understanding of mitosis. It became 
possible to determine the shape of the mitotic spindle and the resulting force exerted on 
chromosomes (Wilson, 1928, Bajer and Mole-Bajer, 1975, Ris, 1949, Ostergren, 1951). In the late 
1940s, Ostergren theorised that the movement of chromosomes toward the metaphase plate was 
achieved by the balancing of spindle forces which emanated from each pole. Consistent with this 
theory, in the 1950s a collection of data revealed that the spindle was made from protein filaments 
which ran parallel to the path of the chromosomes, and that it may be spindle polymerisation that 
drove chromosome dynamics (Inoue and Sato, 1967).  
The development of electron microscopy enabled the observation of the spindle and its connection 
to kinetochores in even finer detail (Bajer and Mole-Bajer, 1975, Brinkley and Stubblefield, 1966, 
McDonald et al., 1992, Ding et al., 1993, Winey et al., 1995). Furthermore, the functioning of the 
spindles was revealed by a number of ingenious experiments such as spindle marking techniques 
that enabled the observation of microtubule dynamics and the intricate use of a micro-needle which 
demonstrated the pulling forces produced by the spindle (Mitchison et al., 1986, Gorbsky et al., 
1988, Maddox et al., 2000, Mallavarapu et al., 1999, Nicklas, 1983). Finally, the discovery of 
motor proteins allowed the development of a more complete understanding of spindle construction 
and instigated the search for further spindle associated proteins (Sharp et al., 2000b, Walczak et al., 
1998).  
The culmination of all this evidence has enabled the development of the current model of cell 
division, and in this introduction I will discuss the current knowledge regarding the regulation of 
this complicated process. As my investigation specifically concerns the Aurora kinase family, I will 
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then explore the current understanding of these proteins and their role in the control of cell 
division. 
1.2 The current understanding of cell division 
Recent advances in experimental techniques have facilitated a greatly improved understanding of 
cell division, revealing the existence of various steps (Figure 1.2). 
1.2.1 Phases in cell division 
In a normal life cycle of a cell, division of the cellular material occurs in ‘M phase’ which 
compromises of mitosis and cytokinesis. The faithful completion of these two steps allows the even 
segregation of the duplicated genome, therefore preserving the hereditary information and 
necessary cytoplasmic content of dividing cells. For this essential process to occur, a tightly 
regulated sequence of mitotic stages must be completed consisting of: prophase, prometaphase, 
metaphase, anaphase and telophase. On successful completion of these mitotic steps, cytokinesis 
allows the cleavage of the mother cell to form two genetically identical daughter cells.  
The progression through the cell cycle is highly regulated to ensure that mitosis is not initiated until 
after cellular replication has been completed and any damaged DNA is repaired. The control over 
the cyclical flow through the cell cycle was found to be dependent on the appropriate activation or 
inactivation of a series of Cdk serine/threonine kinase family members, which are controlled both 
by associations with partner cyclin proteins, and by a complicated system of phosphorylation and 
dephosphorylation reactions. 
1.2.2 The control of mitotic entry: The regulation of Cyclin B1-Cdk1 
Early experiments into the regulation of the cell cycle revealed the cyclic activation and 
inactivation of Cyclin B1 was required to drive the progression from interphase to mitosis and back 
again (Murray and Kirschner, 1989). Later it was shown that Cyclin B1 was actually the activating 
subunit for Cyclin dependent kinase 1 (Cdk1), which was required for the entry into mitosis (for 
review see [Nurse, 1990]).  
In S phase, the transcription of Cyclin B1 is enhanced by the activation of transcription factors, 
which coincides with an increase in its export from the nucleus (Yang et al., 1998, Ziebold and 
Klempnauer, 1997, Saville and Watson, 1998, Chae et al., 2004, Major et al., 2004, Laoukili et al.,  
Spindle
checkpoint
Prophase
Prometaphase
Metaphase
Anaphase
Telophase
Cytokinesis
Interphase
Figure 1.2 The stages of mitosis
The division of animal cells can be divided into a series of stages:
Prophase - chromatin condenses to form defined chromosomes, the nuclear envelope
breaks down and centrosomes migrate to opposite ends of the cell; Prometaphase -
kinetochores become attached to dynamic spindle microtubules, causing the formation of
stable kinetochore-fibres, allowing chromosomes to congress towards the equatorial plane
of the cell; Metaphase - Biorientation of the chromosomes is achieved, allowing the
satisfaction of the spindle checkpoint; Anaphase - The satisfaction of the spindle
checkpoint and the resulting loss of sister chromatid cohesion allows the sisters to be
pulled towards the opposite poles of the cell; Telophase - Arrival of the sister chromatids at
the cell poles promotes their decondensation and a nuclear envelope is formed around
them; Cytokinesis - the formation of an actomyosin-based contractile ring brings about the
division of cellular material (for review see [Nigg, 2001b]).
20
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2008, Hagting et al., 1998). During G2, Cyclin B1 is targeted to the centrosomes by Polo-like 
kinase-1 (Plk1) and Aurora A, which act to amplify the effects of Cyclin B1, allowing the 
formation of the Cyclin B1-Cdk1 complex (Jackman et al., 2003). The activity of the Cyclin B1-
Cdk1 complex is controlled by phosphorylation events which can positively and negatively 
regulate its activity (Tassan et al., 1994, McGowan and Russell 1995). The balancing of these 
activities takes the form of a delicately regulated feedback loop, which is responsible for the major 
regulatory step in mitotic entry (for review see [O'Farrell, 2001]; (Booher et al., 1997, Nakajima et 
al., 2003, Watanabe et al., 2004, Dutertre et al., 2004, Gabrielli et al., 1996, Lammer et al., 1998, 
Lindqvist et al., 2005, Baldin et al., 2002)). Interestingly, if the levels of Cyclin B1 are lowered, 
normal signalling networks do not properly function and mitoses are abnormal, possibly reflecting 
the improper activation of the full signalling network (Lindqvist et al., 2007). 
The phosphorylation from the activated Cdk1 has also been shown to target Plk1 to Cdk1 
substrates such as Cdc25C, Myt1, Wee1, Cyclin B-Cdk1, and a range of others which further 
promote the entry into mitosis (Elia et al., 2003, Watanabe et al., 2004, Watanabe et al., 2005, 
Nakajima et al., 2003, Lowery et al., 2007, Yamaguchi et al., 2005, Litvak et al., 2004, Toyoshima-
Morimoto et al., 2002, Yuan et al., 2002). Cdk1 has also been shown to phosphorylate Bora, the 
Aurora A kinase co-factor, which may help in stimulating the Aurora A mediated activation of Plk1 
(Hutterer et al., 2006, Chan et al., 2008). Indeed, the activity of both Aurora A and Plk1 has been 
shown to be involved in a positive feedback loop with the Cyclin B1-Cdk1 complex, in which the 
three proteins experience increased phosphorylation and recruitment to the centrosomes (for review 
see [Barr and Gergely, 2007]; (Marumoto et al., 2002, Abrieu et al., 1998, Katayama et al., 2001, 
Portier et al., 2007, Dutertre et al., 2004, Hachet et al., 2007)).  
These findings therefore demonstrate the existence of an intertwined and complicated network of 
regulation, which is essential to prevent entry into mitosis in the presence of DNA damage. If DNA 
damage occurs in G2, this network is required to halt the progression until the damage is repaired 
(for review see [Smits and Medema, 2001, Bartek and Lukas, 2007]; (Lukas et al., 2001)). 
Interestingly, various pathways which are redundant in the mitosis of undisturbed cells, become 
essential for the entry into mitosis after DNA damage. In particular Aurora A and Plk1 activity 
were found to be required for mitotic entry after DNA damage (van Vugt et al., 2004, Macurek et 
al., 2008). 
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1.2.3 The controlled progression through mitosis:  The importance of regulating         
Cyclin B1 levels          
After the entry into mitosis, Cyclin B-Cdk1 levels are seen to increase, which allows the 
orchestration of normal mitotic progression (Lindqvist et al., 2007).  Ubiquitination of Cyclin B1 in 
mitosis instigates its ubiquitin-dependent proteosome degradation, consequentially causing the 
reduction of the level of Cyclin B1 and the exit from mitosis  (for review see [Nandi et al., 2006] 
Figure 1.3; (Murray et al., 1989, Glotzer et al., 1991, Hershko et al., 1991)). The E3 ubiquitin 
ligase found to ubiquitinate Cyclin B1 was therefore also found to be required for anaphase onset, 
and was subsequently coined the Anaphase-promoting complex (APC) (Zachariae and Nasmyth, 
1996, Sudakin et al., 2001, Hershko et al., 1994, King et al., 1995). Further investigation into the 
APC has revealed that it is made up of several subunits and is only fully active when bound to one 
of its co-factors, such as Cdc20 and Cdh1, which have different binding affinities for the APC 
depending on the cell cycle phase (for review see [Peters, 2006]).  
The APC co-factor Cdh1 is prevented from binding with the APC by its phosphorylation by Cdks 
during S phase, G2 phase and early mitosis (Zachariae and Nasmyth, 1996, Blanco et al., 2000, 
Kramer et al., 2000). However, during prophase, Cyclin B1-Cdk1 and Plk1 phosphorylate the APC 
at several sites, causing it instead to bind to Cdc20 (Kramer et al., 2000, Rudner and Murray, 2000, 
Golan et al., 2002, Kraft et al., 2003). The appropriately activated APCCdc20 targets Cyclin B1 and 
Securin for proteosome-dependent degradation. Both Cyclin B1 and Securin are important 
regulators of the transition between metaphase and anaphase (Murray et al., 1989, Glotzer et al., 
1991, Hershko et al., 1991, Clute and Pines, 1999, Hagting et al., 2002). Securin inhibits the 
protease called Seperase, and when Securin is degraded, Seperase is released from its inhibitory 
constraints, cleaving Cohesin which allows sister chromatids to separate (reviewed in [Nasmyth, 
2001, Pines, 2006]; (Hagting et al., 2002, Rieder et al., 1994)). 
In the presence of inappropriately attached chromosomes however, a surveillance mechanism 
called the spindle checkpoint ensures that the APCCdc20 complex is prevented from initiating Cyclin 
B1 and Securin destruction, thus delaying the onset of anaphase. This delay allows a period in 
which cells can achieve universal chromosome biorientation thus preventing the development of 
aneuploidy (Kops et al., 2005, Weaver and Cleveland, 2005, Rieder et al., 1995, Rieder et al., 
1994). Indeed the disruption of the spindle checkpoint in mammalian cells causes the disruption of 
cell proliferation and the loss of cell viability (for review see [Dobles and Sorger, 2000, Kops et al., 
2005]).  
E2
Ub
E3
Substrate
Ub
Ub E1
E1
Ub
E2
Ub
E2
Ub
E3
Substrate
Ub
Ub
Substrate
Ub
Substrate
Ub
Ub
Ub
Ub
ATP
AMP
+ PPi
Degradation by 26S proteosome
Figure 1.3 Ubiquitin-dependant protein degradation
Ubiquitin-dependant proteosome degradation commences with the action of an E1
ubiquitin-activating enzyme, which through the consummation of ATP, forms a high-energy
thiolester linkage with a free ubiquitin (for review see [Ravid and Hochstrasser, 2008]).
The activated ubiquitin is then transferred to an E2 ubiquitin-conjugating (UBC) enzyme,
which is required for the degradation of cyclins such as Cyclin B (Hershko et al., 1994).
With the help of a third enzyme, an E3 ubiquitin ligase, which determines the specificity of
the substrate, the UBC enzyme transfers the ubiquitin to a lysine in the target protein. The
E3 ubiquitin ligases are commonly involved in the formation of poly-ubiquitin chains which
cause cells to be recognised and degraded by the 26S proteosome (Figure adapted from
[Ravid and Hochstrasser, 2008]).
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1.2.4 The spindle checkpoint 
Spindle checkpoint activation can be maintained by the presence of just a single unaligned 
chromosome (Rieder et al., 1994, Rieder et al., 1995, Nicklas et al., 1995), which indicates that the 
incorrectly attached chromosomes instigate the production of a diffusible signal, capable of 
preventing APCCdc20 from targeting Cyclin B1 and Securin for proteosome-dependent degradation 
(Figure 1.4). Interestingly however, this diffusible signal does not inhibit the activity of APCCdc20, 
as the complex is still capable of targeting substrates such as Cyclin A and NIMA-related kinase 
2A (Nek2A) for degradation in prometaphase (Geley et al., 2001, den Elzen and Pines, 2001). 
Therefore the checkpoint signal may just prevent the action of APCCdc20 towards specific substrates 
(Hayes et al., 2006).  
1.2.5 The mitotic checkpoint complex 
The identification of a signal produced by unattached chromosomes, prompted the search for its 
component parts. Following the identification of the MAD and BUB genes in budding yeast (Hoyt 
et al., 1991, Li and Murray, 1991), a complex was found to form between Mad2, Mad3, Bub3 and 
Cdc20, in budding yeast mitosis which was found to associate with the APC (Brady and Hardwick, 
2000). Human homologues have since been found (Li and Benezra, 1996, Taylor et al., 1998, 
Meraldi and Sorger, 2005), which similarly form a complex consisting of Mad2, BubR1, Bub3 as 
well as Cdc20, which is known as the ‘Mitotic checkpoint complex’ (MCC) (Sudakin et al., 2001). 
Importantly, although recombinant Mad2 and BubR1 are individually capable of inhibiting the 
APC, their combination into the MCC has a synergistic inhibitory effect, preventing the APC from 
targeting Cyclin B1 and Securin for destruction (Sudakin et al., 2001, Fraschini et al., 2001, 
Morrow et al., 2005, Fang et al., 1998a, Fang et al., 1998b, Fang, 2002, Hardwick et al., 2000, 
Tang et al., 2001, Millband and Hardwick, 2002).  
Generation of the MCC: kinetochore microtubule occupancy 
In early mitosis, checkpoint proteins and Cdc20 begin to accumulate at kinetochores (for review 
see [Cleveland et al., 2003, Musacchio and Salmon, 2007]). These include Mad1, Bub1, Plk1, 
CENP-E and Aurora B which do not form part of the MCC, but function instead to increase the 
formation of the complex and amplify the spindle checkpoint signal or regulate the spindle 
checkpoint in response to chromosomal misalignments (Ditchfield et al., 2003, De Antoni et al., 
2005, Kallio et al., 2002, Tang et al., 2004, Mao et al., 2005, Morrow et al., 2005).  
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Figure 1.4 Microtubule-kinetochore attachments and the satisfaction of the spindle
assembly checkpoint
(A) During the formation of the spindle, optimal chromosome orientation occurs when the
two adjacent sister kinetochores are attached to microtubules which emanate from
proximal spindle poles. Other forms of kinetochore-microtubule attachments do however
form. These alternative attachments activate the spindle checkpoint and are eventually
corrected to allow the universal biorientation of chromosomes within the cell.
(B) When chromosomes are not biorientated on the spindle they generate the checkpoint
signal, which inhibits the APC and prevents the onset of anaphase. When chromosomes
are biorientated however, appropriate force is applied to the kinetochore pair producing a
centromere stretch, thus preventing the generation of the checkpoint signal and promoting
anaphase onset (for review see [Santaguida and Musacchio, 2009, Marseca and Salmon,
2010] Figure adapted from [Maresca and Salmon, 2010]).
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The assembled proteins monitor the attachment of microtubules to chromosomes. Checkpoint 
proteins such as Mad2 and BubR1 attach to unattached kinetochores and are removed as 
microtubules fill the kinetochore occupation sites (Chen et al., 1996, Chen et al., 1998, Li and 
Benezra, 1996, Taylor and McKeon, 1997, Taylor et al., 1998, Waters et al., 1998, Skoufias et al., 
2001). This reduction in levels of checkpoint proteins at attached kinetochores is attributed to the 
increase in microtubules enhancing the level of motile Dynein to the area, which is capable of 
‘stripping’ the proteins (King et al., 2000, King and Nicklas, 2000, Hoffman et al., 2001, Howell et 
al., 2001). BubR1 activity is also silenced via CENP-E in response to kinetochore microtubule 
capture, which silences BubR1 dependent checkpoint signalling (Mao et al., 2005). Mad2 at 
kinetochores is also proposed to be regulated by the inhibitor of the spindle assembly checkpoint 
p31comet, which is thought to compete with Mad2 at kinetochores, thus inhibiting checkpoint 
signalling (Yang et al., 2007, Habu et al., 2002, Xia et al., 2004, Mapelli et al., 2006). It appears 
therefore, that many signalling networks are at work to activate the spindle assembly checkpoint in 
response to insufficient microtubule-kinetochore attachments. However, chromosomes can also be 
incorrectly aligned as a result of their inappropriate attachment to spindle microtubules.    
Generation of the MCC: low inter-kinetochore tension 
To prevent the onset of anaphase until chromosomes are correctly bi-orientated, it has been 
proposed that cells monitor the tension generated by the spindle across sister kinetochores (Nicklas 
et al., 1995, Nicklas, 1997). When chromosomes are incorrectly attached to K-fibres, it is not 
possible for the spindle to assert the same degree of tension as produced at bi-orientated 
chromosomes, thus presenting a method which can be used by the cell to determine incorrectly 
attached chromosomes (Figure 1.4). The existence of such a tension sensing mechanism is 
supported by the observation that kinetochores under tension experience a decrease in levels of 
Bub1 as well as changes in the phosphorylation of proteins recognised by 3F3/2 (Waters et al., 
1998, Morrow et al., 2005, Gorbsky and Ricketts, 1993, Taylor et al., 2001, Chen et al., 1998). 
Furthermore, under conditions where kinetochores are monotelically or synthetically attached to 
the spindle, the chromosomal passenger complex (CPC) including Aurora B, is found to sense the 
low tension and instigate the correction of the attachment (reviewed in [Cimini and Degrassi, 2005, 
Vader et al., 2006b]; (Morrow et al., 2005, Dewar et al., 2004, Cimini et al., 2006, Knowlton et al., 
2006)).  
Despite the evidence in support of it, the existence of a tension-sensing arm of the spindle 
checkpoint still remains controversial. Groups arguing against the ability of cells to delay anaphase 
in the presence of low levels of kinetochore tension, cite experiments where cells can progress 
through to anaphase even when centrosome stretch is prevented by laser ablation or the exploitation 
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of replication defects (O'Connell et al., 2008, Dewar et al., 2004, Skibbens et al., 1995). In these 
experiments, the spindle checkpoint can be satisfied and cells progressed to anaphase following the 
attachment of microtubules. There however remains some debate on whether the distance between 
the inner and outer kinetochore proteins is monitored by the cell as a method of detecting erroneous 
low-tension attachments (Maresca and Salmon, 2009, Uchida et al., 2009, Wan et al., 2009). If this 
method of tension sensing exists in cells, it would still be present in the cited experiments and 
therefore negates the theory that tension is not a factor in the spindle checkpoint. However before 
this area of high debate can be resolved, further investigation must first be carried out (review in 
[Maresca and Salmon, 2010]). 
1.2.6 Destabilisation of low tension microtubule attachments 
K-fibres that do not produce appropriate levels of centromere stretch are destabilised (Hauf et al., 
2003, Cimini et al., 2006, Adams et al., 2001b, Kaitna et al., 2002, Lampson et al., 2004). 
However, the strong relationship between attachment and tension generation at kinetochores makes 
it difficult to distinguish whether low levels of tension directly cause the activation of the spindle 
checkpoint, as changing levels of tension will probably alter the level of microtubule attachment 
(Zhou et al., 2002, Pinsky et al., 2003).  
Aurora B kinase is involved in this destabilisation of low tension microtubule attachments by 
controlling the microtubule-destabilising Kin1 kinesin MCAK (mitotic centromere-associated 
kinesin), the Ndc80/HEC1 complex and the DASH complex, all of which are involved in causing 
the depolymerisation of microtubules at the kinetochore area (Andrews et al., 2004, Cheeseman et 
al., 2002, Ohi et al., 2004, Zhang et al., 2007, Keating et al., 2009, Tien et al., 2010). By 
destabilising the low tension microtubule connections, Aurora B kinase activates the spindle 
checkpoint by causing reduced kinetochore attachment, thus delaying anaphase onset until all 
chromosomes are correctly bi-oriented (Ditchfield et al., 2003, Hauf et al., 2003, Girdler et al., 
2006, Biggins et al., 1999, Pinsky et al., 2006). This role for Aurora B activity was highlighted in 
experiments in which its inhibition permitted mitotic exit despite the absence of appropriate 
centromeric tension (Ditchfield et al., 2003, Hauf et al., 2003, Waters et al., 1998). Cells were 
however retained in mitosis following Aurora B inhibition when both kinetochore attachment and 
tension were lost. This demonstrates that although Aurora B activity is involved in controlling the 
activation of the spindle checkpoint in response to low tension, it is not involved in checkpoint 
activation in response to loss of kinetochore attachment.  
The detection of checkpoint proteins on kinetochores indicates that the kinetochores serve as a 
method of contributing to the formation of the MCC (Howell et al., 2000, Howell et al., 2004, Luo 
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et al., 2002, Shah et al., 2004, De Antoni et al., 2005). There is however some debate over the role 
of kinetochores in the formation of the spindle checkpoint signal, (Sudakin et al., 2001, Fraschini et 
al., 2001, Poddar et al., 2005). Consequently, it has been proposed that there may be two phases of 
checkpoint activation, possibly involving an initial phase that occurs before kinetochores are 
properly matured, and a second that is more dependent on the presence of fully functional 
kinetochores. Mad2 and BubR1 have been put forward as controllers of mitotic timing before the 
maturation of kinetochores, possibly by directly binding and sequestering Cdc20, to inhibit 
premature mitotic exit (for review see [Musacchio and Salmon, 2007]; (Meraldi et al., 2004)).The 
extinguishing of the Mad2, BubR1 signal is thought to coincide with the initiation of the second 
phase of checkpoint signalling, which depends on the newly matured kinetochores (Meraldi et al., 
2004). Therefore, the presence of mature kinetochores may not be required for inhibition of the 
APC and the formation of the MCC. Kinetochores may however increase the association of the 
MCC with the APC, an idea which is supported by the observation that while the MCC is present 
throughout the cell cycle, it is only found to be associated with APC during mitosis (Morrow et al., 
2005).  
1.2.7 Sustained spindle checkpoint activation 
The sustained activation of the spindle assembly checkpoint by long-term treatment with anti-
mitotic drugs, such as Nocodazole, causes cells to be maintained in mitosis for extended periods 
and prevents the satisfaction of the spindle assembly checkpoint (Brito and Rieder, 2006).  Reports 
of the fate of cells after extended checkpoint activation vary greatly, with some describing mitotic 
exit after a prolonged mitosis without division (Jordan et al., 1996, Tao et al., 2005), while others 
show cell death occurring directly in mitosis (Panvichian et al., 1998), or alternatively cells are 
observed to experience abnormal divisions (Chen and Horwitz, 2002). Ultimately however, cells 
incapable of satisfying the spindle checkpoint eventually die (Rieder and Maiato, 2004).  
Recent publications have revealed the existence of a variety of different responses to the sustained 
spindle checkpoint activation (Gascoigne and Taylor, 2008, Brito and Rieder, 2006, Brito and 
Rieder, 2009, Shi et al., 2008). These variations were attributed to the balancing of the death 
signals and Cyclin B1 levels (Gascoigne and Taylor, 2008). Cyclin B1 levels were found to be 
gradually degraded despite sustained spindle checkpoint activation, and when reduced below a 
certain threshold, cells were caused to exit mitosis without first satisfying the spindle checkpoint, 
through a process known as ‘slippage’ (Brito and Rieder, 2006). The variation in cell fate in 
response to sustained checkpoint activation was therefore thought to be derived from the different 
rates of Cyclin B1 degradation and slippage thresholds. Interestingly, mitotic delays inflicted by 
anti-mitotic drugs were shown to be further extended through their combination with caspase 
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inhibition (Shi et al., 2008, Gascoigne and Taylor, 2008, Brito et al., 2008). It was consequently 
theorised that the gradual degradation of Cyclin B1 and the activation of cell death pathways may 
act as two opposing networks working to define the fate of the cell (Gascoigne and Taylor, 2008). 
Thus while the cell death signals increased in response to sustained anti-mitotic drug treatment, the 
Cyclin B1 levels were also falling. The first network to reach its designated threshold would 
determine whether the cell died in mitosis or ‘slipped’ out.  
1.2.8 Satisfaction of the spindle assembly checkpoint 
When the chromosomes are finally aligned, the spindle checkpoint is satisfied, the APCCdc20  targets 
Cyclin B1 and Securin for destruction and Cdk1 is inactivated, allowing the progression through to 
anaphase (Clute and Pines, 1999, D'Angiolella et al., 2003, Potapova et al., 2006). The inactivation 
of Cdk1 promotes the interaction of Cdh1 with the APC through its dephosphorylation, which in 
turn targets Cdc20 for degradation and maintains low levels of Cyclin B1 to enable the correct 
progression through G1 (Prinz et al., 1998, Pfleger and Kirschner, 2000). The appropriate 
phosphorylation of the APC and the dephosphorylation of Cdc20 therefore have antagonistic 
effects towards the binding of the co-factors to the APC. This demonstrates a network of activity, 
and highlights the high degree of control that is held over mitotic progression. Structural elements 
such as microtubule organising centres are however also required for the efficient progression 
through mitosis. 
1.3 Microtubule organising centres 
The accurate delivery of genetic material into two daughter cells requires the formation of a 
spindle, which is dependent on the action of microtubule organising centres. Although 
microtubules can form on their own, microtubule organising centres enable the efficient 
organisation of tubulin subunits to form functional spindles, and have been found in all eukaryotic 
organisms apart from higher plants and yeasts. 
1.3.1 Centrosomes 
When present in cells, centrosomes function as the major method of bipolar spindle formation, 
although bipolar spindles have been shown to still occur after removal of centrioles. Cells lacking 
centrosomes were however sometimes observed to have problems with cytokinesis and to 
eventually arrest in G1 (Hinchcliffe et al., 2001, Khodjakov and Rieder, 2001, Khodjakov et al., 
2000, Basto et al., 2006).  
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In the absence of centrosomes a bipolar spindle can form through a ‘self assembly’ pathway, 
whereby microtubules are nucleated around chromosomes in systems which lack centrosomes 
(McKim and Hawley, 1995, Heald et al., 1996, Heald et al., 1997). In these cases the nucleation of 
microtubules is thought to occur at sites of γ-tubulin complexes which are recruited by a network of 
factors (Luders et al., 2006). This nucleation is mediated by the small GTPase Ran (Dasso, 2002, 
Hetzer et al., 2002), which has been shown to induce bipolar spindle assembly in Xenopus egg 
extracts lacking centrosomes (Carazo-Salas et al., 1999, Kalab et al., 1999, Wilde and Zheng, 1999, 
Ohba et al., 1999). RanGTP is thought to accumulate at chromosomes, where it creates a 
favourable environment for microtubule polymerisation, involving many of the proteins involved in 
centrosome dependent bipolar spindle formation (for review see [Walczak and Heald, 2008]; 
(Kalab et al., 2006)). In this way Ran instigates a cascade of activities including promoting the 
activation of Aurora A via TPX2 binding (Targeting protein for Xklp2), which will be discussed 
later in more detail (Eyers et al., 2003, Tsai et al., 2003).  
1.3.2 The centrosome cycle 
When present in cells, centrosomes nucleate microtubules through the incorporation of α- and β-
tubulin subunits to form long polymers or microtubules (Bornens et al., 1987, Sluder and Rieder, 
1985, Mitchison and Kirschner, 1984, Mitchison and Kirschner, 1986, Brinkley et al., 1981, Soltys 
and Borisy, 1985). The function  is however dependent on the passing of the centrosomes through 
the highly regulated centrosome cycle (Kuriyama and Borisy, 1981) (Figure 1.5). 
Centriole duplication 
Centrioles are composed of α- and β-tubulin subunits arranged in a barrel shape, with a 9-fold axis 
of symmetry (Bornens et al., 1987, Komesli et al., 1989). A pair of centrioles begin the cell cycle 
within a newly formed daughter cell, just after the completion of telophase. In S phase these 
centrioles duplicate to produce procentrioles, which are connected to their mother by a fibrous link 
that prevents any further unwanted duplication (Bahe et al., 2005, Faragher and Fry, 2003, Fry et 
al., 1998, Mayor et al., 2000). In some cell lines such as HeLa and CHO, the presence of a mother 
centriole is not a necessity for the formation of a daughter centriole, although it does make the 
process more efficient as well as limiting the number of centrioles produced (Khodjakov et al., 
2002, Kato and Sugiyama, 1971, Miki-Noumura, 1977, Marshall et al., 2001, La Terra et al., 2005, 
Uetake et al., 2007). In mammalian cells, the mother centriole can be distinguished from the 
daughter by distal and subdistal appendages which mark its state of maturity and nucleation 
capacity (Piel et al., 2000, Vorobjev and Chentsov, 1980, Kuriyama, 1984, Sluder and Rieder,  
Centrosome disengagement
Disengaged but tethered
Cetrosome duplication
Two pairs of centrioles
Centrosome seperation
Centrioles are disengaged
Figure 1.5 The centrosome cycle
The outer circle represents the path of the centrosome cycle, while the inner yellow circle
indicates the concurrent phases of the cell cycle. The centrioles are depicted as grey
cylinders, the darker version is the mature centriole while the lighter is the immature or
daughter centriole. The green areas represent the pericentriolar protein matrix, the curved
grey connecting line indicates the positioning of a putative tether between the mature
centrioles, and the small black dashes connecting the mature and immature centrioles
show that they are engaged to each other (diagram amended from [Lukasiewicz and
Lingle, 2009]).
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1985). The mother and daughter centrioles adopt an orthogonal orientation, with their respective 
ends that are situated closest to the nucleus positioned at right angles to each other (Kuriyama and 
Borisy, 1981).  
A succession of experiments revealed that the duplication of centrioles is dependent on several 
proteins with homologues in human cells, and are coordinated by the activity on Cdk2/Cyclin E 
and/or Cyclin A and Plk4 (Meraldi et al., 1999, Hinchcliffe et al., 1999, Kleylein-Sohn et al., 2007, 
Pelletier et al., 2006, Delattre et al., 2006, Andersen et al., 2003, Leidel and Gonczy, 2003, 
Habedanck et al., 2005). Furthermore the up-regulation of Aurora A or Plk4 expression has been 
shown to cause centrosome amplification (Meraldi et al., 2002, Zhou et al., 1998, Goepfert et al., 
2002, Shao et al., 2006, Duensing et al., 2007, Wang et al., 2006, Ohishi et al., 2010). 
Supernumerary centrosomes such as these have been shown to function as extra microtubule 
organising centres, even nucleating microtubules more efficiently than normal centrosomes (Lingle 
et al., 1998, Pihan et al., 1998). The misregulation of the number of centrosomes has been linked to 
chromosome instability and the development of cancer (Lingle et al., 1998, Lingle et al., 2002, 
D'Assoro et al., 2002, Nigg, 2006, Pihan et al., 1998, Dodson et al., 2004, Boveri, 1889, Lingle and 
Salisbury, 1999, Chng et al., 2006). Furthermore, the absence or disruption of centrosomes at S 
phase in many cells causes a cell cycle arrest at G1, indicating that the loss  of centrosomes is also 
a source of major stress to the cell (Uetake et al., 2007, Srsen et al., 2006, Mikule et al., 2007). 
Damaged DNA however has also been shown to produce multipolar cells through causing 
centrosomes to lose their integrity and split, resulting in the production of multipolar spindles (Hut 
et al., 2003, Keryer et al., 1984, Sluder and Rieder, 1985). 
Elongation and centrosome maturation 
After their duplication, the newly formed procentrioles go through a process of elongation 
throughout S phase to G2, with some cell types recorded as even continuing the elongation process 
during mitosis (Kuriyama and Borisy, 1981).  
The elongating centrioles sit in a fibrous bed called the pericentriolar matrix (PCM), which acts as 
a scaffold to localise many different proteins (Klotz et al., 1990, Sellitto et al., 1992). One such 
protein is the highly conserved γ-tubulin, which has been found to be localised to centrosomes, 
forming a γ-tubulin ring complex (γ-TuRC) mainly between prophase to metaphase (Oakley and 
Oakley, 1989, Oakley et al., 1990, Stearns et al., 1991, Joshi et al., 1992, Felix et al., 1994). 
Through electron microscopy, it was revealed that γ-tubulin forms an open ring structure and was 
found to be localised at the end of microtubules where it is involved in microtubule assembly and 
functional bipolar spindle formation (Oakley and Oakley, 1989, Oakley et al., 1990, Stearns et al., 
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1991, Joshi et al., 1992, Felix et al., 1994) (Paluh et al., 2000, Sampaio et al., 2001, Zheng et al., 
1995, Stearns and Kirschner, 1994, Li and Joshi, 1995, Oakley, 1992).  
In late G2, the PCM undergoes a phosphorylation-dependent maturation process, in which it 
increases its size, the number of γ-TuRC it contains, and its nucleation ability (Khodjakov and 
Rieder, 1999, Casenghi et al., 2003). Plk1, Nek2 protein kinase, protein phosphatase 4 and Aurora 
A have been associated with the control of the centrosome maturation process, which involves 
Hef1, TPX2, Bora, NDEL1 and LATS2. Interestingly, all of these proteins are involved in Aurora 
A signalling, further highlighting the importance of the kinase in the maturation process (Mori et 
al., 2007, Lane and Nigg, 1996, Hutterer et al., 2006, Pugacheva and Golemis, 2005, Deluca et al., 
2006, Toji et al., 2004, Prigent et al., 2005, Martin-Granados et al., 2008). In fact the inhibition of 
either Aurora A or Plk1 activity delays the progression into mitosis as a consequence of reduced 
centrosome maturation, a process which will be discussed later in more detail (Lenart et al., 2007, 
Hirota et al., 2003, Marumoto et al., 2002, Marumoto et al., 2003, Hannak et al., 2001, Portier et 
al., 2007, Hachet et al., 2007, Qian et al., 1998).  
Centrosome separation and bipolar spindle assembly 
In late G2 or early mitosis, the link which connects the two centrosomes together is severed by 
Plk1, Nek2 and possibly Aurora A (Lane and Nigg, 1996, Glover et al., 1995, Fry et al., 1998, 
Bahe et al., 2005, Tsou et al., 2009, Bahmanyar et al., 2008, Mayor et al., 2000, Helps et al., 2000). 
The disengaged centrosomes then begin to migrate away from each other, facilitating the formation 
of the bipolar spindle.  
Centrosome migration has been found to be dependent on many factors including the plus-end 
directed motor protein Eg5 (Mayer et al., 1999) and the minus-end directed motor Dynein and the 
Dynein binding protein CLIP-170 (Fuller and Wilson, 1992, Vaisberg et al., 1993, Pfarr et al., 
1990, Verde et al., 1991, Tanenbaum et al., 2008, Saunders and Hoyt, 1992). However, it is not just 
the balancing of motors that produces the force to allow the development of the bipolar spindle, as 
force generated from kinetochores has also been implicated in centrosomal movement (Toso et al., 
2009, McAinsh et al., 2006). Furthermore, the movement of the centrosomes during prophase has 
also been attributed to the presence of astral microtubules (Verde et al., 1991, Vaisberg et al., 1993, 
Pfarr et al., 1990, Rosenblatt et al., 2004). The regulation of all the forces required to separate the 
centrosomes and create a bipolar spindle is a highly complicated process, with Aurora A and Plk1 
activity playing major parts which will be explored later in this introduction (Lane and Nigg, 1996, 
Glover et al., 1995, Gonzalez et al., 1998).  
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Disengagement 
The mother and daughter centrioles lose their fibrous intercentriolar link in late mitosis through the 
action of the APC, Seperase and Plk1 (Wang et al., 2008a, Tsou et al., 2009, Tsou and Stearns, 
2006, Nasmyth et al., 2000, Wang et al., 2008b). This disengagement allows the centrioles to 
duplicate in the subsequent S phase, allowing the centrosome cycle to continue. 
1.4 The spindle 
The production of mature centrosomes aids in the formation of the highly dynamic tubulin-based 
structure of the spindle, which is required to arrange chromosomes so that they can be equally 
separated into two daughter cells. The mitotic spindle begins to form in prometaphase, and by late 
prometaphase it is fully formed into two radial arrays of dynamically unstable microtubules. The 
spindle is subject to both physical and chemical factors, enabling the proper attachment, alignment 
and segregation of chromosomes (Figure 1.6) (Dumont and Mitchison, 2009, Rieder, 1981, Itabashi 
et al., 2009, Salmon, 1975, Sharp et al., 2000a, Manning and Compton, 2008, Nicklas and Ward, 
1994, Manneville and Etienne-Manneville, 2006, Grill and Hyman, 2005).  
1.4.1 Microtubule composition  
Each spindle fibre consists of α-/β-tubulin heterodimers, which can combine to form 
protofilaments that associate in sets of ten to fifteen in a parallel orientation to create a hollow 
tubulin cylinder known as a microtubule (Nogales et al., 1999). The asymmetry of the tubulin 
subunits confers different physical properties at either end of the microtubule, which allows the 
plus-ends to grow roughly three times faster than the minus-ends (Wiese and Zheng, 2006, Desai 
and Mitchison, 1997).  The growth of the polymers at either end occurs through the addition of 
tubulin dimers, which contain GTP in the nucleotide exchangeable site (E-site) within the β-tubulin 
of the dimer. Depolymerisation occurs upon the hydrolysis of the β-tubulin-bound GTP, which 
induces a conformational change and causes the peeling away of the individual protofilaments 
(Mandelkow et al., 1991, Nogales and Wang, 2006, Wang and Nogales, 2005). The ‘GTP cap’ 
model predicts that the integrity of the microtubule can be maintained by the ‘capping’ of the 
microtubule polymer with GTP-tubulin subunits, and when this cap is lost the parallel tubulin 
filaments peel outward and the microtubule rapidly depolymerises (for review see [Gadde and 
Heald, 2004]). This model indicates a degree of control over the stability of microtubules, a 
phenomenon that is verified by the observation that the rate of mitotic microtubule turnover that is 
ten-fold higher than that seen in interphase (Desai and Mitchison, 1997). The dynamic instability of  
K-fibre
Non-kinetochore
microtubules
Astral microtubules
Chromosome
Centrosome Microtubule
destabilisor
Tubulin polymer Microtubule
motor protein
Figure 1.6 Model of the mitotic spindle
The spindle is composed of kinetochore-fibres (K-fibres), non-kinetochore fibres and astral
microtubules. The structure and the function of the spindle are defined by the delicate
balancing of microtubule stability and movement, which are reliant on microtubule
associated proteins such as microtubule destabilisors and microtubule motor proteins
(figure amended from [Mollinedo and Gajate, 2003]).
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microtubules was investigated using photo-bleaching, which revealed that the turnover of tubulin 
subunits appeared to cause a flow or ‘flux’ of tubulin along the length of the microtubules towards 
the poles (Mitchison, 1989). These findings were advanced with the use of the ‘speckling’ 
technique, in which fluorescently labelled tubulin was incorporated into microtubules in a non-
uniformed manner, causing the fluorescent striping of microtubules (Waterman-Storer and 
Danuser, 2002). This allowed the visualisation of both microtubule flux and the stability of the 
microtubule lattice, thus revealing the dynamics of the spindle during the different phases of the 
cell cycle (for review see [Gadde and Heald, 2004]). 
1.4.2 Cellular microtubule dynamics 
The changes in microtubule dynamics throughout the cell cycle and the observation that cellular 
microtubule dynamics are highly different from those of microtubules formed in vitro out of pure 
tubulin, indicated that cells are able to regulate microtubule stability (reviewed in [Gadde and 
Heald, 2004]). This regulation has been attributed to the presence of microtubule associated 
proteins (MAPs), which have been implicated in the control of many areas of microtubule function 
(Walczak and Heald, 2008, Liska et al., 2004, Mack and Compton, 2001, Gaglio et al., 1996, 
Goshima et al., 2005a, Sharp et al., 2000b). MAPs have been found to be required from even the 
very beginning of spindle formation, with γ-TuRCs initiating microtubule nucleation (Moritz et al., 
1995). Additional MAPs such as the chTOG/XMAP215 and TACC family have been found to 
associate along the length of microtubules to increase their stability and even increase 
polymerisation, while other MAPs have been shown to bind exclusively to microtubule ends (for 
review see [Schuyler and Pellman, 2001, Howard and Hyman, 2003]; (Gard and Kirschner, 1987, 
Tirnauer et al., 2002, Gergely et al., 2000a, Lee et al., 2001)). EB1, EB2 and EB3 as well as 
Clip170 and 155 and the Clasps 1 and 2 have also been found to associate with the plus-ends of 
microtubules, and by doing so control microtubule stability and dynamics by reducing their 
depolymerisation and protecting against microtubule destabilising factors (Tirnauer and Bierer, 
2000, Akhmanova et al., 2001, Mimori-Kiyosue et al., 2005). MAPs have also been found to 
reduce microtubule stability by inducing deploymerisation or increasing the levels of 
depolymerisation. MAPs such as these include the depolymerising kinesins of the Kin I family, 
including MCAK, which can bind to microtubule ends, subsequently distorting the microtubule 
lattice and causing the energy dependent peeling away of microtubule protofilaments (Desai et al., 
1999). Similarly, Op18/stathmin can bind to tubulin dimmers stimulating microtubule catastrophe 
(Cassimeris, 2002), and Katanin can destabilise microtubules by either severing the fibres to reveal 
unstable ends that lack a GTP cap, or breaking microtubules directly at the centrosome (McNally et 
al., 2000).  
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The coordination of the MAPs therefore permits the regulation of microtubule dynamics, which can 
result in substantial pushing or pulling forces that are employed to position chromosomes and 
contribute to spindle positioning (Inoue and Sato, 1967, Dogterom and Yurke, 1997, Maiato et al., 
2005, Faivre-Moskalenko and Dogterom, 2002, Pearson and Bloom, 2004). A mechanism by 
which microtubules exude a pushing force on particular cellular components has been predicted to 
occur through a ‘Brownian ratchet’ method, whereby the formation of transient gaps between the 
plus-end of the microtubule and the bound object, allows the binding of tubulin subunits thus 
creating the pushing force (Peskin et al., 1993). Whether this model is accurate remains to be 
determined, although the existence of proteins associated at the plus-ends of microtubules 
complicates the model somewhat, and debate still remains about whether kinetochores are actually 
pushed by spindle forces (Akhmanova and Hoogenraad, 2005, Skibbens et al., 1993, Toso et al., 
2009, Waters et al., 1996, Khodjakov and Rieder, 1996). The pulling of chromosomes towards 
spindle poles is however an accepted method of chromosomal movement, which mainly occurs 
through K-fibre dynamics (Inoue and Salmon, 1995, Dumont and Mitchison, 2009).  
The control over microtubule dynamics is therefore clearly an important aspect of cellular function, 
however when microtubules reach a certain length or are under a high level of pressure, they can 
bend and even break (Holy et al., 1997, Waterman-Storer and Salmon, 1997, Janson et al., 2003, 
Tran et al., 2001). The detection of compression forces such as these may function as a method of 
controlling microtubule dynamics, as when spindles are placed in a compressed situation structural 
changes to the spindle are observed (Dumont and Mitchison, 2009). Microtubules also have a 
degree of elasticity (Gittes et al., 1993, Rubinstein et al., 2009), and are supported by the 
surrounding elastic cytoskeleton, which together allow the spindle to sustain relatively large 
compressive forces (Brangwynne et al., 2006, Itabashi et al., 2009).  
1.4.3 Actin cytoskeleton 
An interconnected actin-myosin micro-filamentous network present within cells enables them to 
withstand some of the contractile stress they experience (Wang et al., 2001, Ingber, 1993). The 
presence of a supportive structural network is demonstrated when the disruption of cellular tubulin 
microtubules does not change the spreading morphology of many cells, indicating that other 
architectural features are also at work (Domnina et al., 1985, Middleton et al., 1988, Ingber, 1993). 
The tensegrity hypothesis describes how the contraction and compression forces of microtubules 
and the cytoskeleton are balanced for normal cellular function, demonstrating the importance of the 
interconnected relationship between the microtubules and the cytoskeleton (Ingber, 1993). This 
relationship between tubulin microtubules and the actin cytoskeleton is further demonstrated in 
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migrating cells, when the organisation of the actin cytoskeleton influences the organisation of 
microtubules (Salmon et al., 2002). 
1.4.4 Spindle microtubules 
The mitotic spindle is made up of three categories of microtubule: kinetochore microtubules (K-
fibres), non-kinetochore microtubules, and astral microtubules (for recent review see (Dumont and 
Mitchison, 2009). 
K-fibres 
K-fibres are created from bundles of 10 to 30 microtubules which are either nucleated at 
centrosomes then captured by kinetochores, or are nucleated directly from kinetochores (Biggins 
and Walczak, 2003, Cleveland et al., 2003, Maiato and Sunkel, 2004). K-fibres are the most stable 
of the three types of microtubule present in the mitotic spindle (Zhai et al., 1995), and experience 
relatively slow rates of depolymerisation at or near the pole (Hyman and Mitchison, 1990, 
McDonald et al., 1992). K-fibre plus-ends that interact with chromosomes however, experience 
faster fluctuations (Hyman and Mitchison, 1990, McIntosh and Euteneuer, 1984).  The interaction 
between K-fibres and chromosomes occurs via kinetochores, which are protein complexes that are 
intimately associated with the centromeric DNA of each chromatid (Cooke et al., 1993, McEwen et 
al., 1993, Rieder, 1982).  
Non-kinetochore microtubules 
Non-kinetochore microtubules are bundles of relatively dynamic microtubules that span the 
distance between two spindle poles (Mastronarde et al., 1993). Unlike K-fibres, non-kinetochore 
microtubules do not attach to kinetochores, but instead perform structural roles such as defining the 
spindle pole position, while also possibly providing a method of motor protein driven chromosomal 
movement (Saxton et al., 1984, Burbank et al., 2006, Burbank et al., 2007, Inoue and Salmon, 
1995).  
Astral microtubules  
Astral microtubules are the third type of spindle microtubules, which have been found to be 
nucleated at the centrosomes where they are capped with γ-TuRC and have highly dynamic plus-
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ends. (Grill et al., 2003, Rusan et al., 2001). The major function of astral microtubules within the 
cell is the positioning of the spindle within the cell (Cowan and Hyman, 2004, Manneville and 
Etienne-Manneville, 2006). 
1.4.5 Spindle positioning 
The proper positioning of the spindle within cells permits chromosomes to first be appropriately 
positioned during metaphase, and then evenly segregated during cell division. The prevention of 
proper functioning of microtubule dynamics through the mutation of β-tubulin prevents the correct 
positioning of the spindle within cells, demonstrating the importance of microtubules during the 
positioning process (Wright and Hunter, 2003, Gupta et al., 2002). Furthermore, shortened astral 
microtubules are unable to properly position the spindle within C. elegans cells (Cowan and 
Hyman, 2004). Astral microtubules position the spindle by making physical contacts with the 
plasma membrane or the actin cytoskeleton, enabling force to be applied to the spindle (Manneville 
and Etienne-Manneville, 2006). Dynein, Dynactin and LIS1 have been implicated in the generation 
of the pulling force achieved by astral microtubules. Additionally, Dynein has also been attributed 
to controlling microtubule polymerisation dynamics (Dujardin and Vallee, 2002, Dujardin et al., 
2003, Hunter and Wordeman, 2000). Consistent with their role in astral microtubule spindle 
positioning, the leading-edge of migrating cells and the membranes of mitotic cells, have been 
shown to have enriched Dynein or Dynactin which associate with astral microtubule plus-ends 
(Dujardin et al., 2003, Busson et al., 1998, Skop and White, 1998). Dynein is also present at 
centrosomes, and has been found to have essential functions in the linking of the centrosome to the 
microtubule minus-ends (Askham et al., 2002). EB1, Adenomatous Polyposis Coli (APC), and 
Clips 170 and 155, are all also connected either directly or indirectly to Dynein to enable spindle 
positioning through the generation of plus-end astral microtubule forces (reviewed in [Manneville 
and Etienne-Manneville, 2006]). 
The importance of proper spindle positioning is observed during asymmetric cell division, which is 
employed by both single-cell organisms (such as yeast) and during stem cell division in 
multicellular organisms (reviewed in [Fraschini et al., 2008]).  Asymmetric cell division in 
multicellular organisms allows the generation of a daughter cell that is chemically different from its 
mother, permitting growth or the maintenance of tissue homeostasis. Through the regulation of 
astral microtubule pulling forces, G-proteins, PAR proteins and their regulators allow the spindle to 
be arranged in response to polarity factors (Gotta and Ahringer, 2001, Colombo et al., 2003, 
Srinivasan et al., 2003, Grill et al., 2003, Labbe et al., 2003, Ahringer, 2003). The positioning of 
the spindle is monitored by the spindle position checkpoint which delays cytokinesis until the DNA 
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is deposited into both mother and daughter cells. This mechanism inhibits the signalling of the 
mitotic exit network (MEN) in budding yeast, and the septation-initiation network (SIN) in fission 
yeast (for review see [Bardin and Amon, 2001]). Experiments in fission yeast have also revealed 
that the integrity of the actin cytoskeleton is also monitored by the spindle position checkpoint 
((Gachet et al., 2001); reviewed in [Gachet et al., 2006]).  
1.4.6 Spindle length 
Similar to spindle positioning within the cell, spindle length is defined by a number of antagonistic 
pushing and pulling forces (Sharp et al., 1999). Molecular motor proteins cause antiparallel 
microtubules to slide apart, therefore when mid-zone microtubules are disrupted, the poles of 
spindles move in towards the centre of the cell (Leslie and Pickett-Heaps, 1983, Tolic-Norrelykke 
et al., 2004). In addition to experiencing connected movements, centrosomes within vertebrate 
prometaphase cells also experience independent movement, indicating that antiparallel sliding is 
not the only spindle length determinant (Waters et al., 1993). Astral microtubules have been 
implicated in the divergence of centrosomes in interphase and during mitosis (Waters et al., 1993, 
Vogel et al., 2007, Tolic-Norrelykke et al., 2004). Much of this astral microtubule-dependent 
movement is attributed to the connections with the cell cortex that are mediated by Dynein, which 
generates pulling forces, aiding both spindle positioning and elongation (Fink et al., 2006). By 
attaching the spindle to the cortex in this way, astral microtubules can coordinate the length of the 
spindle with that of the cell (Schultz and Onfelt, 2001). In addition to aiding to formation of a 
bipolar spindle, astral microtubules can also limit centrosome separation during anaphase, and 
when severed, the poles are permitted to separate at a faster pace (Aist and Berns, 1981, Aist et al., 
1993).  
1.4.7 Motor MAPS 
As well as regulating spindle length and stability, microtubule associated proteins also promote 
spindle bipolarity by cross-linking microtubules, as well as by transporting cargo along 
microtubules (Walczak et al., 1998, Walczak and Heald, 2008, Wittmann et al., 2001). Motor 
MAPs walk either towards the minus- or plus-ends of microtubules, and by doing so generate 
force. This method of force generation allows the motors to move objects along microtubules, 
move and arrange microtubules or regulate microtubule stability. 
The kinesin-5 motor protein family (Eg5 in human cells) associate preferentially to spindle fibres 
arranged in an antiparallel fashion, where they move along in a plus-end directed manner, causing 
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the sliding apart of the fibres, aiding the formation of bipolar spindles (Kapitein et al., 2005, van 
den Wildenberg et al., 2008, Sharp et al., 1999, Mayer et al., 1999, Brust-Mascher et al., 2009). 
The localisation of Eg5 to spindle microtubules is dependent on a phosphorylation from Cdk1, and 
when localised, its positioning is surprisingly unaffected by microtubule flux (Blangy et al., 1995, 
Sawin and Mitchison, 1995, Kapoor and Mitchison, 2001).  
Similar to the kinesin-5 motor protein family, the minus-end directed kinesin-14 motor proteins 
(HSET in human cells) aid spindle formation by cross-linking fibres, locking together parallel 
microtubules and sliding apart adjacent antiparallel microtubules (Fink et al., 2009, Mountain et al., 
1999, Tao et al., 2006). Similarly, Dynein and Dynactin cross-link microtubule free-ends enabling 
the rearrangement of microtubules and spindle pole focusing (Fink et al., 2006, Verde et al., 1991, 
Gaglio et al., 1997).  
The balancing of forces of motor proteins such as those described, allows the maintenance of a 
steady state spindle length, as well as focusing the spindle poles and organising the spindle 
structure (Burbank et al., 2007). Adding to their roles in spindle organisation, kinesin-5 and -14 
have also been associated with microtubule dynamics by promoting plus-end disassembly in yeast 
(Sproul et al., 2005, Gardner et al., 2008). When the finely tuned balance of kinesins is disrupted, 
such as when using Monastrol to allosterically inhibit Eg5 activity, the spindle structure is 
disrupted. Monastrol works by reducing the motorised movement of Eg5 along microtubules and 
even causes a decrease in Eg5 microtubule association, leading to the collapse of bipolar spindles 
(Kwok et al., 2006, Cochran and Gilbert, 2005, Cochran et al., 2005).  
In addition to motor proteins on antiparallel microtubules, the presence of plus-end directed Kin N 
kinesins on chromosome arms also contributes to movement within the spindle. These motor 
proteins cause the chromosome arms to be pushed away from the spindle poles by their interaction 
with non-kinetochore microtubules, producing a phenomenon called the ‘polar ejection force’ 
(reviewed in [Heald, 2000]). With increased distance from the spindle pole, the polar ejection 
forces decrease, thus producing a steady-state chromosome position (Rieder et al., 1986, Ke et al., 
2009). The kinesin, Kid, has been proposed to be responsible for producing the polar ejection force 
in vertebrate cells (Levesque and Compton, 2001). Indeed, Kid inhibition reduces the distance of 
chromosomes from the poles, highlighting its role in chromosome positioning, however because 
the length of bipolar spindles is only reduced by 20% in mammal cells and spindle lengths are 
unaffected in Xenopus extracts, additional methods of maintaining chromosome positioning are 
clearly in place (Tokai-Nishizumi et al., 2005, Funabiki and Murray, 2000, Levesque and 
Compton, 2001).  
  42 
 
  
Lateral microtubule connections with the kinetochore also cause the movement of chromosomes 
towards poles, a movement that has also been attributed to the presence of motor proteins (Rieder 
and Alexander, 1990, Merdes and De Mey, 1990). Consistent with the existence of motor proteins 
at the kinetochores, the Kin N plus-end directed motor CENP-E has been detected at kinetochores 
and is required for chromosome positioning (Gadde and Heald, 2004). Despite the clear role for a 
variety of motor proteins in the movement of chromosomes and the maintenance of the spindle 
length, deletion of minus-end directed motor proteins in yeast did not appear to affect chromosomal 
movement, indicating that microtubule dynamics play a major role in the process (Grishchuk and 
McIntosh, 2006).  
In addition to their described roles in the proper alignment of chromosomes, MAPs are also 
required to regulate the structure of the spindle after chromatid separation. During anaphase, many 
MAPs associate with the central spindle in order to regulate the process. The most well 
characterised of these MAPs are Centralspindlin, Protein regulating cytokinesis 1 (PRC1), and the 
Chromosome Passenger Complex (CPC) (reviewed in [Glotzer, 2009]). PRC1 in human cells 
cross-links antiparallel microtubules of the spindle, enabling the establishment of the spindle 
midzone to allow additional MAPs to bind and regulate cytokinesis (Zhu et al., 2006, Schuyler et 
al., 2003, Jiang et al., 1998, Peterman and Scholey, 2009). PRC1 also directly binds to Plk1 during 
anaphase, an interaction that is required from the completion of cytokinesis (Neef et al., 2007). 
Similarly, the Centralspindlin complex, consisting of a dimmer of a kinesin-6 motor protein 
(MKLP1) bound to a dimmer of the Rho family GTPase activating protein (GAP) CYK4, also 
promotes microtubule bundling which is required for cytokinesis (Pavicic-Kaltenbrunner et al., 
2007, Mishima et al., 2002). Proteins which are localised to the spindle midzone include the CPC, 
who’s localisation to the area is thought to be dependent on INCENP (inner-centromere binding 
protein) (Wheatley et al., 2001).  
Some MAPs are also directly responsible for the movement and transport of cellular components 
throughout the spindle. NuMA is transported to the minus-ends of microtubules by 
Dynein/Dynactin, where it serves a role in spindle pole cohesion (Merdes et al., 2000). Dynein 
itself is also positioned at the microtubule ends at the cell cortex, and so can also help to orient 
astral microtubules (Gadde and Heald, 2004, Vaughan et al., 2002). 
1.4.8 MAP regulation  
MAPs clearly have a huge diversity of actions, and their delicate coordination is highly 
complicated. MAPs are involved in numerous signalling pathways, a feature that was uncovered 
through the identification of many novel phosphorylation sites on spindle proteins (Nousiainen et 
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al., 2006, Manning and Compton, 2008, Nigg, 2001a).  The balancing of these signalling pathways 
enables the coordination of microtubule dynamics and the development of the spindle structure 
(Howard and Hyman, 2007). 
It is predicted that much of the control over MAPs and their signalling pathways occurs by a 
gradient of morphogens, which diffuse from a source in the chromatin, producing activity gradients 
that define areas of microtubule nucleation and stabilisation (Caudron et al., 2005). Ran-GTP and 
Aurora B kinase activity have been identified as diffusible spindle morphogens (for review see 
[Dumont and Mitchison, 2009]; (Kalab et al., 2006, Caudron et al., 2005, Fuller et al., 2008)). In 
addition to chromosome derived morphogen gradients, spindle poles have also been implicated in 
generating gradients of regulatory factors able to contribute to the formation of the spindle 
(Greenan et al., 2010).  
A sub-category of proteins involved in the signalling pathways are kinases, enzymes which 
phosphorylate specific protein substrates by transferring a phosphate group from a donor molecule, 
such as ATP, to specific sites on the substrate protein. This phosphorylation event can modify the 
activity or localisation of the involved proteins, thus allowing the transmission of chemical signals. 
Protein kinases mediate the majority of signal transduction in eukaryotic cells, and have been found 
to govern the regulation of the spindle assembly, making analysis of these enzymes an essential 
precursor to understanding the functioning of life processes (Manning et al., 2002). The 
misregulation of kinases has also been linked to the onset of disease, demonstrating the important 
regulatory roles they hold (Blume-Jensen and Hunter, 2001, Malumbres and Barbacid, 2007).  
1.5 An overview of the Aurora kinase family   
The Aurora kinases are a family of highly conserved kinases, which phosphorylate the OH group of 
a serine or threonine residue within specific target proteins, and are therefore known as 
serine/threonine kinases. The Aurora kinases contribute to the intricate control of the cell cycle 
from G2 through to cytokinesis in organisms ranging from yeast to humans. Yeast only have one 
Aurora kinase, whereas higher organisms have at least two Aurora family members called Aurora 
A and Aurora B in mammalian cells. A third Aurora kinase, Aurora C, is also seen in specific 
mammalian meiotic cells (for review see [Andrews et al., 2003, Carmena and Earnshaw, 2003]; 
(Chan and Botstein, 1993, Glover et al., 1995, Girdler et al., 2006, Terada et al., 1998, Bernard et 
al., 1998, Marumoto et al., 2003, Kimmins et al., 2007)).  
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1.5.1 The Aurora kinases in Yeast 
The importance of the Aurora family was revealed after certain mutant budding yeast strains 
experienced a gain of chromosomes or ‘increase in ploidy’ after mitosis (Chan and Botstein, 1993). 
Molecular cloning and genetic mapping of the mutant stains identified an uncharacterised gene, 
which was aptly named ‘Increase in Ploidy 1’ (Ipl1). Ilp1 was later recognised as the only Aurora 
family member present in budding yeast and was found to be localised to both the mitotic spindle 
and kinetochores, co-localising with and phosphorylating various kinetochore proteins on an 
Aurora consensus site (Kang et al., 2001, Cheeseman et al., 2002, Biggins et al., 1999, Hsu et al., 
2000). Ipl1 was found to govern kinetochore-microtubule interactions by altering the connections 
in response to the low tension they generated at kinetochores (Pinsky et al., 2006, Biggins and 
Murray, 2001, Biggins et al., 1999, Chan and Botstein, 1993, Tanaka et al., 2002).   
Fission yeast also contains a single member of the Aurora kinase family, named Aurora related 
kinase 1 (Ark1). Similar to Ipl1, Ark1 localises to kinetochores and centromeres during mitosis, 
and transfers to the mitotic spindles during anaphase (Petersen et al., 2001). Furthermore, Ark1 has 
been found to phosphorylate histone H3, contribute to kinetochore activity and regulate spindle 
formation (Petersen et al., 2001). Unlike its budding yeast cousin however, the fission yeast Aurora 
kinase was found to be required for a cellular response to the lack of microtubule-kinetochore 
attachment, as well as controlling the alteration of low tension connections (Petersen and Hagan, 
2003).  
1.5.2 The Aurora kinase family in higher organisms 
The three different Aurora kinase homologues in mammalian cells have varying peptide lengths but 
are highly similar in terms of structure and sequence, with a 70% degree of homology in their 
catalytic domain (Figure 1.7A)(for review see [Keen and Taylor, 2004]). Despite these similarities, 
the different Aurora kinase family members localise to distinct areas and exhibit divergent 
functions during mitosis (Giet and Prigent, 1999, Giet and Glover, 2001, Carmena and Earnshaw, 
2003, Bischoff et al., 1998, Crosio et al., 2002). 
1.6 Aurora A kinase  
Aurora A kinase activity is the target of a number of promising cancer therapies currently in 
development, making it an extremely interesting kinase both clinically and academically 
(Karthigeyan et al., 2010, Ochi et al., 2009). Despite this, at the begining of this project, relatively 
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little was known regarding the kinase and its activity, making it an ideal topic for investigation and 
thus the focus of this research project. 
1.6.1 Aurora A kinase localisation 
Aurora A protein is present throughout the whole cell cycle, although from G1 to S it is only 
present at low levels. The protein localises to the centrosomes immediately after S phase, after 
which its levels increase, reaching a peak early in mitosis (Kimura et al., 1997, Bischoff et al., 
1998, Roghi et al., 1998).  
Human Aurora A is targeted to centrosomes by its first 310 amino acids, a localisation which is 
thought to be stabilised by its catalytic C-terminus interacting with centrosome components, such 
as the motor protein Eg5 (Giet and Prigent, 2001, Roghi et al., 1998, Stenoien et al., 2003). The 
protein remains in constant and rapid flux throughout mitosis, travelling between the centrosomes 
and the adjacent microtubules to the cytoplasm, which is indicative that Aurora A’s major 
functions lie in regulatory signalling, rather than having structural roles (Berdnik and Knoblich, 
2002, Stenoien et al., 2003).  
1.6.2 Aurora A kinase Activity 
Aurora A kinase is initially activated during late G2 through a phosphorylation which occurs on a 
T-loop residue (T288 in humans) within its catalytic domain (Figure 1.7B) (Cheetham et al., 2002, 
Van Horn et al., 2010, Walter et al., 2000, Ohashi et al., 2006, Dodson et al., 2010). In its active 
state, the flexible T-loop is positioned so that the phosphorylated T288 is exposed to the solvent, 
where an inactivating dephosphorylation by protein phosphatase 1 (PP1) can take place (Walter et 
al., 2000).  Aurora A can also phosphorylate and inhibit PP1 activity during mitosis, while the 
regulatory subunit of PP1, Inhibitor 2, has also been shown to bind to and activate Aurora A in 
vitro, indicating the presence of a feedback loop (Katayama et al., 2001, Satinover et al., 2004). A 
second protein phosphatase, PP2A, has also been shown to both indirectly and directly inactivate 
Aurora A kinase activity either by dephosphorylating it or by stabilising Securin,  which can then 
inhibit the kinase (Eyers et al., 2003, Horn et al., 2007, Tong et al., 2008). Similarly, p53 can also 
inhibit Aurora A either indirectly through regulating the transcription of a secondary protein, or 
directly when co-localised with the kinase at the centrosome (Shao et al., 2006). 
Aurora A activity has been shown to be further regulated by the condensation of chromatin which 
activates Ran (a small GTPase), stimulating the release of TPX2 (targeting protein for Xklp2) from 
an inhibitory complex (Kufer et al., 2003, Kufer et al., 2002).  TPX2 binds to the N-terminus of 
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Aurora A, inducing a conformational change which allows the autophosphorylation of Thr288 on 
the T loop of the kinase (Eyers et al., 2003). The bound TPX2 also prevents its dephosphorylation 
by protein phosphatase 1 (PP1) (Eyers et al., 2003, Tsai et al., 2003, Kufer et al., 2003, Kufer et al., 
2002, Bayliss et al., 2003). The interaction with TPX2 localises Aurora A to the mitotic spindle, 
and although attachment to microtubules is not essential, it has been shown to enhance activation 
(Gruss et al., 2001, Eyers and Maller, 2004, Bayliss et al., 2003). TPX2 is also phosphorylated by 
Xenopus Plk1, which increases the activation of Aurora A (Eckerdt et al., 2009).  Interestingly, 
building a spindle of the correct length requires the interaction between TPX2 and Aurora A, 
highlighting the importance of the TPX2 activation of Aurora A (Bird and Hyman, 2008).  
Aurora A also interacts with the LIM domain-containing protein, Ajuba, which promotes the 
phosphorylation and full activation of Aurora A (Hirota et al., 2003, Goyal et al., 1999). The 
depletion of Ajuba has been shown to prevent the activation of Aurora A at centrosomes (Hirota et 
al., 2003). p21-activated kinase 1 (Pak1), a protein important for regulating focal adhesions, can 
also bind to Aurora A, promoting the phosphorylation of Aurora A at both Thr288 and Ser342 
(Zhao et al., 2005). Furthermore, Arpc1b, a component of the actin related protein 2/3 (Arp2/3) 
complex which initiates the formation of actin filaments and has also been found to activate Aurora 
A and thus may aid centrosome maturation (Zigmond, 1998, Goley et al., 2006, Goley and Welch, 
2006, Molli et al., 2010). The depletion or inhibition of Integrin-linked kinase (ILK), which has 
role in focal adhesions, also prevents Aurora A from regulating TACC3, possibly indicating a 
further method of Aurora A activation (Fielding et al., 2008).  
When activated at centrosomes during late G2, Aurora A activates Plk1 through a phosphorylation 
event which is greatly enhanced by Bora, an Aurora A co-factor (Macurek et al., 2008, Hutterer et 
al., 2006). Plk1 has also been shown to regulate Aurora A through Bora, indicating a feed-forward 
mechanism in promoting the activation of both kinases (Chan et al., 2008, Seki et al., 2008).  
1.6.3 The role of Aurora A kinase in bipolar spindle assembly 
Aurora A kinase has been found to serve several functions within the cell, the first of which was 
reported through work with Drosophila embryos which displayed monopolar spindles after the 
inaction of the kinase (Glover et al., 1995). The inactivation of Aurora A kinase activity was later 
observed to also cause the occurrence of monopolar spindles in a range of other organisms from 
Xenopus to humans (Roghi et al., 1998, Girdler et al., 2006, Hannak et al., 2001, Mori et al., 2007, 
Liu and Ruderman, 2006). Indeed, Aurora A inactivation has been shown to cause the collapse of a 
previously assembled bipolar spindles in Xenopus egg extracts (Giet and Prigent, 2000). Other 
reports have alternatively described the formation of ‘abnormal spindles’, in the absence of Aurora 
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A activity, whereby centrosomes were able to separate, but spindles were disorganised (Berdnik 
and Knoblich, 2002, Giet et al., 2002, Schumacher et al., 1998b, Ozlu et al., 2005, Peset et al., 
2005, Hoar et al., 2007, Manfredi et al., 2007). This inconsistency may be due to the different 
experimental strategies employed, however both reports highlight the requirement for Aurora A 
activity in normal bipolar spindle formation.  
Another protein involved in bipolar spindle assembly is the motor protein Eg5, which has been 
shown to interact with and be phosphorylated by Aurora A, possibly indicating an additional 
method by which Aurora A activity controls bipolar spindle formation (Walczak et al., 1998, Giet 
and Prigent, 2000, Giet et al., 1999, Mayer et al., 1999, Kapitein et al., 2005, Koffa et al., 2006). 
Similarly, Aurora A kinase has also been found to interact with and phosphorylate the spindle 
associated protein ASAP (Aster-Associated Protein), which has been found to be required for 
spindle assembly and timely mitotic progression (Saffin et al., 2005). When Aurora A is prevented 
from doing so, ASAP is destabilised  and spindle assembly, spindle pole integrity and even cell 
division are compromised, providing an additional method of Aurora A control over spindle 
formation (Venoux et al., 2008, Eot-Houllier et al., 2010). Additionally Aurora A activity is 
required for the efficient microtubule nucleation of astral microtubules, and therefore the role for 
the kinase in bipolar spindle formation may also be derived from its regulation of these pulling 
forces (Kinoshita et al., 2005, Motegi et al., 2006, Giet et al., 2002, Rosenblatt et al., 2004).  
Aurora A also regulates the activity and localisation the microtubule depolymerisors Kif2a and 
MCAK (or Kif2c), which have been shown to have distinct roles, although both contribute to the 
formation of bipolar spindles (Ganem and Compton, 2004). In Xenopus egg extracts, MCAK 
activity and localisation to Ran asters and spindle poles was found to be regulated by Aurora A 
activity (Zhang et al., 2008). These phosphorylation events were required to aid both  centrosome-
independent pole focusing and bipolar spindle formation (Zhang et al., 2008). Aurora A also 
interacts with and phosphorylates Kif2a, a microtubule depolymerise required for spindle assembly 
and chromosome congression, consequently suppressing Kif2a depolymerise activity (Jang et al., 
2008, Jang et al., 2009). Aurora A inhibition was shown to increase Kif2a on spindle microtubules, 
causing a reduction in microtubule polymers (Jang et al., 2009). Kif2a is also positively regulated 
by Plk1, and due to the interconnected nature of Aurora A and Plk1 throughout mitosis discussed 
previously in this introduction, this antagonistic regulation demonstrates an intriguing and complex 
method of controlling Kif2a activity (Jang et al., 2009). The balancing of depolymerises such as 
MCAK and Kif2a enables the highly dynamic structure of the spindle to remain remarkably 
constant.  
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1.6.4 The role of Aurora A kinase in centrosome-independent bipolar spindle assembly 
Aurora A kinase has also been found to be required for the nucleation, stabilisation and focusing of 
microtubules as well as the formation of bipolar spindles in environments which lack centrosomes. 
In Xenopus egg extracts which lack chromosomes and centrosomes Aurora A is responsible for 
enhancing Ran-GTP-induced bipolar spindle assembly through promoting the formation of a 
particular complex. This complex comprises of the microtubule cross-linking and bipolar spindle 
promoting proteins Eg5 and TPX2 (Kapitein et al., 2005, Manning and Compton, 2007), the 
microtubule stabiliser chTOG/XMAP215, the microtubule bundler HURP (Koffa et al., 2006, Sillje 
et al., 2006) and Aurora A itself (Berdnik and Knoblich, 2002, Liu and Ruderman, 2006). When 
correctly assembled, the different components of the complex work together to provide an method 
of microtubule nucleation and spindle assembly, which is completely independent of centrosomes. 
The requirement for Aurora A in centrosome-independent bipolar spindle assembly highlights the 
kinase’s strong connection with the organisation of microtubules and regulation of microtubule 
stability and prominent role in bipolar spindle formation.  
1.6.5 The role of Aurora A kinase in centrosome maturation 
In addition to regulating the formation of a normal bipolar spindle, Aurora A promotes the proper 
maturation of centrosomes (Hannak et al., 2001, Mori et al., 2007, Berdnik and Knoblich, 2002, 
Giet et al., 2002, Barros et al., 2005, Terada et al., 2003, Hirota et al., 2003, Greenan et al., 2010). 
The maturation of centrosomes increases both their size and nucleation capacity, enabling the 
organised growth of the mitotic spindle (Greenan et al., 2010, Hannak et al., 2001, Khodjakov and 
Rieder, 1999, Piehl et al., 2004). By causing the maturation of the centrosomes, a positive feedback 
loop is created, which promotes further Aurora A recruitment to the centrosome, thus amplifying 
the maturation (Portier et al., 2007).  
 As discussed earlier, centrosomal maturation is an essential step in the organisation and nucleation 
of the mitotic spindle, involving the recruitment of many different proteins, a process found to 
involve Aurora A activity (Hannak et al., 2001, Berdnik and Knoblich, 2002). Aurora A stimulates 
the recruitment of the essential centrosomal component γ-tubulin to the spindle poles, through 
controlling Centrosomin (CNN) in Drosophila and Lats2 in human cells (Berdnik and Knoblich, 
2002, Toji et al., 2004, Terada et al., 2003, Abe et al., 2006). The integrity of the centrosome and 
the organisation of the spindle poles are also proposed to be regulated by Aurora A which, through 
an interaction with Astrin, controls Seperase activity (Gruber et al., 2002, Thein et al., 2007, Yuan 
et al., 2009). Astrin has also been shown to be involved in the localisation of Aurora A to mitotic 
  50 
 
  
spindles, and depleting Astrin levels causes a mitotic arrest similar to that seen after the depletion 
of Aurora A protein (Du et al., 2008).  
The recruitment of TACC3 (transforming acidic coiled coil protein 3) to the centrosome and 
spindle microtubules is also controlled by its direct phosphorylation by Aurora A, or by an indirect 
phosphorylation by Plk1 (Giet et al., 2002, Mori et al., 2007, Barros et al., 2005, Kinoshita et al., 
2005, LeRoy et al., 2007). Interestingly, cells with inactivated Plk1 have reduced centrosome 
maturation and form monopolar spindles, thus highlighting the importance of the kinase in 
centrosome maturation (Lane and Nigg, 1996, Sumara et al., 2004, Lenart et al., 2007) 
Furthermore, the immunodepletion of Aurora A or the prevention of Aurora A phosphorylation of 
TACC, reduces the level of microtubules nucleated from centrosomes, particularly in the case of 
astral microtubules (Barros et al., 2005, Wang et al., 2008a).  
The recruitment of phosphorylated TACC3 stabilises centrosomal microtubules through loading 
chTOG/XMAP215 to the minus-ends of centrosome microtubules (Barros et al., 2005, Kinoshita et 
al., 2001, Kinoshita et al., 2005, Peset et al., 2005, Lee et al., 2001, Gergely et al., 2003). The 
protein known as XMAP215 was first identified in Xenopus egg extracts, were it was found to 
increase the elongation rate of microtubules in vitro (Gard and Kirschner, 1987). The function of 
the protein in increasing microtubule length and mass was determined to be derived through the 
promotion of the polymerisation rate, the slowing in the switching between microtubule 
polymerisation and depolymerisation states, and encouraging the formation of highly dynamic 
microtubules, all of which have particular importance in mitosis (for review see [(Peset and 
Vernos, 2008]). This was later found to be due to the proteins ability to counter the microtubule 
destabilising activity of MCAK (Tournebize et al., 2000). XMAP215 was subsequently discovered 
to be related to a human protein which was over-expressed in tumour cells called chTOG (colonic 
and hepatic tumour over-expressed protein). Depletion of chTOG/XMAP215 produces 
disorganised spindles consisting of relatively robust microtubules (Gergely et al., 2003, Cassimeris 
and Morabito, 2004). The interaction between Aurora A and TACC3/chTOGXMAP215 is 
maintained by the serine/threonine kinase and scaffold protein Integrin-like kinase (ILK), and its 
depletion or inhibition disrupts spindle organisation (Fielding et al., 2008). 
1.6.6 The role of Aurora A in mitotic entry  
The part played by Aurora A in centrosome maturation extends to the regulation of the entry into 
mitosis. Cells depleted of Aurora A experience delays in their nuclear envelope breakdown, 
although the timing of chromosome decondensation is not altered. This phenotype is also seen after 
the prevention of centrosome maturation, further supporting the notion that Aurora A activity is 
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involved in the maturation of the centrosome (Liu and Ruderman, 2006, Hachet et al., 2007, Portier 
et al., 2007). Consistent with its role in promoting mitotic entry, Aurora A has been shown to 
phosphorylate Cdc25B (Dutertre et al., 2004, Cazales et al., 2005), which promotes the activation 
of Cyclin B1-Cdk1and the entry into mitosis (Hirota et al., 2003). Aurora A has also been linked to 
the regulation of the translation Cyclin B1 in late G2, which can then be recruited to the 
centrosome to further promote mitotic entry (Hirota et al., 2003, Warner et al., 2003). Aurora A 
kinase may also control mitotic entry through regulating the threshold of Cyclin B1 that permits the 
entry into mitosis, with delays in the entry to mitosis reported to occur due to an increase in Cyclin 
B1 threshold in interphase cells following the depletion of Aurora A (Satinover et al., 2006, 
Satinover et al., 2004). Cyclin B1-Cdk1 activation is also accentuated by the activation of Plk1 by 
Aurora A and Bora, which initiates mitotic entry following a checkpoint dependent arrest (Lenart et 
al., 2007, Qian et al., 1998, van Vugt et al., 2004, Macurek et al., 2008, Seki et al., 2008, Van Horn 
et al., 2010).  
1.6.7 Aurora A kinase degradation 
At anaphase and early G1, the presence of Aurora A is reduced through ubiquitin-dependent 
proteolysis by the APCCdh1 complex (Marumoto et al., 2002, Gurden et al., 2010, Marumoto et al., 
2003). Degradation of the protein is dependent on the recognition of two motifs: a destruction box 
(D box) at the C-terminus, and an A-box in the N-terminus (Honda et al., 2000, Castro et al., 2002). 
This process is regulated by a phosphorylation at Ser51, which renders the kinase resistant to APC 
mediated degradation and by AIP (Aurora A kinase-interacting protein), which counters this event 
by initiating its proteosome dependent degradation (Kiat et al., 2002). 
1.7 Aurora B kinase 
1.7.1 Aurora B activation and localisation 
Aurora B kinase forms part of a multimeric chromosome passenger complex (CPC) made up of 
INCENP, Survivin and Borealin, which brings about the activation of Aurora B kinase by causing a 
conformational change in its structure and localising it to the chromosomes (Vader et al., 2006a, 
Uren et al., 2000, Wheatley et al., 2001, Bishop and Schumacher, 2002, Bolton et al., 2002, 
Vagnarelli and Earnshaw, 2004, Sessa et al., 2005, Jeyaprakash et al., 2007, Kelly et al., 2007, 
Jelluma et al., 2008).  
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On entry to mitosis the CPC is localised to the arms of chromosomes and inner centromere. The 
proportion of the CPC localised to the chromosome arms decreases as cells progress through 
mitosis, with the majority targeted instead to the inner centromere (Beardmore et al., 2004). Aurora 
A may also be indirectly responsible for the concentration of Aurora B to the inner centromere and 
even kinetochore function through the phosphorylation of CENP-A on Ser7 during prophase 
(Kunitoku et al., 2003). Similarly, Disc-60kD (TD-60), a protein required for the progression from 
prometaphase to metaphase, is also involved in localising Aurora B to centromeres and is required 
for Aurora B to reach its full activation (Mollinari et al., 2003, Rosasco-Nitcher et al., 2008). At 
anaphase the localisation of the complex changes again, relocalising to the spindle midzone. The 
activation of Aurora B at its various localisations is balanced by inhibitory agents such as PP1, 
PP2A and BubR1, which negatively regulate its action (Sugiyama et al., 2002, Lampson and 
Kapoor, 2005, Sun et al., 2008).  
1.7.2 The role of Aurora B kinase and chromosome alignment 
Like the yeast Aurora kinase Ipl1, Aurora B is proposed to sense microtubule-kinetochore 
interactions, and consequently promote chromosome biorientation through destabilising 
kinetochore attachments that induce low tension (Ditchfield et al., 2003, Hauf et al., 2003, Tanaka 
et al., 2002, Sampath et al., 2004, Liu and Lampson, 2009). Microtubule connections are altered by 
Aurora B through targeted phosphorylation of MCAK and Kif2b, which controls their localisation 
and therefore their action at centromeres (Andrews et al., 2004, Gorbsky, 2004, Tanaka et al., 2002, 
Ducat and Zheng, 2004, Kline-Smith et al., 2004, Lan et al., 2004, Bakhoum et al., 2009). Aurora B 
within the CPC also controls the recruitment of a number of additional proteins to centromeres 
such as CENP-E, Dynein, Ndc80 and Plk1, which have been linked to kinetochore function and 
microtubule-kinetochore stability, indicating a possible method of control over microtubule 
attachment (Ditchfield et al., 2003, Murata-Hori and Wang, 2002, Cheeseman et al., 2006, Deluca 
et al., 2006, Goto et al., 2006). 
1.7.3 The role of Aurora B kinase in cytokinesis 
The CPC has also been implicated as a key instigator of the segregation of cellular material and 
cytokinesis, a process which begins with furrow ingression during anaphase and ends with the 
cleavage into two separate daughter cells (Giet and Glover, 2001, Guse et al., 2005, Fuller et al., 
2008).  Aurora B activity also regulates the abscission of cells by stabilising the bridge when 
chromatin from unsegregated chromosomes is trapped in the cleavage furrow (Steigemann et al., 
2009). The various roles of Aurora B and the CPC in cytokinesis demonstrates the kinase’s 
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importance for protecting against tetraploidy. Indeed, the use of small molecule inhibitors to probe 
the role of Aurora B activity have revealed that the inhibition of the kinase produced chromosome 
alignment defects, problems with cytokinesis and aneuploidy (Ditchfield et al., 2003, Hauf et al., 
2003).  
1.8 Aurora C kinase 
A high degree of homology occurs between the kinase domains of Aurora B and C (83%), however 
out of the Aurora kinase family members, the function of Aurora C remains the most elusive 
(Katayama et al., 2003, Keen and Taylor, 2004).  
Aurora C kinase has been found to be expressed in meiotically dividing spermatocytes and oocytes 
(Yanai et al., 1997, Bernard et al., 1998, Tseng et al., 1998, Kimura et al., 1999, Li et al., 2004, 
Tang et al., 2006, Yang et al., 2010b, Chen et al., 1998). Similar to the described localisation of 
Aurora B kinase during mitosis, in mouse meiosis Aurora C has been detected on chromosome 
arms and centromeres, before accumulating on the spindle midzone and midbody during anaphase 
and telophase (Tang et al., 2006, Yang et al., 2010b). This sequence of localisation has given rise to 
the theory that Aurora C may function as a meiotic chromosomal passenger protein like Aurora B 
during female mouse meiosis (Yang et al., 2010b). Indeed, Aurora C has been shown to be 
recruited by INCENP (Chen et al., 2005a), and prologues of additional components of the CPC 
such as Survivin, Borealin and INCENP have been identified in Drosophila meiosis, possibly 
representing a method of meiosis specific Aurora C regulation (Gao et al., 2008). Furthermore, an 
Aurora C kinase-dead dominant negative mutant was found to prevent the localisation of Bub1 and 
BubR1 to the kinetochore in female mouse meiosis (Yang et al., 2010b).  
Merotelic and syntelic attached chromosomes were also seen in meiosis after depletion of active 
Aurora C, indicating that, like Aurora B kinase, Aurora C may also have a role in correcting 
microtubule kinetochore attachments (Yang et al., 2010b). Cells exposed to dominant negative 
kinase-dead Aurora C exhibit cytokinesis failure after MI, consequently producing a polyploidy 
after meiosis in mice (Dieterich et al., 2009, Dieterich et al., 2007).  
Importantly however, Aurora C knockout mice were viable, despite being sterile (Kimmins et al., 
2007), and the loss of a functional Aurora C gene in female oocytes inferred only minor effects to 
oogenesis (Kimmins et al., 2007, Hu et al., 2000, Dieterich et al., 2009). These relatively mild 
effects of the Aurora C kinase’s depletion with no discernable effects to mitotic cells, are in stark 
contrast to the more severe effects seen after the depletion other two Aurora kinase family 
members (Girdler et al., 2006). 
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1.9 Cancer and the Aurora Kinase family 
In recent years the Aurora kinases have raised significant interest due to reports of their over-
expression in various cancers (Mountzios et al., 2008).  
1.9.1 Cancer and Aurora A kinase 
Aurora A is mapped to the chromosome region 20q13.2, which has also been found to be 
frequently amplified in a range of cancers, indeed the over-expression of Aurora A had been 
detected in tumours including breast, bladder, ovarian, colon and pancreatic human cancers 
(Katayama et al., 2003, Karthigeyan et al., 2010, Bischoff et al., 1998, Mountzios et al., 2008). This 
strong correlation between Aurora A over-expression and transformation consequently makes it a 
potential prognostic or malignancy marker as well as a promising anti-cancer target (Dutertre et al., 
2002). 
Further supporting the link between Aurora A activity and cancer susceptibility, the over-
expression of the kinase has been correlated with genetic instability, the override of spindle toxin 
induced spindle checkpoint, augmentation of the G2 arrest in response to DNA damage, and 
resistancy to chemotherapeutic apoptosis (Meraldi et al., 2002, Goepfert et al., 2002, Marumoto et 
al., 2002, Anand et al., 2003, Jiang et al., 2003a).  Aurora A over-expression has also been linked 
to the stabilisation of Cyclin B1 and centrosome amplification, both of which have been attributed 
to tumorigenesis (Meraldi et al., 2002, Goepfert et al., 2002, Yang et al., 2006, Zhou et al., 1998, 
Qin et al., 2009). Additionally, Aurora A has been shown to regulate the tumour suppressors p53 
and BRCA1 (Pascreau et al., 2009, Katayama et al., 2004, Ouchi et al., 2004, Liu et al., 2004). 
Aurora A has been shown to directly interact with p53 through its N-terminal A-box motif, and 
phosphorylate p53 at two locations which either abrogates its transactivation activity or causing its 
ubiquitination and eventual proteolysis (Chen et al., 2002, Katayama et al., 2004, Liu et al., 2004). 
Aurora A over-expression has also been proposed to extend the life-span of the cells by both 
increasing the expression of the human telomerase reverse transcriptase (hTERT), and activating 
telomerase activity possibly through its regulation of c-Myc levels (Otto et al., 2009, Yang et al., 
2004). Aurora A may also promote metastasis of tumour cells through activating factors such as 
RalA which is involved in the transformation pathway, causing enhanced collagen I-induced cell 
migration and anchorage-independent growth (Wu et al., 2005). Considering this large amount of 
data, it is unsurprising to learn that the over-expression of Aurora A has been shown to cause the 
oncogenic transformation of cells (Zhou et al., 1998, Bischoff et al., 1998).  
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In addition to Aurora A being over-expressed or hyper-activated in cancer cell lines, reports have 
also described its deletion and down regulation of the kinase to be apparent in cancer cells (Bibby 
et al., 2009). Intriguingly, these findings were associated to the dual reduction of wild-type p53 in 
cells, with Aurora A inhibition also found to increase the growth of tumours with reduced p53 
levels (Mao et al., 2007, Bibby et al., 2009). Although additional reports have described how 
Aurora A inhibition can cause cell death in p53-deficient cancer cell lines (Dar et al., 2008). This 
ability of Aurora A inhibition to provide a growth advantage to selected tumours therefore 
highlights the requirement for tumour-specific therapies in the fight against cancer progression.  
Whether these changes to Aurora A are however directly involved in cell transformation or are 
simply a product of the numerous mutations that take place during the development of the tumour 
is still to be determined.  
1.9.2 Cancer and Aurora B kinase 
Unlike Aurora A, Aurora B is located at a chromosome position that has not been associated with 
amplification. Aurora B over-expression has however, been reported in some tumour samples such 
as colorectal tumours, with an increase in Aurora B kinase levels has been attributed to  poor 
prognosis, although this may simply represent the heightened mitotic index of the samples (Tatsuka 
et al., 1998, Katayama et al., 2003, Ota et al., 2002). Instead of being a sole inducer of 
tumorigenesis, Aurora B over-expression may cause cell transformation, possibly through the 
hyperphosphorylation of its substrates, when in combination with other misregulated factors 
(Meraldi et al., 2002, Ota et al., 2002, Kanda et al., 2005).  
1.9.3 Cancer and Aurora C kinase 
Although Aurora C expression is limited to germ cells involved with reproduction, the expression 
of the protein has also been described in human leukaemia cells, with its depletion shown to cause 
G0/G1 arrest and apoptosis, indicating that Aurora C kinase may have a role in transformation 
(Kobayashi, 2006).  
1.9.4 Aurora kinase-directed therapies 
The association of the increased expression of the Aurora kinases with transformation, cancer 
progression and metastasis make the Aurora family attractive targets for anti-cancer drugs. 
Furthermore, the up-regulation of Aurora kinases in cancerous cells and in cells undergoing mitosis 
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also allow Aurora directed therapies to weald a degree of targeted action towards tumours cells, 
which may help avoid damage to the healthy tissues. 
1.10 The development of small molecule Aurora A kinase inhibitors 
A range of Aurora targeted therapies have been developed as anti-cancer treatments, a number of 
which are presently in clinical trials (Karthigeyan et al., 2010). Small molecule inhibition allows a 
high degree of temporal control over kinase inactivation, as they are easily diffusible so have a 
rapid speed of action, but their inhibitory effects can also be washed out and therefore reversed 
with relative ease. These properties have meant that small molecule inhibitions have been both a 
useful method of therapy and exciting investigative tools which can be used to dissect the complex 
and intricate roles of the Aurora kinases (Garcia-Echeverria et al., 2000, Ditchfield et al., 2003, 
Hauf et al., 2003, Girdler et al., 2006, Girdler et al., 2008, Dar et al., 2008). 
A drawback of small molecule Aurora inhibition in both clinical and experimental usage however, 
is the difficulty of specifically targeting one kinase in isolation. The three members of the Aurora 
kinase family share a high degree of sequence homology between their catalytic domains (reviewed 
in [Karthigeyan et al., 2010]), and also bear close structural similarities to CDK-2, GSK-3β and 
SRC kinase (Cheetham et al., 2002, Dancey and Sausville, 2003, Garber, 2005). These similarities 
make it extremely difficult to design and develop inhibitors that are specific to just one of the 
Aurora kinase family members. 
This problem with specificity became evident following the attempted development of ZM447439 
(herein referred to as ZM1) and VX680 as inhibitors of Aurora A activity (Ditchfield et al., 2003, 
Harrington et al., 2004). ZM1 was generated from a screen of 250,000 compounds using Aurora A 
kinase activity as an inhibition target, while VX680 was synthesised using knowledge regarding the 
structure of Aurora A (Andrews, 2005). Application of either of the drugs caused a reduction of 
histone H3 phosphorylation on Ser10 as well as the inhibition of cell division, producing tetraploid 
cells (Girdler et al., 2006, Ditchfield et al., 2003, Harrington et al., 2004). These phenotypes were 
suggestive of Aurora B inhibition, rather than Aurora A, and it was revealed that VX680 was 
equipotent for the two kinases as well as inhibiting a number of additional kinases, while ZM1 
inhibited Aurora B more potently than Aurora A (Girdler et al., 2006, Cheetham et al., 2007, Tyler 
et al., 2007).  
Despite the lack of specificity towards Aurora A activity, both ZM1 and VX680 have been shown 
to selectively kill tumour cells in vitro, although ZM1 never progressed to clinical trials and VX680 
has now been removed from trials due to complications in the development process (Ditchfield et 
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al., 2003, Girdler et al., 2006, Harrington et al., 2004, Keen and Taylor, 2009, Georgieva et al., 
2010).   
The majority of small molecule inhibitors characterised to date predominantly inhibit Aurora B 
kinase activity. However, in 2006 the ZM-related inhibitor ZM3 was reported to cause the 
formation of monopolar spindles, which is consistent with Aurora A inactivation (Girdler et al., 
2006, Barr and Gergely, 2007). Following ZM3 development, another small molecule named 
MLN8054, was also found to cause the development of monopolar spindles. It has been claimed 
that in vitro, MLN8054 can inhibit Aurora A activity over 40 times more potently than Aurora B, 
and more than 100 times more potently than a panel of selected kinases (Hoar et al., 2007). 
MLN8054 is an ATP competitive and reversible inhibitor of Aurora A kinase activity, and has been 
shown to cause the induction of apoptosis and senescence in laboratory tests (Huck et al., 2010, 
Manfredi et al., 2007). Clinical treatment of the drug did however cause somnolence in patients, 
prompting the development of a secondary compound called MLN8237, which at the time of 
writing, is in phase II clinical trials and has been found to produce encouraging levels of 
cytotoxicity when used as a combination therapy (Moore et al., 2010, Karthigeyan et al., 2010, 
Nawrocki, 2008).  
1.11 Methods of investigating Aurora A function 
Many techniques have been successfully employed in the past to characterise the role of the 
Auroras within cells. In vitro and in vivo methods have been detailed in the literature, ranging from 
RNAi and conditional knockouts of Aurora A, to micro-injection of anti-Aurora A antibodies and 
the use of Aurora A mutant proteins (Giet and Prigent, 2001, Marumoto et al., 2002, Glover et al., 
1995, Girdler et al., 2006, Girdler et al., 2008, Hannak et al., 2001, Cowley et al., 2009, Mori et al., 
2007, Berdnik and Knoblich, 2002). It is however important to distinguish between reports 
specifically concerned with the role of the kinase activity, and those that investigate the function of 
the entire protein. Removing a protein from the system (using techniques such as null models and 
RNAi) induces effects that reflect the prevention of the kinase from performing its structural 
function as well as any chemical roles. To specifically investigate the role of kinase activity, the 
physical protein must still be present in the cell to allow the activity of the kinase to be examined in 
isolation.  
Clearly, developing an understanding of the role of a particular kinase’s activity is a delicate and 
intricate process. However, investigation into Aurora A kinase activity has been elegantly 
conducted in the past by creating phospho-mimics of Aurora A substrates, and by using catalytic 
inactive Aurora A mutants (Mori et al., 2007, Glover et al., 1995, Berdnik and Knoblich, 2002, 
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Girdler et al., 2006). The creation of mutant proteins has been used to collect valuable information, 
however it is not possible with the current techniques to have temporal control, a feature that has 
extensive advantages when investigating temporally controlled kinases. The mutant proteins must 
either be continually expressed, or their expression must be induced over a relatively long period 
(Berdnik and Knoblich, 2002, Hannak et al., 2001). In comparison, the ability to rapidly manipulate 
small molecule inhibitors means that they can be used in experiments to examine intricate and 
specific areas of the cell cycle without the need for long treatment periods (Sawyers, 2004, Keen 
and Taylor, 2009).  
1.12 Outline of this investigation 
The Aurora kinase family are integral to the regulation of mitotic progression, and numerous 
reports detail their importance in the process. Aurora A kinase has attracted particular interest due 
to the strong links between its over-expression and cancer. Despite a good number of discoveries 
made regarding the role of Aurora A however, the limitations of experimental techniques have 
meant that relatively little is known about the role of its kinase activity. The aim of the study 
presented in this thesis was therefore to exploit the experimental benefits of small molecule 
inhibition in order to probe the role of Aurora A activity in mitosis. During the course of this thesis 
I will describe the experimental findings that resulted from my exploration of the role of Aurora A 
kinase activity.  
In the first results section described in chapter 3, I describe how the small molecule inhibitor 
MLN8054 was selected as the best tool with which to investigate Aurora A kinase activity. Then in 
chapter 4, I describe how MLN8054 was employed to examine the role of Aurora A activity within 
cells, showing that its inhibition resulted in the formation of bipolar spindles of a reduced length, 
with fewer long K-fibres and a lower level of microtubule organisation. Despite demonstrating that 
Aurora A activity has a role in spindle formation, the results were in contrast to previous reports 
which associated the removal of Aurora A activity with the production of a monopolar spindle 
phenotype (Roghi et al., 1998, Glover et al., 1995, Liu and Ruderman, 2006, Girdler et al., 2006).  
The functional consequences of the spindle abnormalities seen after Aurora A inhibition are 
demonstrated in chapters 5 and 6, with data showing that Aurora A inhibition prevents cells from 
being able to efficiently align their chromosomes and maintain genetic integrity. These findings are 
consistent with reports of Aurora A depletion and Aurora A antibody micro-injection, which 
described the treatments as causing chromosomal misalignments despite the presence of a bipolar 
spindle (Marumoto et al., 2003, Kunitoku et al., 2003). When examining the role of Aurora A 
activity in chromosomal alignment, it became apparent that Aurora A activity was not required for 
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the attachment of kinetochores to the spindle. Additionally, when causing the dramatic reduction in 
centromeric stretch by inducing the formation of monopolar spindles in cells treated with 
MLN8054, monotelically orientated chromosomes were observed. This ability of MLN8054-
treated cells to produce monotelically orientated chromosomes when kinetochores are under 
reduced tension thus confirmed that Aurora B activity was not inhibited by the MLN8054 treatment 
(Hauf et al., 2003). Furthermore, contrary to predictions, the finding also appeared to demonstrate 
that Aurora A does not cooperate with Aurora B in regulating chromosomal attachment (Marumoto 
et al., 2003). Therefore, the role of Aurora A activity in the alignment of chromosomes was instead 
predicted to be derived from its function in regulating spindle formation.  
When exploring the role of Aurora A activity in the regulation of the formation of a functional 
mitotic spindle, TACC3 was found to be completely mislocalised following Aurora A inhibition, 
which is consistent with reports in the literature, and chTOG localisation to the centrosomal area 
was also diminished (Giet et al., 2002, Kinoshita et al., 2005, LeRoy et al., 2007, Lee et al., 2001). 
Aurora A localisation to spindle microtubules was also found to be partially destabilised by its 
inhibition and centrosome size appeared reduced. 
Despite the clear role for Aurora A activity in spindle assembly and chromosomal alignment, the 
majority of cells performed cytokinesis after extended mitotic delays. This observation conflicts 
with data from Aurora A RNAi or antibody micro-injection experiments, which may therefore 
highlight divergent structural and catalytic roles for Aurora A in the process (Marumoto et al., 
2003). Despite the ability of cells to divide in the absence of Aurora A activity, segregation defects 
were observed and the cells became aneuploid. This requirement for Aurora A activity to evenly 
segregate segregation the genetic material is consistent with Drosophila data and a report published 
during the investigation (Hoar et al., 2007, Glover et al., 1995).  
Despite the clear role for Aurora A activity in spindle assembly and mitotic progression, the effects 
of its inhibition were not as profound as indicated in many reports in the literature (Roghi et al., 
1998, Glover et al., 1995, Liu and Ruderman, 2006, Girdler et al., 2006). Therefore, to address 
whether Aurora A activity could be inhibited more potently, in chapter 7 I used a cell line which 
made it possible to increase the concentration of inhibitor applied to cells, while maintaining its 
specificity towards Aurora A over Aurora B activity. These cells exhibited a monopolar spindle 
phenotype in response to Aurora A inhibition, although they were still able to divide, thus 
supporting the notion that although Aurora A activity is required for spindle formation it is not 
involved in cytokinesis. 
In comparison to the cancer cell lines tested, investigation into non-transformed cells during 
chapter 8, revealed that they could form bipolar spindles of a normal length, which were able to 
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more efficiently align their chromosomes in the absence of Aurora A activity compared to the 
cancer cell lines tested. The non-transformed cells tested also only suffered relatively short mitotic 
delays following Aurora A inhibition and did not accumulate a substantial sub-G1 population, 
unlike the cancer cells, which became profoundly unviable after the equivalent treatment.  
In summary therefore, I will describe my findings which demonstrate that Aurora A activity is 
involved in the formation of a functional spindle and efficient alignment of chromosomes. Through 
the development of a functional spindle, I will demonstrate that the kinase activity of Aurora A 
enables the appropriate detection of alignment defects, allowing the even segregation of genetic 
material, although it does not play a prominent part in the spindle assembly checkpoint or 
cytokinesis. Finally, I will describe a number of intriguing differences between the cell lines in 
response to Aurora A inhibition, which have important connotations for the targeting of Aurora A 
as an anti-cancer therapy. 
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2 Materials and Methods 
2.1 Cell culture 
The cell lines used during this investigation (described in Table 2.1) were grown in Dulbecco’s 
modified Eagle’s media (DMEM) (Invitrogen) supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin, 2 mM glutamine (all from Lonza) and 10 % (v/v) foetal calf serum (FCS) 
(Invitrogen). GFP-H2B HeLa and RPE cell lines were also treated with 0.5 and 3 µg/ml puromycin 
respectively, to select for their pLPCX-based plasmids.  
Cell Line Origin Source p53 
DLD-1 Human colorectal 
adenocarinoma 
American Type Culture 
Collection 
WT 
TA-HeLa Human cervical 
carcinoma 
(Taylor and McKeon, 
1997) 
WT (inactive) 
HCT116 Human colon carcinoma American Type Culture 
Collection 
WT 
HCT116 R12 Human colon carcinoma (Girdler et al., 2008) WT 
hTERT RPE Telomerase immortalised 
human retinal pigment 
epithelial cell 
A gift from Dr. S, 
Doxsey, University of 
Massachusetts 
WT 
GFP H2B TA-HeLa Human cervical 
carcinoma virally infected 
with pLPCX 
(Gascoigne and Taylor, 
2008) 
WT (inactive) 
GFP H2B hTERT RPE Telomerase immortalised 
human retinal pigment 
epithelial cell virally 
infected with pLPCX 
(Gascoigne and Taylor, 
2008) 
WT 
Table 2.1: Cell lines. The tissue and cell type of the cell line origin are described as in the ATCC 
database, and the p53 status are designated as either wild type (WT) of inactivated form of 
the p53 gene (WT (inactive)), as detailed in the Mutant P53  loss of activity database. 
The cells were cultured as monolayers in a humidified atmosphere at 37ºC and 5% CO2 and 
passaged when necessary by first washing with phosphate buffered saline (PBS) then incubating at 
37°C for 5 minutes with 1% (v/v) trypsin in PBS (Invitrogen). After detachment of the cells by 
trypsinisation, fresh media was used to both quench the trypsin and appropriately dilute the cells.  
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For storage, the cells were harvested as above then centrifuged at 1000 rpm for 5 minutes. The 
resulting pellet was resuspended in freezing media (FCS with 10% (v/v) dimethyl sulfoxide 
(DMSO) (Sigma)) and aliquoted into cryotubes (Nunc). The tubes were incubated at -80°C in 
polystyrene boxes for a minimum of 24 hours before being transferred to liquid nitrogen for long-
term storage.  
2.2 Drug treatment  
The drugs used were stored at -20ºC at stock concentrations in DMSO or, in the case of MLN8054, 
sterile water (Table 2.2). To achieve the final concentrations, drugs were diluted with media, 
although DMSO was never more that 0.1% (v/v) of the final concentration. Samples with 
equivalent concentrations of DMSO were used as controls for experiments using drugs stored in 
DMSO.  
Drug Stock concentration Final concentration 
Nocodazole (Sigma) 5 mg/ml 30 ng/ml 
AZ138  
(A gift from AstraZeneca) 
10 mM 1 µM 
Monastrol 100 mM 100 µM 
ZM447439 (Tocris) 10 mM 2 µM 
MLN8054 
(A gift from Millennium 
Pharmaceuticals) 
10 mM 1 µM 
Table 2.2: Drug concentrations. The stock concentrations of the drugs were diluted to make the 
indicated final concentrations with media. 
2.3 Cell Biology 
2.3.1 Flow Cytometry 
Cells were seeded into 10 cm Petri dishes and cultured for 24 hours before drug treatment. 
Following the drug treatment, media was collected from the plates and the cells were carefully 
washed with 2 ml PBS, which was also subsequently collected. The cells were harvested by 
trypsinisation, pooled with the media and PBS collected earlier, then centrifuged at 1000 rpm for 5 
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minutes to form a pellet. The pellet was resuspended in 150 µl PBS and fixed using 350 µl 100% 
ice-cold ethanol, which was added in a drop-wise fashion while gently vortexing. The fixed cells 
were then incubated at -20ºC for at least 16 hours. 
To assess the DNA content and mitotic index of the cells were stained with propidium iodide (PI) 
and an antibody against MPM-2 respectively. Before the staining however, the cells were washed 
to remove ethanol by adding 10 ml PBS and centrifuging at 1000 rpm for 5 minutes. The 
supernatant was removed and the cells were incubated at 4ºC in the dark for 2 hours with 500 µl 
mouse monoclonal MPM-2 (Upstate) diluted to 1:2000 in PBS. The samples were then washed 
again by adding 10 ml PBS, centrifuging at 1000 rpm for 5 minutes and discarding the supernatant. 
Anti-mouse-FITC secondary antibody (Jackson Labs), diluted to 1:1000 in PBS, was added for 1 
hour after which samples were washed with PBS once more and then resuspended in 500 µl 
propidium iodide solution (40 µg/ml PI, 50 µg/ml ribonuclease A in PBS: Sigma) and incubated in 
the dark at 4°C for 30 minutes. If it was not necessary to observe the mitotic index of the cell 
population, the addition of primary and secondary antibodies against MPM-2 was omitted from the 
protocol. The stained cells were analysed using CyAn™ (DakoCytomation) and Summit analysis 
software (Dako), with 10,000 cells analysed from each sample. 
2.3.2 Phase-contrast time-lapse microscopy 
To observe individual cell progression through mitosis, cells were plated into a clear-bottomed 24-
well dish (Corning) and cultured for 24 hours before drugs were applied. To reduce the evaporation 
of media from the cells and therefore maintain the allocated drug concentrations, the unused wells 
of the 24-well dish were filled with media in order to create a humidified environment. Filming of 
the cells was started 1 hour after drug application, with images being taken every 2 minutes with a 
CoolSNAP HQ camera (Photometrics) operated by MetaMorph software (Universal Imaging). 
Phase contrast was used to visualise cells with a 32x Apo Plan objective and 200 ms exposure 
using a Zeiss Axiovert 200 fitted with a PZ-2000 motorised stage (Applied Scientific 
Instrumentation) to enable point revisiting. Culture conditions of 37ºC and 5% CO2 were 
maintained during filming through the use of an environmental control chamber and heater (Solent 
Scientific). A syringe needle was inserted into the plastic dish lid to deliver humidified CO2 to the 
cells.  
The images produced from the procedure were analysed using Metamorph software (Universal 
Imaging), and the time taken from cells to progress from the point of nuclear envelope breakdown 
to chromosome decondensation was used to determine the mitotic period of the cells.  
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2.3.3 Fluorescent spinning-disc time-lapse microscopy  
Spinning-disc time-lapse microscopy enabled the collection of high-resolution imaging, allowing 
the observation of individual fluorescently marked chromosomes within live cells. The cells in 
question expressed GFP-histone H2B to enable the visualisation of the DNA, and were plated in a 
35 mm Petri-dish with a 14 mm2, 0.16 – 0.19mm thick glass insert (Mat Tek). The cells were left to 
settle for around 24 hours, after which the media was removed and replaced with the appropriate 
drug concentration diluted using fresh media. The culture conditions of 37ºC and 5% CO2 were 
maintained by enclosing the cell plate in a heated environmental control chamber (Solent 
Scientific). Following a 1 hour period which was used to allow the cell environment to stabilise, a 
100x objective was used to take a series of 7 z-sections every 2 minutes with a CoolSNAP HQ 
camera (Photometrics) and spinning disc (Yokogawa) operated by MetaMorph software (Universal 
Imaging).  
2.3.4 Immunofluorescent staining of cell samples 
Immunofluorescence microscopy was used to observe mitotic spindles within cells as well as the 
positioning of various proteins in response to various treatments. To do this, the cells were first 
seeded onto 19 mm glass cover slips using 450 µl of 1.2 or 2.4 x 105/ml cell suspension. 24 hours 
after plating the cells, the media was removed and replaced with the appropriate drug treatment. 
Following the specifically allocated treatment period, the cell samples were fixed, washed and 
blocked according to Table 2.3, and 100 µl of primary antibody in blocking agent was applied to 
each slip (Table 2.4). After washing the cells three times with PBS plus 0.1% (v/v) Triton X-100 
(PBST), 100 µl of secondary antibody conjugated to Cy2, Cy3 or Cy5 (all used at 1:500 from 
Jackson Immunoresearch Laboratories) diluted in blocking agent was applied to each slip and 
incubated in the dark for 30 minutes. To stain the DNA, after washing with PBS three further times 
with PBST to remove unbound secondary antibodies, Hoechst No. 33358 (Sigma) diluted to 1 
µg/ml in PBS was applied to the samples for 2 minutes. After washing with PBST three final times 
to remove the Hoechst, the cover slips were inverted and positioned onto mounting media (90% 
glycerol (v/v) with 20 mM Tris HCL pH 8.0) which had been placed on glass slides. Nail varnish 
was applied to the edges of the cover slips to seal them to the glass slide.  
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                                                  Fixation techniques Protocol 
step Methanol Formaldehyde PEM extraction PEM/methanol 
Microtubule 
extraction 
None. None. Aspirate off media, 
wash with PBS, and 
then apply 
microtubule extraction 
buffer PEM (100 mM 
PIPES pH 6.9, 1 mM 
MgCl2, 0.1 mM 
CaCl2, 0.1 % triton) 
for 90 seconds. 
Aspirate off media, 
wash with PBS, then 
apply PEM for 90 
seconds. 
Fixation Aspirate off media and 
carefully wash once with 
PBS. Remove PBS by 
and submerge into ice-
cold 100% ethanol for 10 
seconds. Fix cells by 
placing in fresh ice-cold 
100% ethanol and 
incubate at –20°C for 10 
minutes. 
Aspirate off media 
and wash once with 
PBS, then apply 
1% (v/v) 
formaldehyde in 
PBS for 5 minutes. 
Aspirate off PEM and 
apply 4% (v/v) 
formaldehyde in PEM 
for 10 minutes. 
Remove PEM and 
submerge into ice-
cold 100% ethanol for 
10 seconds. Fix cells 
by placing in fresh 
ice-cold 100% ethanol 
and incubate at –20°C 
for 10 minutes. 
Wash 3-times with PBST 3-times with PBST 3-times with PEM 3-times with PEM 
Block 5% (w/v) fat-free milk 
powder (Marvel) in 
PBST for 10 minutes. 
Glycine in PBS for 
5 minutes. 
Glycine in PEM for 5 
minutes. 
% (w/v) fat-free milk 
powder (Marvel) in 
PEM for 10 minutes. 
Experiment Figures 5.3 and 5.5. Figures 3.4B, 3.4C, 
4.2, 4.4, 4.5, 4.6, 
5.1, 7.1A, 7.4 and 
8.3.  
Figures 3.4A, 4.1, 
5.4A, 4.7A, 4.7B, 
8.6A and 8.6B.  
Figures 4.7C. 4.7D 
and 8.6C.  
Table 2.3: Fixation techniques. Four different protocols were selected for the fixation of samples 
from immunofluorescence, which involved specifically tailored methods of microtubule 
extraction, sample fixation, washing and blocking. The figures in which each of the 
methods were used are indicated at the bottom of the table.  
2.3.5 Immunofluorescence microscopy  
Immunofluorescently stained samples were analysed in a range of different methodologies. When 
simply counting cells, a Zeiss Axioskop 2 microscope with a 100x objective and epifluorescence 
was used. Single plane images were taken of the cell samples through the use of a CoolSNAP HQ 
CCD camera (Photometrics) and Metamorph software (Universal Imaging).  
For the acquisition of z-sectioned fluorescence images of the cells or the quantitation of areas of 
fluorescence through measuring pixel intensity, a wide-field optical sectioning microscope (Delta 
Vision; Applied Precision) driven by SoftWorx (Applied Precision) was used. Image stacks were 
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created by taking z-sections at 0.2 µm intervals to create image stacks, which were then 
deconvolved using 10 cycles of enhanced ratio deconvolution (SoftWorx). These stacks could 
either then be projected to make 2D images or used to observe the cell image in 3D. 
Antibody Antigen Dilution for IF Dilution for WB Source 
SAA-1  Sheep anti-Aurora A 1:5000 1:5000 (Girdler et al., 2006) 
TAT1 Mouse monoclonal anti-
α-tubulin  
1:200 - Gull Lab (Woods et al., 
1989) 
Pericentrin Rabbit polyclonal anti-
Pericentrin 
1:1000 - Abcam 
4B12/6 Mouse anti-Bub1 1:10 - (Taylor and McKeon, 
1997) 
pH3 Rabbit anti-phospho-S10-
Histone H3 
1:500 1:500 Chemicon 
SAB.1 Sheep polyclonal anti-
Aurora B 
1:1000 1:1000 (Ditchfield et al., 2003) 
SM2.1 Sheep polyclonal anti-
Mad2 
1:500 - (Johnson et al., 2004) 
ACA Human anti-centromere 1:800 - Bill Earnshaw 
TACC3 Rabbit anti-TACC3 1:500 1:1000 (Gergely et al., 2000a) 
Phospho-TACC3 Rabbit anti-
phospho(Ser558)TACC3 
- 1:1000 A gift from Fanni 
Gergely (University of 
Cambridge) 
chTOG Rabbit polyclonal anti-
chTOG 
1:500 - Abcam 
2914 Rabbit anti-Phospho- 
Aurora A (Thr288), 
Aurora B (Thr232), and 
Aurora C (Th198)* 
- 1:1000 Cell Signalling 
SB1.2 Sheep anti-Bub1 1:1000 - (Taylor et al., 2001) 
MIL  Rabbit anti-pT288 - 1:2000 Millennium 
Pharmaceuticals 
Table 2.4: Antibodies used for immunofluorescence and Western blotting. The concentrations of 
primary antibodies used for immunofluorescence microscopy (IF) or immunoblotting of 
Western blots (WB). NB: Antibody 2914 was to detect phospho-Aurora in Figures 3.1 and 
3.3, while MIL was used in Figure 3.2. 
*It is claimed by the manufacturer that the antibody 2914 recognises a phophorylation event on Aurora C, I 
however have no evidence to support this claim. 
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2.3.6 Immunoblotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting 
were used to observe the presence of different forms of proteins within cell samples that had been 
exposed to a range of drug treatments. Before the treatment of the cells, they were plated in 6-well 
dishes and allowed to settle 24 hours, then mitotically enriched with Nocodazole for 16 hours. 
After this period the cells were treated for further 2 hours with the indicated Aurora A inhibitor 
concentrations in combination with MG132 and Nocodazole. A 500 µl portion of the media was 
then collected from the wells and the rest was discarded. The cells were gently washed with PBS, 
which was pooled with the collected aliquots of media. The cells were harvested by trypsinisation 
and combined with the collected media and PBS, which served to quench the trypsin. The samples 
were centrifuged at 1000 rpm for 5 minutes, the supernatant was discarded, the pellet was 
resuspended in 2 x Laemmli SD sample buffer (10% (v/v) β-mercaptoethanol, 125 mM Tris, 4% 
SDS, 20% (v/v) glycerol, 0.02% (w/v) bromophenol blue) and then incubated at 100ºC for 5 
minutes to lyse the cells and denature proteins. After allowing the samples to cool to room 
temperature, they were centrifuged for 15 seconds at 14,000 rpm, after which the samples could 
then either be stored at –20°C or loaded into a 12% polyacrylamide gel (see Table 2.5).  
Reagent Resolving gel (12%) Stacking gel 
Water 5.1 5.7 
Tris 1.5M pH 8.8 3.75 - 
Tris 0.5M pH 6.8 - 2.5 
SDS 10% 0.15 0.1 
Acrylamide 30% 6 1.7 
Ammonium persulphate (APS) 10% 0.15 0.1 
Table 2.5: Resolving and stacking gels for SDS PAGE. Volumes of the indicated reagents are in 
ml. ‘12%’ refers to the final percentage of acrylamide within the resolving gel. All the 
reagents are from Sigma, apart from the acrylamide, which is from National Diagnostics.   
The SDS PAGE gels were made with the ingredients indicated in Table 2.5, and polymerisation of 
the resulting solutions was aided and/or induced by the addition of TEMED (Sigma). To make a 
gel, a mould was made from a 10 cm x 10.5 cm glass plate clamped to a notched ceramic plate 
separated by 1.5 mm spacers (all from Hoefer). The gel solution was prevented from flowing out of 
the vertical plates by standing on a section of Para-film (Scientific Laboratory Supplies). To make a 
gel plug, 1 ml aliquot of resolving gel solution was combined with 10 µl of TEMED and poured 
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into the mould, and after it had polymerised, the remaining resolving solution was combined with 
15 µl of TEMED and poured between the plates. To help remove bubbles from the gel and flatten 
the top, a 0.1% (w/v) SDS solution was poured onto the hardening resolving gel. When the 
resolving solution had solidified, the SDS solution was poured away and the sacking solution was 
poured into the mould after adding 12 µl of TEMED. Wells for the samples were made by inserting 
a fifteen-tooth comb (Hoefer) into the solidifying resolving gel. When the gel was fully solidified, 
the comb was removed and the wells were washed thoroughly. The gel, which as still held between 
the two plates, was then clamped into a running tank (Hoefer) filled with running buffer (25 mM 
Tris, 200 mM glycine, 0.1% (w/v) SDS) and a 30 mA charge was applied to each gel for 90 to 120 
minutes to separate the proteins.  
To observe the separated proteins, the SDS PAGE gel was carefully removed from the plates and 
immersed in transfer buffer (25 mM Tris, 190 mM glycine, 0.1% (w/v) SDS, 20% methanol). The 
gel was sandwiched between six Whatman paper squares and Immobilon-P membrane (Millipore) 
all of which were also soaked in transfer buffer. The gel, paper squares and membrane were then 
placed in an EB10 or EB20 Electro-Blot Unit (Wolf Laboratories), and a preferential difference of 
15 V was applied in the Electro-Blot unit, causing the proteins to be transferred from the gel onto 
the membrane.  
After the transfer, the membrane was removed from the unit and incubated for 1 hour in 5 % (w/v) 
fat-free dried milk powder (Marvel) which had been diluted in TBST (100 mM Tris, 150 mM 
NaCl, 0.1 % (v/v) Tween-20, pH 7.5). To detect specific proteins, the membrane was incubated 
with primary antibodies which had been diluted to specific concentrations in blocking agent 
overnight at 4ºC (Table 2.4). Unbound antibody was removed by agitating the membranes for 30 
minutes in TBST, after which secondary antibodies conjugated to horseradish-peroxidease-
conjugated (HRP) (Zymed) diluted to 1:2000 in blocking agent, were applied to the membrane for 
1 hour at room temperature. After a another 30 minute agitated wash in TBST to remove any 
unbound secondary antibody, the HRP signal was detected using Super Signal west pico luminal 
based chemiluminecent substrate (Pierce), which is oxidised by HRP to produce luminescence. The 
luminescence was imaged on Biomax MR film (Kodak), enabling the visualisation of the HRP 
signal. 
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3 The characterisation of the Aurora A inhibitors 
3.1 Introduction 
Aurora A kinase plays a key role in several stages of mitosis, in addition Aurora A expression has 
been implicated in oncogenesis (Bischoff et al., 1998, Zhou et al., 1998, Carmena and Earnshaw, 
2003, Keen and Taylor, 2004). These observations have made Aurora A an exciting area of 
research for those studying both mitosis and potential anti-cancer therapies. Numerous groups have 
consequently endeavoured to characterise the kinase, a line of investigation that has been greatly 
advanced by the development of RNA interference (RNAi) (Elbashir et al., 2001, Marumoto et al., 
2003, Hannak et al., 2001, Motegi et al., 2006). Despite the many benefits of using RNAi as an 
investigative technique, the depletion of endogenous protein induced by the treatment does not 
allow for the distinction between any possible catalytic roles and the identification structural 
function. To address this issue, groups have induced the expression of mutated proteins in 
combination with using RNAi to deplete endogenous protein, to mimic the effects of Aurora A 
kinase inhibition. This treatment has been described to cause the development of monopolar 
spindles, a phenotype that was consequently attributed to the inactivation of Aurora A kinase 
activity (Girdler et al., 2006, Liu and Ruderman, 2006, Mori et al., 2007). Despite these promising 
results, Girdler and colleagues (2006) warned against assuming that such experiments demonstrate 
a solid role for Aurora A activity in bipolar spindle formation, as it was argued that there was little 
evidence to indicate Aurora A was truly inactivated. Instead, the writers called for the use of 
antibodies, which recognise both the phosphorylated T-loop of Aurora A and phosphorylated forms 
of Aurora A downstream targets, to enable the accurate depiction of the role of Aurora A kinase 
activity in cells.  
Subsequent to the introduction of RNAi techniques, the development of small molecule inhibitors 
opened new doors for the investigation of kinase activity (for review see [Taylor and Peters, 
2008]). The highly penetrant and often reversible effects of small molecule inhibitors, in 
conjunction with their rapid speed of action, aptitude for dose-response investigations and precise 
temporal control, make them a highly attractive method of experimentation (Sawyers, 2004, Keen 
and Taylor, 2009). Most importantly however, the use of small molecule inhibitors enables the 
specific inhibition of enzymic activity, without also affecting the protein’s levels or structural 
interactions, thus enabling the role of the catalytic action to be more efficiently characterised. The 
many advantages of using small molecule inhibitors to probe catalytic activity therefore make them 
ideal tools for investigating the role of Aurora A kinase activity.  
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To date, a number of small molecule inhibitors have been developed to target the Aurora kinases, 
however the high degree of homology shared between Aurora A and B, has made the identification 
of a specific Aurora A inhibitor rather challenging (for review see [Keen and Taylor, 2004, Giet et 
al., 2005, Carmena and Earnshaw, 2003]). Although Aurora C also shows a high degree of 
structural similarity to the other Aurora family members, it has been observed to be expressed in 
specific mammalian meiotic cells, with no endogenous protein detected in HeLa or DLD-1 cells 
(Yanai et al., 1997, Tang et al., 2006, Bernard et al., 1998, Tseng et al., 1998, Li et al., 2004, 
Kimura et al., 1999, Yang et al., 2010b, Girdler et al., 2006).  
Frustratingly, the majority of Aurora inhibitors characterised to date principally inhibit Aurora B 
activity (Hauf et al., 2003, Ditchfield et al., 2003, Girdler et al., 2006, Girdler et al., 2008, 
Bebbington et al., 2009, Harrington et al., 2004). Indeed the first small molecule developed to 
inhibit Aurora A activity, ZM1, was later revealed to actually inhibits Aurora B activity more 
potently than Aurora A (Ditchfield et al., 2003, Girdler et al., 2006). Encouragingly however, three 
further small molecule Aurora inhibitors, VX680, ZM3 and MLN8054, have recently been reported 
to target the activity of Aurora A kinase. At certain concentrations though, these three inhibitors 
have also been shown to also affect Aurora B activity (Harrington et al., 2004, Bebbington et al., 
2009, Girdler et al., 2006, Hoar et al., 2007). Therefore, before any one of these three inhibitors 
could be used to probe the role of Aurora A kinase activity, I first needed to determine whether 
they could be used to specifically inhibit Aurora A without also effecting Aurora B activity in my 
chosen experimental system. Human tumour DLD-1 and HeLa cell lines were selected for use in 
the investigation, as both have previously been well characterised in the fields of cell division and 
anti-mitotic drug response (Jordan et al., 1996, Gascoigne and Taylor, 2008).  
To determine the selectivity of the small molecule inhibitors for Aurora A activity in the chosen 
cell lines, I used a combination of immunofluorescence and immunoblotting techniques to analyse 
changes in specific phosphorylation events in response to individual inhibitor treatments (Jackman 
et al., 2003, Girdler et al., 2008). The level of Aurora A inhibition achieved by the inhibitors was 
gauged using immunoblotting to observe changes in the auto-phosphorylation on the T-loop 
(residue Thr288) in the catalytic region of Aurora A (see Figure 1.7), as well as the 
phosphorylation of TACC3 on an Aurora A phosphorylation site (residue Ser558) (Bischoff et al., 
1998, Littlepage et al., 2002, Walter et al., 2000, Liu and Ruderman, 2006, Ohashi et al., 2006, 
Barros et al., 2005, Giet et al., 2002, LeRoy et al., 2007, Peset et al., 2005, Tyler et al., 2007). In 
addition, I also assessed whether any unwanted Aurora B inhibitory effects were produced by the 
inhibitors, which may occur as a result of the close structural similarities between the active sites 
Aurora A and B. Changes in Aurora B activity were determined by observing its phosphorylation 
on Thr232, together with detecting the kinase’s effect on one of its down-stream targets by 
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analysing the phosphorylation of histone H3 (Ser10) (Nigg, 2001b, Carmena and Earnshaw, 2003, 
Vagnarelli and Earnshaw, 2004, Ditchfield et al., 2003). In addition to this, immunofluorescence 
microscopy was used to compare the effects of the three inhibitors on cell morphology, thereby 
highlighting any other off-target effects caused by the inhibitors. By addressing whether VX680, 
ZM3 and MLN8054 produced off-target cellular effects as well as assessing their potency towards 
Aurora A activity, I aimed to determine their suitability as experimental tools to investigate the role 
of Aurora A kinase activity in mitosis.  
3.2 VX680 inhibits both Aurora A and Aurora B activity 
Following the development of ZM1, VX680 was the subsequent Aurora kinase inhibitor to be 
characterised (Harrington et al., 2004). VX680 was originally designed to target all three members 
of the Aurora family, however encouragingly it was found in vitro to be most potent against Aurora 
A activity, with tests showing IC50 values of 0.6, 18 and 4.6 nM for Aurora A, B and C 
respectively (Harrington et al., 2004, Bebbington et al., 2009). I therefore set out to determine if 
this specificity of VX680 indicated in the in vitro tests could also be seen in vivo, and thus whether 
it could be used as a tool to investigate Aurora A kinase activity. 
To characterise the inhibitory action of VX680, I treated both HeLa and DLD-1 cells with a range 
of concentrations of VX680, before lysing and then separating the samples by SDS PAGE. 
Immunoblotting of the separated cell lysates revealed that increasing the concentration of VX680 
caused the reduction of both phospho-Aurora A and phospho-TACC3 signals in both HeLa and 
DLD-1 cell samples (Figure 3.1). Therefore, consistent with the published in vitro data, VX680 
could be used to inhibit Aurora A activity in an in vivo environment (Harrington et al., 2004, 
Bebbington et al., 2009). This inhibition was determined to be maximally achieved by 350 nM and 
900 nM of VX680 in HeLa and DLD-1 cells respectively. Crucially however, at these 
concentrations, a reduction could also be seen in the presence of phosphorylated Aurora B and 
histone H3 in the immunoblotted samples. This indicated that Aurora B activity was inhibited at 
equivalent concentrations to that of Aurora A. This finding conflicts with the results of the kinase 
assays of Harrington and colleagues (2004), but is consistent with two reports published during the 
course of my investigation (Scutt et al., 2009, Tyler et al., 2007). This lack of selectivity 
demonstrated by VX680 thus reduced its value as a tool to investigate the role of Aurora A kinase 
activity. Consequently, I turned my attention to the other small molecule Aurora inhibitors 
available for investigation, to assess whether they would make more suitable investigative tools. 
Aurora A
pH3
Aurora B
pTACC
p-Aurora A
p-Aurora B
[VX680] nM [VX680] nM
HeLa DLD-1
Figure 3.1 VX680 inhibits both Aurora A and B kinase activity
HeLa (A) and DLD-1 cells (B) were treated with Nocodazole for 16 hours to mitotically
enrich the cell population, after which the cells were treated with MG132 together with a
range of concentrations of VX680 for a further 2 hours. To compare the inhibition
produced by VX680 with that of MLN8054, the last lane of the gel was used for cells
which had been treated with 1 µM MLN8054 and MG132 in parallel to the VX680
treatments. After the various drug treatments, the cells were harvested and lysed, and
whole cell lysates were separated using SDS PAGE. Immunoblotting was used to detect
the presence of: Aurora A, Phopho-Aurora A (Thr288), phopho-Aurora B (Thr232),
phopho-TACC (Ser558), Aurora B and phospho-histone H3 (Ser10). The images
displayed represent results that were consistent over three independent experiments.
* It is claimed by the antibody manufacturer that the indicated band is generated by
antibodies against the phosphorylated form of Aurora C (Thr198), however I have no
evidence to support this.
A B
*
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3.3 ZM3 inhibits both Aurora A and Aurora B activity 
The next small molecule inhibitor selected for further characterisation was ZM3. This ZM-related 
compound had previously been reported to inhibit Aurora A activity 20-times more potently than 
ZM1 in kinase assays, making it an exciting new candidate for use in the investigation (Girdler et 
al., 2006). However, to corroborate the in vitro data and determine whether ZM3 could be used to 
specifically inhibit Aurora A activity in vivo, I treated both HeLa and DLD-1 cells with a range of 
ZM3 concentrations, then lysed and separated the samples by SDS PAGE. Immunoblotting the 
separated cell lysates revealed that, like VX680, ZM3 caused a reduction in phospho-Aurora A 
signal, confirming that ZM3 could also be used to inhibit Aurora A activity in both HeLa and 
DLD-1 cells (Figure 3.2). The immunoblots showed that Aurora A activity was inhibited in HeLa 
cell samples treated with 1 µM of ZM3, whereas in DLD-1 it took 4 µM of ZM3 before Aurora A 
activity was fully inhibited. Despite these encouraging results, Aurora B activity was also inhibited 
at similar concentrations as Aurora A, an observation that was deduced from the reduction in 
phospho-histone H3 band intensity. In fact, Aurora B activity even appeared to be affected at only 
0.25 µM of ZM3 in both cell lines, a finding which is consistent with published in vitro data, which 
described ZM3 as being more potent towards Aurora B activity than Aurora A (Girdler et al., 
2006). Therefore, although both ZM3 and VX680 can be used to inhibit Aurora A activity, their 
dual inhibition of Aurora B activity reduced the potential of using them as tools to specifically 
investigate Aurora A activity.  
3.4 MLN8054 can be used to inhibit Aurora A activity without also inhibiting Aurora B 
activity 
Subsequent to the finding that both VX680 and ZM3 lacked selectivity towards Aurora A, my 
search for a suitable investigative tool was extended to a third small molecule inhibitor: MLN8054. 
This is a compound that has been shown in vitro by it’s manufacturing company to be the first truly 
specific Aurora A inhibitor, thus making it an attractive potential tool investigate Aurora A activity 
(Hoar et al., 2007, Manfredi et al., 2007).  
To verify these claims and confirm MLN8054 specificity for Aurora A activity, I treated the cells 
with a range of MLN8054 concentrations before lysing and separating them by SDS PAGE. The 
immunoblotting of the separated lysates showed that both auto-phosphorylated Aurora A and 
phospho-TACC3 antibody signal were reduced following their treatment with increasing 
concentrations of MLN8054 (Figures 3.3A and 3.3B), showing that, consistent with the published 
literature, MLN8054 could be used to inhibit Aurora A activity (Hoar et al., 2007, Manfredi et al.,  
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2007). Aurora A activity was inhibited in both HeLa and DLD-1 cell lines by 1 µM MLN8054, 
although importantly Aurora B activity suffered no observable decrease at this concentration, as 
judged by levels of antibodies against the phosphorylated Aurora B and Histone H3 (Figures 3.3A 
and 3.3B). Importantly, Aurora B activity appeared to only be affected at 2 µM MLN8054 and 
above in DLD-1 cells, but not until 4 µM in HeLa cells. MLN8054 can therefore inhibit Aurora A 
activity without also inhibiting Aurora B in vivo, making it an ideal tool to probe the role of Aurora 
A activity.  
To quantitate the degree of Aurora A inhibition achieved by 1 µM MLN8054, I compared the level 
of phospho-Aurora A antibody staining seen on treated immunoblotted samples, with that of a 
series of increasingly diluted control samples presented on the same gel. Importantly however, 
phospho-Aurora antibody signal was not detectable on samples which were diluted below 5% of 
the total cell lysate (Figures 3.3C and 3.3D). Taking this antibody limitation into consideration, 
immunoblotted HeLa lysates from cells treated with 1 µM MLN8054 showed only an extremely 
weak phospho-Aurora A band, even when overexposing the blot (Figure 3.3C). In comparison, 
DLD-1 cell lysates treated with 1 µM MLN8054 showed a band similar to that observed by 
diluting down to 5% of the total control cell lysates. Therefore, by comparing diluted control 
samples with samples of cells treated with MLN8054, it was deduced that 1 µM MLN8054 
inhibited Aurora A activity to more than 95% in HeLa cells and to around 95% in DLD-1 cells.  
3.5 ZM3 and MLN8054 produce similar cellular phenotypes, while the comparative 
severity of the cellular effects of VX680 treatment may be indicative of its off-target 
effects  
All three small molecule inhibitors tested were shown to be capable of inhibiting Aurora A activity, 
however MLN8054 was the only compound that could potently inhibit Aurora A without also 
affecting the activity of Aurora B (Figure 3.3). These results were encouraging, although it was not 
yet clear whether MLN8054 exhibited inhibitory action towards kinases other than those of the 
Aurora family. Previously conducted tests show MLN8054 to be more potent for Aurora A activity 
in vitro than a panel of selected kinases, however the hundreds of remaining kinases that make up 
the human kinome have, as yet, not been tested (Hoar et al., 2007, Manning et al., 2002). It was 
therefore essential to further understand the specificity of MLN8054 before it could be used to 
investigate the role of Aurora A kinase activity.  
Therefore to explore whether MLN8054 exhibited inhibitory action in addition to Aurora A 
activity, I compared the cellular effects of MLN8054 with those seen after VX680 and ZM3  
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Figure 3.3 MLN8054 can be used to specifically inhibit Aurora A activity
HeLa (A and C) and DLD-1 cells (B and D) were treated with Nocodazole for 16 hours to
mitotically enrich the cell population. The cells were then treated with MG132 in
combination with a range of concentrations of MLN8054 for a further 2 hours, after which
the cells were harvested and lysed, and whole cell lysates were separated using SDS
PAGE. Immunoblotting was used to detect the presence of: Aurora A, Phospho-Aurora A
(Thr288), phospho-Aurora B (Thr232), phospho-TACC (Ser558), Aurora B and
phospho-histone H3 (Ser10). A range of increasingly diluted control cell lysates was used
as a comparative tool to enable the determination of the level of active Aurora A remaining
in HeLa (C) and DLD-1 cells (D) after treatment with 1 µM of MLN8054. The images
displayed represent results that were consistent over three independent experiments.
*It is claimed by the antibody manufacturer that the indicated band is generated by
antibodies against the phosphorylated form of Aurora C (Thr198), however I have no
evidence to support this.
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treatments. The thinking behind this methodology was that if used at concentrations that 
equivalently inhibited Aurora A activity, one would expect that that all three inhibitors would 
simply cause the equivalent range of spindle defects to the treated cells. This theory is based on a 
considerable body of evidence implicating Aurora A activity in spindle assembly (Peset et al., 
2005, Cowley et al., 2009, Liu and Ruderman, 2006, Roghi et al., 1998, Marumoto et al., 2003, 
Glover et al., 1995, Hannak et al., 2001, Girdler et al., 2006, Schumacher et al., 1998a, Berdnik and 
Knoblich, 2002, Hoar et al., 2007). The fact that Aurora B activity is also dually inhibited by ZM3 
and VX680 makes the comparison of their inhibition with that of MLN8054 a little more complex. 
However, because Aurora B activity is involved in resolving improper kinetochore-microtubule 
interactions and its inhibition has been shown to cause chromosome misalignment, any difference 
in chromosome alignment between the three inhibitors was disregarded so as to allow for a fair 
comparison of the inhibitors (Ditchfield et al., 2003, Hauf et al., 2003, Girdler et al., 2006). 
Therefore by comparing the cellular effects of the three small molecule inhibitors, and ignoring any 
differences in chromosome alignment caused by Aurora B inhibition, I hoped to highlight any 
additional off-target effects of the inhibitors, with particular emphasis on those of MLN8054.  
To enable the effective comparison of the effects of the three inhibitors, equivalent levels of Aurora 
A inhibition were determined by the examination of Western blots which exhibited the various 
inhibition profiles (Figures 3.1, 3.2 and 3.3). Analysis of the inhibitors inhibitory profiles in this 
way revealed that equivalent Aurora A inhibition was achieved by VX680 at 350 nM in HeLa and 
800 nM in DLD-1 cells, by ZM3 at 1 µM in HeLa and 4 µM in DLD-1 cells, and by MLN8054 at 1 
µM in both cell lines.  
When the selected inhibitor concentrations were applied to cells, which were consequently fixed 
and immunostained, all three inhibitors were found to produce a range of cellular effects in both 
HeLa and DLD-1 cells (Figure 3.4). Out of the three inhibitors however, VX680 appeared to cause 
the most severe cellular effects, with around 44% of DLD-1 cells observed to be monopolar, and 
the rest showing severely reduced spindle lengths (Figure 3.4B), which bears close resemblance  to 
the findings of two recently published reports  (Scutt et al., 2009, Tyler et al., 2007). In HeLa cells, 
VX680 caused the majority (76%) of HeLa cells to appear to have numerous centrosomal foci 
(Figure 3.4C), which is similar to a report of high numbers of multipolar HeLa cells following the 
microinjection of an inhibitory Aurora A antibody (Marumoto et al., 2003). 
In contrast to the effects of VX680 in HeLa cells, the treatment with MLN8054 or ZM3 allowed a 
large proportion the cells to form bipolar spindles (68% and 55% of MLN8054 and ZM3 treated 
cells respectively) (Figure 3.4C). Similarly, DLD-1 cells were also able to form bipolar spindles 
following MLN8054 or ZM3 treatment, although at slightly reduced levels compared to HeLa cells  
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(54% of MLN8054-treated cells and 42% of ZM3 treated cells) (Figure 3.4B). The observation of 
bipolar spindle formation following Aurora A inhibition in both DLD-1 and HeLa cells is 
surprising when considering the large amount of evidence implicating Aurora A in bipolar spindle 
assembly (Figures 3.4B and 3.4C) (Peset et al., 2005, Cowley et al., 2009, Liu and Ruderman, 
2006, Roghi et al., 1998, Marumoto et al., 2003, Glover et al., 1995, Hannak et al., 2001, Girdler et 
al., 2006, Schumacher et al., 1998a, Berdnik and Knoblich, 2002, Hoar et al., 2007). 
In addition to permitting bipolar spindle formation, treatment of cells with MLN8054 and ZM3 
produced very similar cellular phenotype ranges. DLD-1 cells exposed to the designated 
concentrations of MLN8054 or ZM3 exhibited a near-even mixture of monopolar, bipolar and 
mini-spindles (Figure 3.4B). This finding is similar to a published report of the effects of ZM3 
inhibition, which described around 29% of cells becoming monopolar following the treatment, 
while others were detected as having a range of normal and shortened spindle lengths (Girdler et 
al., 2006). The equivalent effects of MLN8054 on spindle length had not been described in the 
literature at the time of writing, however during the investigation a report was published describing 
the creation of around 75% abnormal spindles in HCT116 cells in response to treatment with 0.25 
µM MLN8054 for 5 hours (Hoar et al., 2007). This bears a close resemblance to the 66% of 
‘abnormal spindles’ (referred in my analysis as monopolar and mini-spindles) produced by 1 hour 
of 1 µM MLN8054 treatment in DLD-1 cells.  
Consistent with DLD-1 cells, HeLa also were observed to exhibit similar morphology profiles 
when exposed to the selected concentrations of MLN8054 or ZM3 (Figure 3.4C). HeLa cells did 
however not seem as affected by either drug treatment as DLD-1 cells, with only 11% and 14% of 
the cells having monopolar spindles after MLN8054 or ZM3 treatment respectively.  Interestingly 
though, proportionally more HeLa cells were observed as having multipolar spindles after 
MLN8054 or ZM3 treatments than in DLD-1 cells. This increase in multipolar spindles following 
Aurora A inactivation is similar, although not as pronounced, as seen that seen after VX680 
treatment or the microinjection of Aurora A antibodies into HeLa cells (Marumoto et al., 2003). 
Interestingly however, increasing the concentration of microinjected antibody was also reported to 
allow 85% of cells to form bipolar spindles, as opposed to the high proportion of multipolar 
spindles seen at the lower concentration (Figure 3.4C) (Marumoto et al., 2003). This surprising 
effect of apparently further reducing Aurora A activity, produces cellular effects that are similar to 
those seen after MLN8054 or ZM3 inhibition, instead of the more profound multipolar spindle 
phenotype seen after VX680 treatment of HeLa cells.  
Therefore, the initial hypothesis that all three Aurora inhibitors would produce similar cellular 
effects was incorrect. Instead, VX680 treatment caused distinct array of cellular phenotypes, 
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appearing to be the ‘odd one out’ of the three small molecule inhibitors, possibly indicating ‘off-
target’ inhibition (Figures 3.4A and 3.4B). Comparatively, the cellular effects of ZM3 and 
MLN8054 treatments are highly similar, suggesting that they may not affect the activity of ‘off-
target’ kinases. ZM3 however, was shown to inhibit Aurora B activity at equivalent concentrations 
to Aurora A. In comparison, MLN8054 acts specificity towards Aurora A activity over other the 
other family members, thus making it an ideal tool to probe the role of the kinase in mitosis.  
3.6 Summary 
In this chapter I have described my work into determining a small molecule inhibitor that could be 
used to specifically inhibit Aurora A activity in HeLa and DLD-1 cultured cells. Western blotting 
was used to select concentrations of three small molecule inhibitors, MLN8054, ZM3 and VX680, 
at which Aurora A activity could be potently inhibited. Consistent with the current literature 
however, Aurora B activity was inhibited in combination with Aurora A activity by both VX680 
and ZM3 (Bebbington et al., 2009, Harrington et al., 2004, Girdler et al., 2006). MLN8054 was 
found to be the only inhibitor out of the three tested that could be used to specifically inhibit 
Aurora A activity over Aurora B. This finding is consistent with published in vitro data, in which 
MLN8054 was found to be more than 40-times more selective for Aurora A activity than for that of 
Aurora B (Manfredi et al., 2007). In the same publication, in vitro data was used to show 
MLN8054 was more potent towards Aurora A activity than a panel of 226 other kinases. In 
agreement with these findings, comparative immunofluorescence microscopy revealed no obvious 
off-target effects produced by the MLN8054 or ZM3 treatment. Surprisingly however, treatment of 
cells with either MLN8054 or ZM3 appeared to only affect a small proportion of mitotic spindles 
despite potent Aurora A inhibition. This result appeared to conflict with findings described in the 
published literature, which links Aurora A inactivation with the observation of a high proportion of 
monopolar spindles (Roghi et al., 1998, Glover et al., 1995, Liu and Ruderman, 2006, Girdler et al., 
2006). In comparison, VX680 treatment caused more acute cellular phenotypes, which instead of 
being linked with more potent Aurora A inhibition, was predicted to reflect inhibition of off-target 
kinases due to the inconsistency with the other two inhibitor effects. Consistent with this idea, 
VX680 has previously been reported to target kinases other than the Aurora family (Harrington et 
al., 2004, Carter et al., 2005, Giles et al., 2007).  
Therefore in summary, all three of the small molecule inhibitors tested inhibit Aurora A activity 
with varying degrees of potency, which is consistent with reports in the published literature (Hoar 
et al., 2007, Manfredi et al., 2007, Girdler et al., 2006, Harrington et al., 2004, Bebbington et al., 
2009). MLN8054 however, was identified as the only small molecule out of the three, which could 
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be used to inhibit Aurora A activity without also inhibiting Aurora B in vivo. Furthermore, the 
comparison of the cellular effects of the three inhibitors indicated that, unlike ZM3 and MLN8054, 
VX680 may have had additional cellular effects other than to the Aurora family. The lack of 
specificity demonstrated by both VX680 and ZM3 therefore strengthened the decision to select 
MLN8054 as the best tool available for probing the role of Aurora A kinase activity. 
In the next chapter, I describe how MLN8054 was used as a tool to understand why a large 
proportion of spindles appeared to be unaffected by Aurora A inhibition, despite a large amount of 
literature to the contrary (Hoar et al., 2007, Manfredi et al., 2007, Girdler et al., 2006, Harrington et 
al., 2004, Bebbington et al., 2009).  
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4 Examining the role of Aurora A activity in spindle assembly 
4.1 Introduction 
In the last chapter I analysed the effects of three small molecule inhibitors and evaluated their 
specificity towards Aurora A activity. Surprisingly, it was revealed that most cells were capable of 
forming bipolar spindles in the absence of Aurora A activity despite reports describing a monopolar 
spindle phenotype after the inactivation of Aurora A kinase (Roghi et al., 1998, Glover et al., 1995, 
Liu and Ruderman, 2006, Girdler et al., 2006). The unexpected occurrence of bipolar spindles after 
Aurora A inhibition in my experiments therefore warranted further investigation. 
Despite the large body of evidence implicating a prominent role for Aurora A activity in spindle 
assembly, descriptions of this role do however vary throughout the published literature. Some 
groups have shown that bipolar spindles are present after the inactivation of Aurora A, although 
their spindles were often reported as being disorganised (Berdnik and Knoblich, 2002, Peset et al., 
2005, Giet et al., 2002, Hoar et al., 2007). Therefore it may be possible that effects of Aurora A 
inhibition may have gone undetected, as spindle organisation was not intricately scrutinised in the 
previous chapter. Thus to determine whether this was indeed the case, I performed a more detailed 
examination of spindles formed during MLN8054 treatment on to assess whether Aurora A activity 
had a more prominent role in spindle assembly than indicated in the previous chapter.   
4.2 Aurora A activity has a key role in spindle assembly  
Immunofluorescence microscopy was used to closely examine the spindles of immunostained 
control and MLN8054-treated HeLa cells. Clear images of the spindles were produced by 
extracting the cells before fixation, using conditions that maintained stable K-fibres but caused the 
loss of spindle and astral microtubules (Mitchison et al., 1986). The imaging of the cells revealed 
some distinct differences between the spindles exposed to the different treatments (Figure 4.1). 
Control cells displayed robust and clearly visible K-fibres, which formed bipolar spindles with well 
separated poles and chromosomes that were neatly aligned on the metaphase plate (Figure 4.1A). In 
contrast, bipolar spindles formed during MLN8054 treatment exhibited poorly defined K-fibres, 
with spindles that appeared to be shorter than those seen in control cells (Figure 4.1B). The vast 
majority of K-fibres seen in MLN8054-treated cells seemed to be attached to both kinetochores and 
the centrosomal area, however some long microtubules could also bee seen to extend away from 
the centrosomes towards the cytosol. The chromosomes were also often less organised, forming  
AZ138
Figure 4.1 Aurora A activity is required for the formation of normal spindle
structures
HeLa cells were treated with DMSO (A), 1 µM MLN8054 (B and D) or the Eg5 inhibitor
AZ138 (C) for 2 hours in combination with MG132. After treatment the cells were fixed and
immunostained with antibodies against Bub1 (green), Tubulin (red) and Pericentrin (blue
and green). Hoescht was used to identify the DNA (pink). Z-sectioned images were taken
of each of the cells and projected to produce the images shown.
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broader metaphase plates, with some chromosomes pulled closely into the poles. This showed that, 
although Aurora A inhibition did not prevent bipolar spindles from occurring, significant 
differences in spindle morphology were clearly visible when compared to control cells. Thus, 
Aurora A activity did appear to play a more prominent role in spindle assembly than indicated in 
the previous chapter. 
Having inspected the spindles of bipolar cells, I extended the investigation to monopolar cells, 
comparing those created by Aurora A inhibition with those seen after inhibiting Eg5 activity. Eg5 
is a plus-end directed motor protein, whose inhibition produces monopolar spindles by causing the 
collapse of the centrosomes through the inability to maintain their separation, without affecting the 
length of spindle fibres (Mayer et al., 1999, Walczak et al., 1998). By comparing the morphologies 
of the two monopolar spindle types, I hoped to highlight any further spindle abnormalities 
produced by Aurora A inhibition. The same extraction and immunostaining process was used to 
examine spindles, with the imaging of the cells showing that consistent with the published 
literature, treatment with the Eg5 inhibitor caused spindles to collapse (Mayer et al., 1999, Walczak 
et al., 1998). The resulting monopolar spindles exhibited straight, robust K-fibres, which radiated 
out from the centrosome area towards the attached chromosomes (Figure 4.1C). The chromosomes 
were mono-orientated with just one kinetochore of the pair attached to a K-fibre. These monotelic 
attachments were highlighted by weak Bub1 staining on the attached kinetochore sisters, while the 
unattached sisters showed strong Bub1 staining, reflecting the different level of microtubule 
connections with the kinetochores (Taylor et al., 2001). In comparison, the monopolar spindles 
formed during MLN8054 treatment and therefore in the absence of Aurora A activity, displayed 
noticeably shortened K-fibres, which caused the chromosomes to be pulled closely into the 
centrosomal area (Figure 4.1D). Furthermore, long non-kinetochore microtubules could sometimes 
also be seen to protrude from the centrosomal area, similar to those observed in MLN8054-treated 
bipolar cells (Figure 4.1B). These spindle abnormalities therefore demonstrate a prominent and 
complex role for Aurora A kinase activity in spindle assembly.   
4.3 Aurora A activity is involved in the separation of centrosomes 
Out of the many structural abnormalities seen after MLN8054 treatment, two of the most notable 
were the reduction of K-fibre length and degree of centrosome separation (Figures 3.4 and 4.1B). 
To test whether these observations represented a quantifiable reduction in the average spindle 
length, I measured the distance between the centrosomes of fixed and immunostained cells (Figure 
3.2A). The collection of the data revealed that populations of both control and MLN8054-treated 
cells exhibited a range of spindle lengths, presumably reflecting the different stages of centrosome  
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separation (Figure 4.2). When the inter-pole distances were plotted on a graph, the control cell data 
formed a bell-shaped distribution, with the most common category of inter-pole distance being 8 
µm to 8.99 µm (Figure 4.2B). In contrast, the largest category of MLN8054-treated cells (26%) had 
inter-pole distances of only 6 µm to 6.99 µm, which was notably shorter than the most common 
spindle length in control cells. A second peak could also be seen in MLN8054-treated samples, 
representing an increase in the proportion of cells with greatly reduced inter-pole measurements.  
Interestingly, the proportion of cells with greatly reduced inter-pole distances  (between 0 and 1.99 
µm long) is consistent with the proportion with monopolar spindles produced after MLN8054 
treatment described in chapter 3 (14% and 11% respectively) (Figure 3.4C and 4.1D). Therefore, 
although only a small proportion of cells become monopolar after Aurora A inhibition, Aurora A 
activity has a definite role in the separation of centrosomes in mitotic cells.  
4.4 Inhibiting Aurora A activity reduces the number of long K-fibres  
The examination of MLN8054-treated spindles appeared to indicate that they consisted of 
shortened K-fibres (Figures 4.1B and 4.1D). It was therefore hypothesised that the shortened K-
fibres may cause reduced spindle length, thus providing a possible explanation as to how Aurora A 
activity is involved in the determination of centrosome separation (Figure 4.2).  
To determine whether the reduction in K-fibre length observed in images of cells was quantifiable, 
I treated DLD-1 and HeLa cells with MLN8054, an Eg5 inhibitor or a combination of the two 
treatments. The samples were then extracted to remove all the tubulin polymers apart from K-
fibres, before fixing and immunostaining the cells. Antibodies against tubulin were used to observe 
K-fibres, while antibodies recognising Bub1 and Aurora A were used to detect kinetochores and 
centrosomes respectively. Using DNA and centrosomal staining as a guide for spindle polarity, 
images were taken only of cells with monopolar spindles. Circles of a fixed size were then placed 
over the cell images, and the number of long K-fibres per cell was determined by counting Bub1 
foci that fell outside of the circle circumference (Figure 4.3A).  
As a negative control for the experiment, cells were treated with an Eg5 inhibitor, which caused the 
formation of monopolar spindles consisting of K-fibres radiating out from the centrosomal area 
towards the connected kinetochores (Figure 4.3A). The chromosomes of within cells treated with 
the Eg5 inhibitor were situated at a distance from the centre of the cell, producing a relatively 
disperse effect. In contrast, the chromosomes of cells treated with MLN8054 were seen to be 
tightly clustered around the centrosomal area. Similarly, the dual inhibition of Eg5 and MLN8054 
also caused chromosomes to appear gathered in towards the collapsed centrosomes. To determine 
whether this positioning of chromosomes close to the centrosomes reflected a shortening of K- 
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fibres, the number of Bub1 foci pairs present outside of the analysis circles was analysed. DLD-1 
cells treated with an Eg5 inhibitor had an average of 28 Bub1 foci pairs outside of the analysis 
circles, which dropped to only 7 when cells were treated with MLN8054 or 15 when combining the 
Eg5 and MLN8054. Similarly, Eg5 inhibition in HeLa cells allowed an average of 48 Bub1 foci 
pairs to be counted outside analysis circles, compared with 16 and 15 after MLN8054 and the 
combined treatments respectively. Therefore, the relatively low number of Bub1 foci pairs recorded 
after MLN8054 treatment, indicated that Aurora A inhibition did indeed cause a reduction in the 
presence of long K-fibres. Therefore, Aurora A activity must therefore have a role in determining 
K-fibre length,  which  may explain the diminished inter-pole distances also seen after MLN8054 
treatment (Figure 4.1 and 4.2).  
4.5 Aurora A activity is required to maintain the separation of centrosomes 
The data so far in this chapter has shown that Aurora A activity is required the formation of normal 
bipolar spindles, although it is not clear whether Aurora A activity is also required to maintain a 
bipolar spindle (Figures 3.4, 4.1, 4.2 and 4.3). Previous investigations, carried out in Xenopus egg 
extracts, describe the collapse of previously formed bipolar spindles after the addition of a 
recombinant kinase-dead Aurora A protein, a monoclonal Aurora A antibody or the non-catalytic 
region of Aurora A (Giet and Prigent, 2000, Giet and Prigent, 2001). These observations therefore 
demonstrate that, in Xenopus egg extracts at least, Aurora A activity is required to maintain a stable 
bipolar spindle. Using a similar methodology, I examined whether this was also the case in human 
cells, by inhibiting Aurora A activity in cells with previously assembled bipolar spindles. However, 
before I could investigate the role of Aurora A activity in bipolar spindle maintenance, I first 
explored potential positive controls for the experiment, a line of investigation which was to give an 
intriguing and unexpected outcome.  
An ideal positive control would be a condition which would both prevent the development of a 
normal bipolar spindle (as seen after Aurora A inhibition), as well as hindering the maintenance of 
spindle bipolarity.  Eg5 inhibition was selected as a potential positive control, as it has previously 
been found to be required for the formation of bipolar spindles, and was therefore predicted to also 
be required for bipolar maintenance (Figure 3.1C; (Walczak et al., 1998, Mayer et al., 1999). 
Indeed, consistent with the published literature, inhibiting Eg5 activity in DLD-1 cells revealed that 
the cells were unable to separate their centrosomes (Figure 4.4A). In comparison, although the 
majority of HeLa cells also were unable to separate their centrosomes after Eg5 inhibition, 33% 
were still able to form bipolar spindles (Figure 4.4B). Despite this proportion of bipolar HeLa cells,  
Figure 4.4 Eg5 activity is required for the maintenance of spindle bipolarity in DLD-1
but not in HeLa cells
DLD-1 (A) and HeLa cells (B) were treated with MG132 or MG132 and the Eg5 inhibitor
AZ138 for 2 hours. The cells were then fixed and stained with Hoechst to observe DNA
and antibodies against Aurora A to determine the resulting spindle phenotype, which were
then plotted on in the form of histograms. (C) Diagram representing the protocol used to
observe the effect of Eg5 inhibition on the maintenance of bipolar spindles. Cells were
treated as indicated in protocol (C), then fixed and stained with Hoechst and antibodies
against Aurora A. The resulting spindle phenotypes seen in DLD-1 and HeLa cells were
displayed in graphs (D) and (E) respectively. In the graphs (A), (B), (D) and (E) 300 cells
were counted for each condition from 3 independent experiments. Error bars represent
s.e.m.
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Eg5 activity was clearly required in the majority of cells analysed for the creation of spindle 
polarity.  
To test whether Eg5 activity was also required to maintain a bipolar spindle, I first collected cells 
with assembled bipolar spindles by treating cell samples with the proteosome inhibitor MG132. 
This has been shown to inhibit the degradation of Securin and other target proteins of the anaphase 
promoting complex, consequently preventing the onset of anaphase and stopping any additional 
cells from entering mitosis, thus resulting in an accumulation of cells with bipolar spindles 
(Sherwood et al., 1993, Wojcik et al., 1996). These cells were then exposed to an Eg5 inhibitor to 
determine whether they required the activity of Eg5 to maintain their bipolarity (Figure 4.4C). 
DLD-1 bipolar cells collapsed following the treatment, confirming that Eg5 activity was required to 
maintain bipolar spindles (Figure 4.4 D). Surprisingly however, the equivalent treatment in HeLa 
cells showed that 90% were able to maintain separated centrosomes (Figure 4.4E). This unexpected 
divergence in results therefore revealed some important differences that exist between HeLa and 
DLD-1 cells, which will be discussed in the summary in more detail, as well as highlighting the 
danger of forming universal assumptions based on a single cell line.  
Despite this unexpected result, the experimental test showed that the protocol could be used to 
investigate the capacity of cells to maintain their bipolar spindles in response to drug treatment. 
Therefore, following an adapted version of the protocol, I treated bipolar DLD-1 cells with 
MLN8054 to determine if they were dependent on Aurora A activity for the maintenance of their 
bipolarity (Figure 4.5A). The quantitation of the cells revealed that MLN8054 treatment caused 
only 11% of the bipolar spindles to collapse into monopolar or mini-spindles, while the majority 
(76%) were able to maintain their bipolarity (Figure 4.5B). This result appeared to indicate that 
most cells did not require Aurora A activity to maintain their bipolar spindles. However, a similar 
method of spindle phenotype characterisation, employed in the previous chapter, was found to be 
misleading resulting in the underestimation of the full effects of Aurora A inhibition (Figure 3.4). 
Therefore, to explore whether the bipolar cells were truly unaffected by the Aurora A inhibition, I 
measured their inter-pole distances. The analysis of control bipolar inter-pole distances showed 
they were maintained at an average length of 12.6 µm, while MLN8054 treatment significantly 
reduced the bipolar inter-pole distance to 9.4 µm (Figure 4.5C). Therefore, although it did not 
cause the complete collapse of centrosomes, Aurora A activity was required for the maintenance of 
normal spindle length in DLD-1 cells.  
To determine whether HeLa cells were also dependent on Aurora A activity for the maintenance of 
normal spindle bipolarity, the same protocol was used (Figure 4.6A). The analysis of the resulting 
effects showed that, similar to as observed in DLD-1 cells, only a small proportion (8%) of HeLa  
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bipolar cells collapsed following Aurora A inhibition, while the majority of cells were analysed as 
remaining bipolar. To determine whether these bipolar spindles were reduced in length, similar to 
observed in DLD-1 cells, they were also measured. The measurement of the bipolar spindles 
revealed that while the average inter-pole distance of control bipolar HeLa cells was 10.4 µm, 
MLN8054 treatment caused a significant reduction in the spindle length of bipolar cells to 6.9 µm. 
Therefore the combined HeLa and DLD-1 data demonstrates that Aurora A activity is required to 
maintain the normal inter-pole separation in both HeLa and DLD-1 cells.  
4.6 Aurora A activity is required for the maturation of the centrosome 
Aurora A activity is clearly involved in both the efficient formation and maintenance of mitotic 
spindles, however to explore how the kinase is involved in these processes, I analysed changes in 
the cellular localisation of particular spindle components in response to Aurora A inhibition. 
Through the detailed analysis of changes in the localisation of various cellular components I hoped 
to identify regulatory pathways that may be dependent on Aurora A activity. 
The Aurora A protein itself has been found to be rapidly exchanged between the centrosome and a 
cytoplasmic pool (Stenoien et al., 2003, Berdnik and Knoblich, 2002), although in Xenopus, its 
centrosomal localisation has been reported to be stabilised by substrate interaction (Giet and 
Prigent, 2001, Roghi et al., 1998, Stenoien et al., 2003). Furthermore, the application of VX680 to 
DLD-1 cells has also been shown to cause a reduction of the proportion of Aurora A protein that is 
localised to centrosomes (Tyler et al., 2007). These findings suggest that Aurora A localisation may 
be effected by its activity, however previously discussed evidence suggests that VX680 may have 
off-target effects (Figure 3.4). Furthermore, both a kinase-dead mutant and small molecule 
inhibited Aurora A have been shown to still be able to localise to the centrosomes, indicating that 
its activity may not be required for its localisation (Girdler et al., 2006, Manfredi et al., 2007). To 
resolve these discrepancies in the current literature and determine if Aurora A localisation is indeed 
dependent on its activity, I analysed images of fixed cells that had been immunostained with 
antibodies against Aurora A to determine any changes in response to MLN8054 treatment (Figure 
4.7A). In control cells, Aurora A was strongly localised to the centrosomes and along the spindle 
microtubules. Cells exposed to MLN8054 however, showed reduced Aurora A antibody staining on 
the spindle, although no apparent reduction could be seen in Aurora A centrosome localisation. 
Intriguingly however, if the protocol was altered so as not to extract the cells before their fixation, 
no change could be seen in the localisation of Aurora A antibody to either the centrosomes or the 
spindle after MLN8054 treatment when compared to control cells (data not shown). This therefore 
suggests that Aurora A activity may not be required for the localisation of Aurora A protein to the  
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centrosome and spindle. However, because Aurora A protein could be partially ‘washed away’ 
from the spindle after MLN8054 treatment by extracting them before fixation, the kinase activity 
may be just one of the cellular features required for the stable localisation of the protein to the 
spindle microtubules.  
Aurora A activity has also been reported to be required for the localisation of various other spindle 
and centrosomal components during the process of centrosome maturation (Berdnik and Knoblich, 
2002, Hannak et al., 2001, Mori et al., 2007, Terada et al., 2003).  In particular, the phosphorylation 
of TACC by Aurora A has been reported to be required for the localisation of TACC protein to the 
spindle and centrosome (Giet et al., 2002, Kinoshita et al., 2005, LeRoy et al., 2007). Contrary to 
these findings however, a mutant form of TACC, which cannot be phosphorylated on a Aurora A 
consensus phosphorylation site, has been shown in Drosophila embryos to partially localise to 
centrosomes (Barros et al., 2005). To determine any differences in TACC localisation after Aurora 
A inhibition in my experimental set up, I once again used immunofluorescence microscopy to 
observe changes in protein localisation after MLN8054 treatment. The observation of 
immunostained cells enabled me to confirm that TACC3 was localised along the spindle 
microtubules and on the centrosomes of control cells (Figure 4.7B). The inhibition of Aurora A 
activity with MLN8054 treatment however, caused TACC3 to be completely mislocalised from the 
centrosomes and spindle, thus confirming that Aurora A activity was indeed required for TACC3 
localisation.  
A demonstrated role for TACC at the centrosome and spindle, is to load chTOG/XMAP215 onto 
the minus-ends of the microtubules and cause an increase to its microtubule stabilising activity 
(Peset et al., 2005, Lee et al., 2001, Gergely et al., 2003, Kinoshita et al., 2005). I therefore wanted 
to determine if the mislocalisation of TACC3 from the centrosome and spindle, which was seen 
after Aurora A inhibition, also caused the mislocalisation of chTOG. Immunofluorescence 
microscopy revealed that chTOG was clearly localised to the centrosomal area of control cells. 
This localisation was reduced in some of the cell population after treatment with MLN8054, 
however a proportion of cells seemed not be effected (Figure 4.7C). Therefore to determine 
whether Aurora A inhibition caused an overall mislocalisation of chTOG from centrosomes, I 
quantified antibody intensity at the centrosomes of monopolar cell samples, and then divided this 
by its level in the rest of the cell. This latter step was employed to normalise the antibody intensity 
readings and give a value of chTOG ‘centrosome/cell’. By inhibiting Eg5 activity, I was able to 
induce the monopolarity and allow efficient and comparable analysis of the centrosomal and 
cellular chTOG levels. Following this methodology, it was revealed that cells exposed to just Eg5 
inhibition showed average levels of chTOG at 9.3 centrosome/cell, whereas MLN8054 treatment 
combined with Eg5 inhibition caused the antibody intensity to be reduced to 7.5 centrosome/cell  
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Figure 4.7 Aurora A activity is required for the proper localisation of Aurora A,
TACC3 and chTOG in HeLa cells
HeLa cells were treated with 1 µM MLN8054, AZ138 or a combination of the two
treatments for 2 hours. The samples were fixed and stained with Hoescht to visualise DNA
and immunostained with Tubulin in combination with Aurora A (A), TACC3 (B) or
chTOG(C) to observe changes in protein localisation (scale bars = 3 µM). All images
shown were created from projected z-section images. The localisation of chTOG was
quantitated in (D) by determining antibody intensity at the centrosome then normalising it
by dividing the value at the centrosome by the antibody intensity from the whole cell. The
graph represents data taken from 3 independent experiments. *** = P<0.001 two-tail
t test.
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(Figure 4.7D). This therefore confirmed that Aurora A activity was involved in localising chTOG 
to the centrosome.  
The localisation of Kif2a and MCAK have also been shown to be regulated by Aurora A activity 
(Jang et al., 2009, Zhang et al., 2008). Interestingly both have also been shown to effect 
microtubule stability and are required to maintain normal steady state microtubule length, 
microtubule nucleation and spindle bipolarity (Ganem and Compton, 2004, Jang et al., 2008, 
Manning and Compton, 2007, Moore and Wordeman, 2004, Walczak et al., 1996, Zhang et al., 
2008). I could not however, detect any changes in the localisation of either Kif2a or MCAK after 
MLN8054 treatment (data not shown). 
4.7 Summary 
In this chapter I described how Aurora A activity is involved in the separation of centrosomes and 
the determination of spindle length, a role which is likely to be at least partially dependent on the 
control of K-fibre length. Aurora A inhibition did not however, have as a profound effect on 
spindle bipolarity as inhibiting Eg5 activity, or produce effects as potent as described in previous 
publications (Roghi et al., 1998, Glover et al., 1995, Liu and Ruderman, 2006, Girdler et al., 2006). 
Despite this, the detailed examination of spindles formed in the absence of Aurora A activity 
nonetheless indicated that Aurora A activity plays an important role in spindle construction.  
The spindle abnormalities seen after MLN8054 treatment indicate that the inactivated Aurora A 
kinase is unable to perform its usual roles in the phosphorylation and organisation of various 
spindle and centrosomal components. Indeed, the stable localisation of a proportion of Aurora A 
protein to the spindle was found to be dependent on its activity. Furthermore, consistent with 
previous reports, Aurora A activity was also found to be required for the proper localisation of 
TACC3 to the centrosomes and spindle (Giet et al., 2002, Kinoshita et al., 2005, LeRoy et al., 
2007). This relationship between TACC3 and Aurora A activity may be responsible for the 
determination of K-fibre length, as shortened microtubules were also seen in Drosophila embryos 
expressing non-phosphorylateable TACC3 (Barros et al., 2005). Similar to TACC3, chTOG was 
also dependent on Aurora A activity to achieve normal levels of localisation to the centrosome. 
This reduction of chTOG at centrosomes after Aurora A inhibition may have been the result of 
TACC3 mislocalisation, as TACC is proposed to load chTOG/XMAP215 onto the minus-ends of 
the microtubules (Peset et al., 2005, Lee et al., 2001, Gergely et al., 2003, Kinoshita et al., 2005). 
The reduction in the levels of chTOG on the centrosome may have contributed to the 
disorganisation of spindles after MLN8054 treatment, as similar spindle abnormalities have also 
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been seen after the depletion of chTOG/XMAP215 (Cassimeris and Morabito, 2004, Gergely et al., 
2003).  
In addition to Aurora A activity being involved in spindle formation and maintenance, consistent 
with published reports, data presented during this chapter demonstrated that Eg5 activity also 
played a part in spindle development (Blangy et al., 1995). Interestingly however, inter-cell line 
differences were observed in response to the requirement for Eg5 activity in the formation and 
maintenance of spindle bipolarity. Indeed, while DLD-1 cells were prevented from forming bipolar 
spindles following Eg5 inhibition (Figure 4.4A), 33% of HeLa cells were found to exhibit bipolar 
spindles after the same treatment (Figure 4.4B). Furthermore, bipolar spindles which had been 
previously formed in DLD-1 cells were unable to be maintained after Eg5 inhibition, causing them 
to collapse into monopolars (Figure 4.4D). In contrast, 90% of HeLa cells were able to maintain 
previously formed bipolar spindles once Eg5 activity was inhibited (Figure 4.4E).  
These contrasting responses to Eg5 inhibition may be explained by the different methods employed 
by the cell lines to separate and maintain the separation of centrosomes.  HeLa cells are capable of 
separating their centrosomes before nuclear envelope breakdown through the nucleation of astral 
microtubules and their associations with cortical actin and the actin cytoskeleton (Whitehead et al., 
1996, Buttrick et al., 2008, Robinson et al., 1999, Cytrynbaum et al., 2005, Cao et al., 2010). 
Conversely, DLD-1 cells exhibit late centrosome separation, which is dependent on astral 
microtubules connections with the cell cortex following nuclear envelope breakdown and the 
nucleation of the spindle microtubules (see (Morrow et al., 2005) for schematic). These 
observations may highlight integral differences in spindle construction between the two cell lines 
which may therefore explain their divergent dependencies on Eg5 activity.  
A further explanation for the differences in response to Eg5 inhibition may be that HeLa cells could 
be able to maintain centrosome separation early in mitosis due to the dependence on astral 
microtubules before nuclear envelope breakdown. Therefore when Eg5 activity is inhibited, HeLa 
cells may rely on astral microtubule connections to separate and maintain the separation of their 
centrosomes before the formation of spindles, which may represent the 33% of bipolar spindles 
observed after MLN8054 treatment. HeLa cells may also have increased astral microtubule 
attachments after the formation of a spindle, which may offer support the bipolar spindle structure 
when Eg5 activity is inhibited. Immature HeLa spindles, which are unable to form appropriate 
levels of support to stabilise their bipolarity may however collapse on inhibition of Eg5, possibly 
explaining why 90% and not 100% of HeLa cells are able to maintain their bipolarity after Eg5 
inhibition (Figure 4.4B). Consistent with the dependency of HeLa cells on astral microtubules, 
previous reports have highlighted the presence of astral microtubules as acting as spindle tethers in 
HeLa cells (Thery et al., 2007).  In contrast, DLD-1 cells may not have an equivalent supportive 
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spindle mechanism and this may explain why they are not capable of maintaining previously 
formed bipolar spindles on Eg5 inhibition. This is however a speculative hypothesis, and there are 
other potential explanations for the inter-cell line variation, such as the differing sensitivities of the 
two cell lines to the Eg5 inhibitor. 
Despite the inter-cell line differences observed in response to Eg5 inhibition and whatever their 
cause may be, the main focus of this chapter was the demonstration that Aurora A activity is 
involved in the process of spindle formation and maintenance. In the next chapter, I will describe 
whether this role for Aurora A activity in spindle assembly extends to the ability to efficiently align 
chromosomes.  
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5 Investigating the importance of Aurora A activity in 
chromosome alignment  
5.1 Introduction 
The major function of the mitotic spindle is to properly align chromosomes to form a metaphase 
plate, it is therefore unsurprising to learn that conditions which disrupt the proper functioning of the 
spindle, also cause chromosomal misalignment (Mayer et al., 1999, Gascoigne and Taylor, 2008, 
Schneider et al., 2007). Thus, as Aurora A activity has been shown to have an important role in 
spindle assembly (Figures 4.1 to 4.7) it was apparent that it may have an additional function in the 
alignment of chromosomes. Aurora A has even been shown to interact with the kinetochore protein 
CENP-A, which has been implicated in the recruitment of various proteins to the kinetochore, thus 
the proper functioning of the kinetochore (Kunitoku et al., 2003). Indeed, consistent with a role for 
Aurora A activity in chromosome alignment, previous investigations have shown that the 
inactivation of Aurora A kinase to causes severe chromosomal misalignments (Glover et al., 1995, 
Mori et al., 2007, Girdler et al., 2006, Liu and Ruderman, 2006). The chromosome misalignments 
described in these publications, were however reported to occur as a result of the high occurrence 
of monopolar spindles. Such potent monopolar effects were not seen after Aurora A inhibition in 
my investigation, nor were they in a number of similar investigations (Berdnik and Knoblich, 2002, 
Peset et al., 2005, Hoar et al., 2007). I therefore set about to determine whether the less acute 
spindle defects produced by the Aurora A inhibition during my investigation would also cause 
problems with chromosome alignment during mitosis. This investigation would consequently 
facilitate both a better understanding of the role Aurora A activity in the regulation of spindle 
assembly and determine whether this role extends to facilitating proper spindle function.  
5.2 Aurora A activity is required for efficient chromosome alignment 
To test the efficiency of cells to align chromosomes, I first induced a consistent degree of 
chromosomal misalignments by treating HeLa cells with an Eg5 inhibitor. I then washed away the 
inhibitor, and allowed the cells to recover from the induced alignment defects in a series of 
different conditions (Figure 5.1A). After this recovery period, the cells were fixed and 
immunostained to observe any problems in chromosome realignment.  
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Analysis of the fixed cell samples revealed that maintaining exposure to the Eg5 inhibitor produced 
severe chromosome misalignment in 100% of cells (Figure 5.1B), with 97% also displaying 
monopolar spindles, a phenotype that is consistent with the published literature (Figure 5.1C) 
(Mayer et al., 1999, Kapoor et al., 2000). The high occurrence of monopolar spindles after Eg5 
inhibition indicates that the chromosomal misalignments were a consequence of the acute spindle 
defects. In contrast to sustained Eg5 inhibition, the removal of the Eg5 inhibitor and its 
replacement with DMSO, allowed 97% of cells to form bipolar spindles, most of which were able 
to align their chromosomes. In fact, only 9% of cells allowed to recover from the Eg5 inhibition in 
DMSO showed signs of severe chromosomal misalignment. Conversely, when an Aurora B 
inhibitor was applied to cells after the removal of the Eg5 inhibitor, severe chromosome 
misalignments were seen in 96% of cells analysed. This inability to align chromosomes in the 
absence of Aurora B activity is consistent with previous reports implicating Aurora B activity in 
the process (Kapoor et al., 2000).  However, unlike the sustained Eg5 treatment, which produced a 
similar severity in chromosome alignment defects, 94% of cells treated with the Aurora B inhibitor 
were seen to have bipolar spindles after Aurora B inhibition.  
To determine whether Aurora A activity, like that of Aurora B, was required for efficient 
chromosome alignment in the presence of a bipolar spindle, I analysed the fixed cell samples to 
assess their ability to recover from Eg5 inhibitor-induced alignment defects in the presence of  1 
µM MLN8054 (Figure 5.1A). The quantitation of the treated cells revealed that most showed signs 
of chromosomal misalignment after the treatment with only 23% of MLN8054-treated cells 
displayed neatly organised metaphase plates (Figure 5.1B). This level of chromosome 
misalignment therefore demonstrates that Aurora A activity was indeed required for efficient 
chromosome alignment in cells. Interestingly however, similar to the effects of Aurora B inhibition, 
the majority (78%) of MLN8054-treated cells exhibited bipolar spindles (Figure 5.1C). This 
finding is comparable to data derived from the depletion of Aurora A or the use of micro-injected 
antibody to disrupt its function, both of which caused misalignment defects despite the formation 
of a bipolar spindle (Marumoto et al., 2003, Kunitoku et al., 2003).  
The inability to align chromosomes therefore suggests that either, similar to the effects of Aurora B 
inhibition, the chromosome alignment defects were not a result of inadequately formed spindle 
structures, or conversely, the complete effects of the Aurora A inhibition on spindles were not 
detected. To investigate the latter possibility, I measured the inter-pole distances of the cells to 
highlight any potentially undetected defects in the spindles (Figure 5.1D). Unsurprisingly, the 
measurement of the inter-pole distance of cells exposed to sustained Eg5 inhibition, revealed an 
average measurement of only 1.6 µm, reflecting the monopolarity of the spindles. In comparison, 
washing the effects of Eg5 inhibition from cells and replacing it with either DMSO or the Aurora B  
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Figure 5.1 Aurora A activity is required for the efficient alignment of chromosomes
in HeLa cells
(A) The protocol used to determine whether Aurora A activity has a role in chromosome
alignment. After treating HeLa cells according to the protocol outlined in (A), cells were
then fixed and immunostained with antibodies against Pericentrin and Tubulin to
determine the spindle phenotype and Aurora B together with Hoerscht to allow
determination of chromosomal alignment. (B) Quantitation of chromosomal alignment.
Cells were classified as having ’mild’ misalignment if up to four of their chromosomes
were unaligned, or if there were more than four, they were classified as having ’severe’
misalignment. Cells were classified as being ’aligned’ if all their chromosomes were in the
form of a neat metaphase plate. Cell samples treated with 1 µM MLN8054 were found to
have significantly fewer bipolar spindles than those threated with DMSO. (C) Histogram to
show spindle phenotypes of the samples treated as indicated in (A). (D) Measurement of
spindle lengths of samples treated as indicated in (A), calculated from z-stacked images.
All graphs represent data taken from three independent experiments. ** = P<0.01 two-
tailed t test.
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inhibitor, showed average spindle lengths of 8.9 µm and 9.5 µm respectively. Importantly however, 
if cells were instead treated with MLN8054 after removing the Eg5 inhibitor, an average spindle 
length of only 5.7 µm was detected. Some cells were even recorded to have spindle lengths as low 
as 1.9 µm. Therefore, although MLN8054 did not have such a dramatic an effect on spindle 
polarity as Eg5 inhibition, the observed shortened spindle lengths after MLN8054 treatment 
showed that Aurora A activity was required in the process of spindle reassembly after induced 
monopolarity. This role for Aurora A activity in spindle formation is consistent with previous 
observations (Figure 4.2), and may provide an explanation as to why cells are unable to realign 
their chromosomes after Aurora A inhibition.   
5.3 Aurora A activity is required for the regulation of microtubule nucleation and 
organisation 
Having clearly shown that Aurora A activity functions in the regulation of the assembly of spindle 
structures (Figure 4.1, 4.2 and 5.1), I next sought to identify how the kinase controls spindle 
formation and function. Many reports, including those in the previous chapter, have linked the 
presence of the Aurora A protein or its kinase activity to the maturation of centrosomes, thus 
implicating a role for the kinase in the regulation of microtubule nucleation from the centrosome 
(Figure 4.7) (Mori et al., 2007, Terada et al., 2003, Hannak et al., 2001, Berdnik and Knoblich, 
2002, Hachet et al., 2007, Barros et al., 2005, Piehl et al., 2004). Aurora A activity has also been 
associated with the regulation of spindle formation in the absence of centrosomes in Xenopus egg 
extracts (Koffa et al., 2006, Liu and Ruderman, 2006, Zhang et al., 2008). In support of this 
finding, chromosome/kinetochore microtubule nucleation has also been linked to the interaction of 
Aurora A with its activator, TPX2, in human cells (Bird and Hyman, 2008). These studies all 
indicate that Aurora A kinase activity serves to regulate the nucleation of microtubules in order to 
create normal spindle structures, which could explain why reduced K-fibre lengths and inter-pole 
measurements are seen after Aurora A inhibition (Figure 4.2 and 4.3). 
To confirm whether the role described for Aurora A activity in the regulation of microtubule 
nucleation would explain the abnormal spindle structures seen after MLN8054 treatment, I 
analysed the effect of the treatment on microtubule repolymerisation. To effectively observe 
microtubule repolymerisation, I first induced the depolymerisation of all cellular microtubules 
through a combination of cold treatment and the depolymerising effects of Nocodazole. The cells 
were subsequently incubated in warmed Nocodazole to ensure that they were able to regain their 
function after the cold treatment. When released from the Nocodazole, the cells were allowed to 
repolymerise in a range of different conditions, before being fixed and immunostained to observe 
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their tubulin polymers and various kinetochore components (Figure 5.2). As a comparative control 
for the experiment, I maintained the exposure of some cells to Nocodazole, to enable the 
examination of cells that were completely unable to reform spindles (Figures 5.2 A(i) and 5.3 A). 
Interestingly, unlike cells analysed immediately after the Nocodazole and cold treatment (data not 
shown), immunofluorescence microscopy revealed that a large number of short tubulin polymer 
stubs were present over the DNA of the Nocodazole treated cells. This suggested that a limited 
amount of centrosome-independent microtubule nucleation may have been possible, although the 
tiny microtubule polymers were clearly unable to form any kind of spindle. The ability to carry out 
chromosome/kinetochore microtubule nucleation has been previously reported to be dependent on 
the interaction of Aurora A with its activator, TPX2 (Bird and Hyman, 2008). This observation thus 
indicates that the process of chromosome/kinetochore nucleation may be reliant on active Aurora 
A. To test this theory, preceding the cold and Nocodazole treatments, I treated cells with MLN8054 
in combination with Nocodazole, and looked for evidence of similar microtubule polymers over the 
DNA (Figure 5.2B(i)). In contrast to the effects seen after preventing Aurora A and TPX2 
interaction however, the inhibition of Aurora A activity did not appear to cause a reduction in the 
level of the small tubulin polymers, suggesting that Aurora A activity may not be required for the 
initiation of chromosome directed microtubule nucleation (Figure 5.3B) (Bird and Hyman, 2008). 
To determine whether Aurora A activity was required for the control of more general microtubule 
polymerisation, I observed spindles which were permitted to form in the absence of Nocodazole 
(Figure 5.2Aii). Unsurprisingly, in cells which had not been treated with either Nocodazole or 
MLN8054, microtubules were able to polymerise and form bipolar spindles with robust K-fibres, 
which emanated out from the centrosomal area and attached to the kinetochores of chromosomes 
(Figure 5.3C). These K-fibre attachments were highlighted by low Mad2 levels at kinetochores and 
the neat organisation of chromosomes within cells (Waters et al., 1998, Chen et al., 1996, Waters et 
al., 1996). Importantly however, microtubules nucleated in the presence of MLN8054 were 
noticeably disorganised compared with those within control spindles (Figures 5.2B(ii) and 5.3B). 
In many cases, the spindles of MLN8054-treated cells did not appear to have any clear canonical 
structure, and were made up of unfocused and often crooked microtubules of varying thickness and 
length. Some microtubules could even be seen to extend outside of the spindle bundle, with their 
unattached ends stretching out into the cell with no apparent function. Despite the disorganised and 
chaotic state of the spindles formed in the absence of Aurora A activity, the spindle fibres appeared 
to be attached to kinetochores, as judged by low levels of Mad2 at kinetochores. Unsurprisingly 
however, the chromosomes within the cells were not generally aligned on the metaphase plate. 
From the immunofluorescent images of the various samples it can therefore be deduced that Aurora 
A activity is involved in the regulation of microtubule nucleation, and is necessary for their 
organisation and the formation of a functional spindle. 
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Figure 5.2 Protocols to determine whether Aurora A activity is involved in the
regulation of microtubule nucleation and organisation
(A(i))-A(iii)) Protocols used to examine the regrowth of microtubules in the absence of
MLN8054 treatment. (B(i)-B(iii)) Protocols used to examine the regrowth of microtubules
following MLN8054 treatment.
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Figure 5.3 Aurora A activity regulates the formation and organisation of spindle
microtubules
Immunofluorescence images of HeLa cells treated according to the microtubule regrowth
protocols shown in Figure 5.2:
(A) Nocodazole: Figure 5.2A(i)
(B) MLN8054 and Nocodazole: Figure 5.2B(i)
(C) Control: Figure 5.2A(ii)
(D) MLN8054: Figure 5.2B(ii)
The cells were fixed and immunostained with antibodies against ACA (red), Tubulin
(green) and Mad2 (blue), Hoescht was use to visualise the DNA (white). Z-sectioned
images were taken of the samples, which were then projected to produce the images
shown. Blow-ups were used to highlight microtubule-kinetochore attachments.
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5.4 Aurora A activity is required for the formation of a functional spindle 
The chromosome misalignments observed in cells with spindles nucleated in the absence of Aurora 
A activity indicated that the kinase activity is required for the regulation of spindle function as well 
as the formation of its structure.  An alternative hypothesis however, is that Aurora A activity may 
be required for the proper attachment of kinetochores to the spindle microtubules. In support of this 
hypothesis, the activity of Ipl1, the single yeast Aurora kinase, has been shown to be involved in 
the regulation of chromosome attachment to the spindle, indicating that mammalian Aurora A may 
also have a similar role (Biggins and Murray, 1999, Li et al., 2002, Biggins and Murray, 2001). 
Furthermore, I have been able to faintly detect Aurora A antibody at the centromeres of 
immunostained cells, which may indicate a proportion of cellular Aurora A which may carry out its 
potential function in regulating microtubule attachments (Figure 5.4A). Aurora A over-expression 
has also been shown to cause an increase in unattached chromosomes, thus potentially 
strengthening the association between the kinase and the regulation of microtubule-kinetochore 
attachments (Anand et al., 2003). The link between Aurora A activity and chromosomal attachment 
could therefore provide an alternate explanation as to why cells are not able to efficiently align 
their chromosomes after Aurora A inhibition. 
To explore this alternative hypothesis, I carried out the close examination of kinetochore 
microtubule occupancy in cells with spindles formed in the absence of Aurora A activity. 
Immunofluorescent images of these spindles appeared to indicate that microtubules were however 
attached to kinetochores (Figure 5.3), although to gain a more definitive understanding of 
chromosome attachment, I employed a quantifiable approach. By using the pixel intensity of 
Mad2-directed antibody at kinetochores of images of fixed and immunostained cells, I was able to 
quantify the level of microtubule occupancy at kinetochores (Waters et al., 1998, Chen et al., 
1996). This level of Mad2 at kinetochores was normalised by dividing the pixel intensity with that 
of ACA on adjacent centromeres to give a value of Mad2/ACA. As a negative control for the 
experiment, cells were prevented from forming microtubules through their treatment with 
Nocodazole. These cells showed high levels of Mad2 at kinetochores (average 3.7 Mad2/ACA), 
which is consistent with the notion that microtubule occupation at kinetochores causes a reduction 
in Mad2 levels (Figures 5.2A(i), 5.3A and 5.4B). The encouragingly high Mad2 level at 
kinetochores is also consistent with the observation that no long microtubules were formed after the 
Nocodazole treatment (Figure 5.3A). When MLN8054 was added in conjunction with Nocodazole, 
cells were observed to have similarly high levels of Mad2 at their kinetochores (average of 3.6 
Mad2/ACA) (Figures 5.2 B(i), 5.3B and 5.4B). This similarity in Mad2 levels at kinetochores after 
the two treatments was vital to the integrity of the experiment, as it indicated that the MLN8054  
107
ns *** ***
**
*** ***
***
  108 
 
  
treatment did not cause a reduction in Mad2 at kinetochores independent of microtubule 
attachment.  
Control cells that had been permitted to nucleate their microtubules unperturbed, exhibited an 
average Mad2 level of only 0.8 Mad2/ACA at kinetochores (range of -10.5 to 27.6) (Figures 
5.2A(ii) and 5.4B). This relatively low value indicated the presence of high numbers of 
microtubule connections with kinetochores. Similarly, when MLN8054 was used to inhibit Aurora 
A activity in cells, low levels of Mad2 at kinetochores were also seen. Interestingly however, 
MLN8054-treated cells showed slightly lower levels of Mad2 than seen in the control cell samples, 
with cells showing on average 0.3 Mad2/ACA (range of -2.3 to 8.2). This finding demonstrated 
that Aurora A activity is not required for the attachment of spindle fibres to kinetochores. 
Therefore, the chromosomal misalignments seen after Aurora A inhibition were not produced by 
the failure of chromosomes to attach to the spindle.  
To further examine how Aurora A activity is involved in the alignment of chromosomes, I next 
looked at the requirement for the kinase’s activity in the generation of spindle mechanical force. If 
the spindle structural abnormalities observed after inhibiting Aurora A activity were sufficiently 
severe enough to prevent the generation of adequate spindle force on chromosomes, the cell would 
therefore be unable of efficiently align its DNA (Skibbens and Salmon, 1997, Skibbens et al., 
1993). This could therefore explain the existence of chromosome misalignments after Aurora A 
inhibition. To test this theory, I measured the inter-kinetochore distances of cells exposed to a 
variety of different treatments, to determine whether appropriate tension was being generated by 
the spindle (Chen et al., 1996, Waters et al., 1996). Analysis of cells exposed to sustained 
Nocodazole treatment, whether combined with MLN8054 treatment or not, revealed that they 
displayed relatively small inter-kinetochore distances, averaging at 0.9 µm (Figures 5.2A(i), 
5.2B(i) and 5.4C). This small inter-kinetochore measurement indicated a lack of tension across the 
kinetochore pairs, which is consistent with the  treatment of Nocodazole preventing the formation 
of a spindle capable of generating force to chromosomes (Figures 5.3A and 5.3B). In contrast to 
this, cells which were permitted to re-nucleate microtubules without their treatment with 
Nocodazole or MLN8054, exhibited kinetochore pairs that were held on average 1.4 µm from each 
other (Figures 5.2A(ii) and 5.4C). This larger inter-kinetochore distance is indicative of force 
generated across the centrosome by a functional spindle (Figure 5.3C). In comparison however, 
cells with spindles formed in the presence of MLN8054 were only able to produce an average 
kinetochore separation of 1.1 µm (Figure 5.4C). This suggests that although MLN8054 treatment 
did permit the formation of a spindle which was able to produce some mechanical force across 
kinetochore pairs, the tension generated was not as great as that seen in the control cells. Therefore, 
Aurora A activity may be required for the formation of spindles capable of applying adequate force 
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to chromosomes, and consequently enabling their efficient alignment. Interestingly however, the 
greater inter-kinetochore distances seen in MLN8054-treated cells compared to the Nocodazole 
treated samples, suggested that Aurora A activity was not required for the generation of all the 
mechanical force exerted on the chromosomes. This observation therefore indicates the presence of 
additional factors other than Aurora A activity work to control spindle function, thus possibly 
explaining how some cells were able to correct severe chromosomal misalignments even in the 
absence of Aurora A activity (Figure 5.1B). 
Despite the ability of cells to generate some tension across kinetochore pairs after Aurora A 
inhibition, Aurora A activity was clearly required to produce normal levels of force on the 
chromosomes.  To test whether these observations could be related to inadequacies in the spindle 
structure, I measured the inter-pole distances of the spindles to assess defects in spindle structure 
(Figures 5.2 and 5.4D). Cells that had been exposed to Nocodazole, either with or without 
MLN8054, exhibited a large range of inter-pole distances, possibly reflecting the inability to affect 
centrosomal positioning after nuclear envelope breakdown due to the lack of spindle microtubules 
(Figures 5.3A and 5.3B). Intriguingly however, most cells which had been exclusively treated with 
Nocodazole showed a notably larger degree of centrosome separation than cells that had been 
additionally exposed to MLN8054. In comparison to Nocodazole treated cells, control cells with 
undisrupted microtubule re-growth were observed to have a relatively small range of spindle 
lengths, with an average inter-pole distance of 7.1 µm. Importantly through, the average spindle 
length reformed in after MLN8054 treatment was only 4.7 µm. The shortened spindle lengths 
observed after MLN8054 treatment is consistent with previous findings (Figure 5.1D), which 
together with the observation that the spindles are also disorganised (Figure 5.3D), further highlight 
the existence of abnormal spindles after Aurora A inhibition. These spindle abnormalities could be 
used to explain how the cells are unable to produce normal levels of inter-kinetochore tension and 
consequently efficiently align their chromosomes following Aurora A inhibition.  
5.5 Chromosome alignment defects seen after MLN8054 treatment are produced by 
Aurora A inhibition and not Aurora B inhibition 
Despite the evidence suggesting that Aurora A inhibition causes chromosome alignment defects, it 
could be argued that the effects could be caused by off-target Aurora B inhibition by the treatment 
with MLN8054 (Figure 5.1B) (Adams et al., 2001b, Ditchfield et al., 2003, Hauf et al., 2003). I 
have previously shown MLN8054 to have a high degree of specificity towards Aurora A activity at 
the 1 µM concentration employed throughout the investigation however, at certain concentrations it 
can also inhibit Aurora B activity (Figure 3.3). Therefore to confirm that the MLN8054 treatment 
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does not inhibit Aurora B when used at 1 µM, I employed a further method of testing for Aurora B 
activity. This method relied on exploiting the role of Aurora B activity in the correction of 
improper microtubule/kinetochore attachments as a way of identifying whether Aurora B activity 
was being inhibited. Key to this method was the creation of monopolar spindles and the 
consequential prevention of normal levels of spindle-induced tension across kinetochore pairs. The 
production of monopolar spindles should therefore only allow monotelic attachments to exist in the 
presence of Aurora B activity to lack of the centrosomal stretch generated by amphitelic 
kinetochore attachment (see Figure 1.4) (Hauf et al., 2003, Cassimeris et al., 1994, Cimini et al., 
2006, Kapoor et al., 2000). Therefore the existence of any kinetochore pairs that were attached to 
the spindle in any way other than through a monotelic connection, would be evidence of inactivated 
Aurora B kinase. Consistent with this theory, only monotelic attachments were detected in spindles 
treated with an Eg5 inhibitor, highlighting the presence of active Aurora B (Figures 5.2A(iii) and 
5.5A). Importantly, cells treated with MLN8054 in combination with the Eg5 inhibitor, also 
appeared to exclusively demonstrate monotelic attachments (Figures 5.2B(iii) and 5.5B). The short 
K-fibres produced by the MLN8054 treatment however, made analysis of microtubule attachments 
difficult. Therefore, as a further method of detecting microtubule occupancy, Mad2 
immunostaining was used to detect the single disconnected sisters of monotelically attached 
kinetochore pairs. Using this method of detection, single unattached kinetochores were observed to 
occur in MLN8054-treated cells, thus indicating the presence of monotelic attachments, and 
supporting the finding that Aurora B activity was not inhibited by the MLN8054 treatment. 
Furthermore, the observation that Mad2 levels were not reduced after the MLN8054 treatment also 
indicated the presence of active Aurora B after the MLN8054 treatment, as Aurora B inhibition has 
been shown to cause the reduction in Mad2 levels at kinetochores (Ditchfield et al., 2003). This 
collective evidence therefore demonstrates that Aurora B must have been active after the 
MLN8054 treatment, further validating my previously described Western blot results (Figure 3.3). 
Consequently, the chromosomal misalignments seen after the MLN8054 treatment must have been 
a product of Aurora A inhibition, thus demonstrating the requirement for Aurora A activity in the 
regulation of the development and organisation of structurally and functionally sound spindles 
(Figures 5.1B and 5.3D). 
5.6 Summary 
Through observing the effects of MLN8054 on the ability of a cell to recover from severe spindle 
disruption, I have shown that Aurora A activity was required for the efficient alignment of 
chromosomes. The alignment defects seen after Aurora A inhibition were not caused by problems 
with kinetochore/spindle attachments. Instead, reduced levels of inter-kinetochore tension and  
DNA MergeACA Tubulin
Figure 5.5 Aurora B activity is not inhibited by 1 µM MLN8054 in HeLa cells
Immunofluorescence images of HeLa cells treated according to the microtubule regrowth
protocols shown in Figure 5.2:
(A) Monastrol: Figure 5.2A(iii)
(B) Monastrol and MLN8054: Figure 5.2B(iii)
The cells were fixed and immunostained with antibodies against ACA (red), Tubulin
(green) and Mad2 (blue), Hoescht was use to visualise the DNA (white). Z-sectioned
images were taken of the cells with blow-ups to highlight microtubule-kinetochore
attachments. Images levels were scaled identically.
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shortened spindle lengths and levels of organisation seen after the MLN8054 treatment indicated 
that the role for Aurora A kinase activity in the alignment of chromosomes was derived from its 
function in spindle assembly.  
The roles for Aurora A activity in spindle assembly and chromosome alignment potentially have 
important implications in mitotic progression. In the next chapter, I will discuss whether the 
chromosome misalignments observed after Aurora A inhibition are capable of extending the 
mitotic period and examine their effect on long-term cell viability.  
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6 Investigating the role of Aurora A activity in mitotic 
progression and the preservation of cell viability 
6.1 Introduction 
In the previous chapter I described the role played by Aurora A activity in the efficient alignment 
of chromosomes. An inability of cells to align their chromosomes such as that described after 
Aurora A inhibition has previously been shown to maintain the activation of the spindle assembly 
checkpoint, delaying a cell’s progression into anaphase and consequently extending the time spent 
in mitosis (Mayer et al., 1999, Musacchio and Hardwick, 2002, Nicklas and Koch, 1969, Li and 
Nicklas, 1995, Rieder et al., 1995). One could therefore infer that the inhibition of Aurora A 
activity would also increase the time cells spent in mitosis.  Consistent with this theory, Aurora A 
inhibition has been shown to cause an increase in the proportion of mitotic cells, thus indicating 
that cells were delayed in mitosis (Manfredi et al., 2007). Additionally, the micro-injection of anti-
Aurora A antibodies was even shown to often prevent the completion of mitosis (Marumoto et al., 
2003). Furthermore, during the course of this investigation, Hoar and colleagues also reported that 
the inhibition of Aurora A caused a delay to the progression from prophase to anaphase, with the 
time spent in mitosis more than doubling (Hoar et al., 2007). These reports of mitotic delays 
indicate that the spindle assembly checkpoint is activated by Aurora A inactivation, presumably in 
response to the dependency on Aurora A to efficiently align chromosomes (Figure 5.1B).  
Intriguingly, although cells without active Aurora A were often observed to divide after extended 
mitotic periods, many displayed segregation defects and the progeny was detected as being 
aneuploid (Marumoto et al., 2003, Hoar et al., 2007, Katayama et al., 2001, Glover et al., 1995).  
The observation of segregation defects after Aurora A inhibition suggested that not all of the 
chromosomes had been properly aligned before the commitment to anaphase. Interestingly, two 
reports published after this investigation linked Aurora A activity with the ability to maintain 
spindle checkpoint activation, which may explain the occurrence of segregation defects after the 
inactivation of the kinase (Wysong et al., 2009, Kaestner et al., 2009). Alternatively, the apparent 
ability of the cells to exit mitosis without aligning chromosomes, could be attributed to the cells 
‘slipping’ from mitosis after the extended delays, as in similar reports of the effects of spindle 
disruption cells have been shown to exit mitosis after extended delays to produce aneuploid 
progeny (for review see [Musacchio and Hardwick, 2002, Musacchio and Salmon, 2007, Rieder 
and Maiato, 2004, Weaver and Cleveland, 2005]; (Mayer et al., 1999, Li and Nicklas, 1995, Rieder 
et al., 1995, Gascoigne and Taylor, 2008)). Importantly however, the spindle checkpoint has been 
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shown to be functional in these cells, with the segregation errors being attributed to merotelic 
attachments that had gone undetected by the cell (Gascoigne and Taylor, 2008).  
Therefore to better understand the role of Aurora A activity in mitotic progression, I set out to 
examine whether Aurora A inhibition in my experimental set up caused delays to mitosis, and 
whether cells were capable of dividing after the delay. I also examined whether Aurora A activity 
was required for the maintenance of the overall viability of cells, a line of investigation that would 
have important implications for targeting of Aurora A activity as an anti-cancer therapy.  
6.2 Aurora A activity is required for normal mitotic progression 
To test whether cells were dependent on Aurora A activity for their timely progression through 
mitosis, I treated DLD-1 cells with MLN8054, using phase contrast time-lapse microscopy to track 
the progression of individual cells through the cell cycle. By distinguishing the breakdown of the 
nuclear envelope and subsequent decondensation of chromatin within the cells, I was able to 
ascertain the duration of mitosis. I also assessed the ability of cells to perform cytokinesis and 
divide into two cells following their exit from mitosis. The results of this observation would 
provide an indication of whether it was eventually possible to adequately correct the spindle 
abnormalities and chromosome misalignments previously observed after Aurora A inhibition 
(Figures 3.4, 5.1 and 5.3). 
The analysis of time-lapse microscopy movies revealed that control cells spent an average of 47 
minutes in mitosis, before dividing into two daughter cells (Figure 6.1). In comparison, treating 
cells with MLN8054 caused cells to spend an average of 71 minutes in mitosis, 54% longer than 
control cells. An increase in mitotic period in response to Aurora A inhibition is consistent with 
reports of similar spindle defect-inducing treatments, indicating the sustained activation of the 
spindle assembly checkpoint activation in response to the misaligned chromosomes (Mayer et al., 
1999, Kapoor et al., 2000). Interestingly however, cells exposed to MLN8054 were capable of 
dividing into two daughter cells after their extended mitotic period, although the nature of the 
phase-contrast imaging made it difficult to identify any possible chromosome segregation defects.  
Similar to the MLN8054 treatment, treating cells with an Eg5 inhibitor also caused a mitotic delay 
compared to control cells, however the extension to the time in mitosis experienced by cells was 
even more pronounced. Cells treated with the Eg5 inhibitor took an average of 689 minutes to exit 
mitosis, after which they were observed to exit mitosis without dividing, similar to recent reports of 
the effects of the treatment in the literature (Gascoigne and Taylor, 2008). This extended mitotic 
delay followed by the exit without division indicated that cells were unable to produce a spindle  
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capable of aligning chromosomes, suggesting that cells were only permitted to exit mitosis by 
mitotic slippage (Rieder and Maiato, 2004, Brito and Rieder, 2006, Weaver and Cleveland, 2005, 
Gascoigne and Taylor, 2008). The difference observed in how cells are affected by Eg5 and Aurora 
A inhibition is consistent with the differing severity of spindle effects produced by the two 
treatments (Figures 4.2 and 5.1).  
The large mitotic delay seen after Eg5 inhibition not only indicated the presence of severe 
chromosome misalignments, but also highlighted the existence of a functional checkpoint, which 
was capable of detecting them. Similarly, after Aurora A inhibition, the mitotic delay prior to 
division also suggested the activation of the spindle assembly checkpoint consequently preventing 
anaphase onset. Interestingly however, Aurora A activity has been implicated in the proper 
functioning of the spindle assembly checkpoint (Wysong et al., 2009, Kaestner et al., 2009, 
Kunitoku et al., 2003). Furthermore, Aurora A over-expression has also been reported to cause the 
override of the spindle assembly checkpoint (Anand et al., 2003, Dutertre and Prigent, 2003, Jiang 
et al., 2003a, Rong et al., 2007).  The role of Aurora A kinase activity in the checkpoint override 
following Aurora A over-expression is however up for debate, as some studies have found the 
activity to be required for the override of the checkpoint (Anand et al., 2003), while others have 
found it not to be (Jiang et al., 2003a, Littlepage and Ruderman, 2002, Meraldi et al., 2002). This 
large range of varying reports implicating Aurora A in the spindle checkpoint provoked the 
examination of the integrity of the spindle assembly checkpoint following MLN8054 treatment, in 
order to resolve the role of Aurora A activity in the process. 
Therefore, to explore the role of Aurora A activity in the spindle assembly checkpoint, I exposed 
cells to both Eg5 and Aurora A inhibition. If the checkpoint was indeed dependent on Aurora A 
activity, the extended delay seen after Eg5 inhibition should no longer be seen after the combined 
treatment, as the cells would not have a functional checkpoint to alert them to the severely 
unaligned chromosomes caused by inhibiting Eg5 activity. In a similar experiment, Aurora B 
inhibition has been previously shown to cause the override of a Taxol induced mitotic arrest, 
driving cells out of mitosis and highlighting a compromised checkpoint in the absence of active 
Aurora B (Ditchfield et al., 2003). Surprisingly however, although a decrease in average mitotic 
timings was seen after the dual inhibition of Eg5 and Aurora A, the cells were not driven straight 
out of mitosis. Instead, cells were held in mitosis for an average period of 481 minutes.  This result 
is similar to two recently published papers, which also used MLN8054 to show that spindle toxin 
induced mitotic arrest could be slightly reduced by inhibiting Aurora A activity (Wysong et al., 
2009, Kaestner et al., 2009).  
  117 
 
  
6.3 The extended mitotic period observed after Aurora A inhibition is due to the cells 
inability to efficiently align their chromosomes 
Similar to DLD-1 cells, HeLa cells also suffered mitotic delays after MLN8054 treatment (Figure 
6.2A). The induced delay was however more substantial than that described in DLD-1 cells, as 
after MLN8054 treatment the average HeLa mitotic timing was extended to 292.7 minutes, 289% 
longer than the mitotic period of control cells (Figure 6.4A). Also like DLD-1 cells, the majority of 
HeLa cells were capable of dividing following MLN8054 treatment, although a small number of 
cells suffered from cytokinesis defects, while others were observed to start blebbing during mitosis, 
indicating the instigation of cell death (Charras, 2008).  
The long mitotic delays produced in both DLD-1 and HeLa cells, indicated that Aurora A 
inhibition caused chromosome alignment defects, thus preventing the onset of anaphase (for review 
see [Taylor et al., 2004]). Consistent with this idea, I previously described how Aurora A inhibition 
prevented the efficient alignment of chromosomes (Figure 5.1). Although to determine whether the 
mitotic delay following MLN8054 treatment was in direct response to chromosome misalignments 
caused by Aurora A inhibition, I analysed live HeLa cells which had been transfected with GFP-
Histone H2B. Analysis of this cell line with the use of time-lapse fluorescent microscopy enabled 
the examination of chromosome alignments in response to different treatments. The analysis of 
control cells showed that their chromosomes were able to efficiently align after nuclear envelope 
breakdown to form a metaphase plate, before evenly dividing (Figure 6.2B(i)). Cells treated with 
MLN8054 however, were not able to align their chromosomes as efficiently as control cells 
(Figures 6.3(ii) and 6.3(iii)). Instead, chromosomes moved around each other in a disorganised 
bundle for extended periods. In some instances, the MLN8054 treatment even prevented 
chromosomes from forming a metaphase plate at all, causing cells to decondense their 
chromosomes without dividing (Figure 6.2B(ii)). Many cells were however observed to form 
metaphase plates and divide after the MLN8054 treatment, although segregation errors were 
detected (Figure 6.2B(iii)). The observation that cells treated with MLN8054 were able to progress 
to anaphase despite the presence of misaligned chromosomes or exit mitosis without dividing was 
predicted to have a detrimental effect on the long-term viability of cells.  
6.4 Aurora A inhibition causes aneuploidy and cell death 
The purpose of mitosis is to produce two genetically identical daughter cells. The inhibition of 
Aurora A however, appeared to cause problems with the ability of cells to evenly divide, indicating 
that many of the treated cells’ progeny may be aneuploid. To test this possibility and investigate 
whether Aurora A activity has a role in preserving the genetic stability and thus the viability of  
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cells, I used flow cytometry to analyse the DNA content of the cells that had been treated with 
MLN8054. 
As a positive control for the experiment, I observed what effect long-term Eg5 inhibition had on 
the DNA content of cells. I had previously observed Eg5 inhibition to produce severe spindle 
assembly defects, chromosome misalignments and long mitotic delays, and I therefore expected the 
cell cycle profiles to reflect this severity of the treatment (Figures 5.1 and 6.1). Consistent with this 
prediction, the flow cytometry profiles showed that the exposure of the cells to an Eg5 inhibitor 
caused a huge increase in the proportion of cells with 4N DNA (Figure 6.3A(i)). A massive 44% of 
cells were shown to accumulate in mitosis after 24 hours of treatment, compared with only 3% of 
mitotic cells in control samples. Additionally, after 24 hours of treatment only a minimal peak 
representing cells with 2N DNA could be seen. This is consistent with the live cell imaging data, as 
it indicates that cells were unable to divide into two genetically identical daughter cells. A large 
sub-G1 peak could also be seen after only 24 hours of Eg5 inhibition, with near total genetic 
disintegration seen after 48 hours of inhibitor treatment. The occurrence of such profound sub-G1 
population indicated that cell death was induced by the Eg5 inhibitor, which is consistent with data 
from a recent publication (Gascoigne and Taylor, 2008). 
Similar to the effects of Eg5 inhibition, the flow cytometry profiles of MLN8054-treated cells also 
revealed an accumulation of cells in mitosis (Figure 6.3(ii)). The proportion of cells accumulated in 
mitosis after MLN8054 treatment was not however as profound as that seen after Eg5 inhibition, 
with only 19% of cells being identified as being mitotic after 24 hours of treatment.  Interestingly, a 
clear peak could still be seen representing cells with 2N DNA even after 48 hours of MLN8054 
treatment, which consistent with the live-cell imaging, suggested that cell division was possible 
(Figure 6.2A). As the treatment period increased however, the peaks representing both 2N and 4N 
DNA were notably diminished. A large sub-G1 population could be detected after 72 hours of 
MLN8054 treatment, 24 hours longer than it had taken Eg5 inhibition to cause roughly equivalent 
cellular effects. Eventually, after 96 hours of MLN8054 treatment only 1% of cells were recorded 
as being in mitosis. This finding, together with the considerable sub-G1 population, indicated that 
like Eg5 inhibition, sustained MLN8054 treatment caused profound cell death.  
To test whether the increase in the proportion of cells in the sub-G1 population seen after extended 
MLN8054 treatment, did actually represent the loss of cell viability, I tested the growth and 
survival of cells exposed to MLN8054 using a colony formation assay (Figures 6.3B and 6.3C). 
The crystal violet staining of control colony formation samples illustrated the occurrence of many 
colonies after 14 days of growth. In comparison, sustained treatment with the positive control 
inhibitor, ZM1, prevented the occurrence of cell colonies after the same time period. This is 
consistent with published data, which described ZM1 treatment as negatively effecting the  
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Figure 6.3 Aurora A inhibition causes an accumulation of HeLa cells in mitosis, and
eventually lose viability
(A) Flow cytometry PI cell cycle profiles of HeLa cells treated with the Eg5 inhibitor AZ138
(i) or 1 µM MLN8054 (ii) for the indicated time periods. The numbers shown in the top
right-hand corner of the graphs refer to the percentage of the cell population in mitosis as
determined by MPM-2 staining. (B) HeLa cells were treated with DMSO, 1 µM MLN8054,
4 µM MLN8054 or 2 µM ZM1 for 14 days before fixing and then staining with crystal violet.
(C) Qunatitation of the colony formation assay shown in (B).
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proliferation and viability of cells (Girdler et al., 2006). Similar to this result, the treatment of cells 
with either 1 µM or 4 µM MLN8054, also prevented the formation of colonies. This observation 
therefore indicates that Aurora A activity is required for the preservation of the long-term viability 
of cells presumably through the maintenance of cells genetic integrity (Hoar et al., 2007). In 
agreement with these findings, reports have shown Aurora A inhibition or depletion to bring about 
apoptosis (Huck et al., 2010, Dar et al., 2008, Kaestner et al., 2009, Yang et al., 2010a). Indeed, 
such as activation if the DNA damage checkpoint may occur as a result of the production of the 
aneuploidy, which was shown to be caused by the MLN8054 treatment 
6.5 Summary 
In this chapter I described how the inhibition of Aurora A activity caused a marked delay of cells in 
mitosis. This delay was found to be related to the diminished ability of cells to align their 
chromosomes after Aurora A inhibition, indicating the presence of a functional spindle assembly 
checkpoint. Cells were capable of dividing after the mitotic delays induced by Aurora A inhibition, 
however segregation errors were observed. Long–term Aurora A inhibition caused the development 
of aneuploidy and the occurrence of sub-G1 peak with eventual loss of cell viability, demonstrating 
the degenerative effect of the segregation errors.  
The analysis of the effects of Aurora A inhibition on mitosis therefore presented an interesting 
paradox, in which the spindle assembly checkpoint was activated causing a delay to anaphase, 
although the segregation defects and aneuploidy produced by the treatment indicated that cells 
were capable of dividing with misaligned chromosomes. The occurrence of such a phenomenon has 
been attributed to the dependency on Aurora A activity to maintain the activation of the spindle 
assembly checkpoint (Wysong et al., 2009, Kaestner et al., 2009). To explore this theory, I used the 
spindle disrupting power of an Eg5 inhibitor to cause the prolonged activation of the spindle 
assembly checkpoint, but found that the co-inhibition of Aurora A activity did not compromise the 
spindle checkpoint to the same extent as seen after inhibiting Aurora B (Ditchfield et al., 2003). 
The combined Eg5 and Aurora A inhibition did however cause cells to spend less time in mitosis 
than cells treated with just Eg5 inhibitor, although evidence for a direct role for Aurora A activity 
in the maintenance of the spindle assembly checkpoint is yet to be presented (Wysong et al., 2009, 
Kaestner et al., 2009). The simplest explanation for the reduction in mitotic delay after the 
combined treatment is instead that the two drugs have an antagonistic effect when used together, a 
phenomenon that has been noted to occur in the past with the combination of treatments (Lee et al., 
2008, Borisy et al., 2003, Hata et al., 2005). This increases potency on the combination may be 
derived from increased off-target effects. Thus drugs which individually have minimal effects on 
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off-target kinases may cause the augmentation of additional effects, providing an explanation of the 
accelerated of the mitotic slippage experienced by cells (Manfredi et al., 2007, Mayer et al., 1999).  
Despite the occurrence of a slight acceleration to mitotic slippage, the observation of considerable 
mitotic delays following combined Eg5 and Aurora A inhibition, suggests that Aurora A activity 
does not play a prominent role in the spindle assembly checkpoint. This proposition is supported by 
the extended mitotic delays seen when inhibiting just Aurora A activity, as well as the maintenance 
of the localisation of checkpoint protein when treating cells with Nocodazole in combination with 
MLN8054. This combined evidence therefore indicates that cells exposed to an Aurora A inhibitor 
must therefore have been able to satisfy the spindle assembly checkpoint in order to progress to 
anaphase and divide. The existence of segregation defects after Aurora A inhibition is therefore not 
likely to be a general loss of checkpoint function, but may instead be indicative of the altered 
ability of cells to identify chromosomal misalignments. This phenomenon may be derived from the 
disorganised nature of the spindles formed after Aurora A inhibition which, despite their abnormal 
appearance, are capable of connecting to kinetochores. The abnormal spindles formed after Aurora 
A inhibition may be able to produce adequate tension to kinetochores regardless of their unaligned 
state, thus enabling the satisfaction of the checkpoint, consequentially allowing cells to progress to 
anaphase with segregation errors (Li and Nicklas, 1995, Nicklas et al., 1998, Nicklas et al., 1995, 
Skoufias et al., 2001, Biggins and Murray, 2001, Stern and Murray, 2001). Consistent with this 
idea, I have described the incidence of multipolar spindles and spindle deformities after Aurora A 
inhibition, which may be capable of applying sufficient degrees of tension to kinetochores 
irrespective of their alignment on the metaphase plate (Figures 3.4 and 5.3D). Furthermore, in the 
previous chapter, I showed that spindles grown in the absence of Aurora A activity were able to 
attach chromosomes to a high degree, despite their low inter-kinetochore stretch and misalignment. 
This high level of K-fibre attachment therefore reduced the levels of Mad2 on the kinetochores. 
The reduction level of Mad2 has been previously shown to allow cells to prematurely exit mitosis 
without first arranging chromosomes on metaphase plates (Orr et al., 2007). Therefore, the ability 
of spindles formed in the absence of Aurora A to sufficiently reduce the levels of kinetochore 
Mad2 even on misaligned chromosomes, may permit the progression through to anaphase without 
first properly aligning chromosomes. Therefore, although it is not completely clear how cells can 
progress through to anaphase despite the presence of misaligned chromosomes, a number of 
interesting possibilities must first be considered instead of simply assuming Aurora A activity has a 
role in the spindle assembly checkpoint. In the next chapter, I will discuss my investigation into 
increasing the potency of MLN8054 towards Aurora A activity, to determine whether it is possible 
to increase the severity to the effects to mitotic spindles and mitotic progression.   
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7 Increasing the potency of Aurora A inhibition 
7.1 Introduction 
I have previously described how the inhibition of Aurora A activity caused the development of 
shortened and disorganised spindles, preventing the efficient alignment of chromosomes and 
consequently delaying mitosis. Previous studies had however found the inactivation of Aurora A to 
have more potent effects on mitotic spindles than I had observed, describing instead the high 
occurrence of monopolar spindles (Glover et al., 1995, Mori et al., 2007, Girdler et al., 2006). The 
spindle phenotypes described in these reports are highly similar to those seen after the inhibition of 
Eg5 activity, which also produces monopolar spindles, as well as causing cytokinesis defects and 
the loss of cell viability (Figures 4.1, 6.1 and 6.3) (Mayer et al., 1999, Walczak et al., 1998). In this 
chapter, I examine whether Aurora A can be inhibited more potently to produce phenotypes more 
similar those seen after Eg5 inhibition, than the relatively mild spindle effects I have described so 
far in the investigation (Figures 3.4 and 4.2). 
Throughout the investigation I employed MLN8054 at a concentration of 1 µM, which was 
determined by Western blotting to have a high degree of potency towards Aurora A kinase activity 
(Figure 3.3). The accuracy of techniques such as Western blotting however, is limited by the 
sensitivity of the experimental components, such as the antibodies used to immunoblot the samples. 
Indeed, the phospho-Aurora antibody used for the Western blots was incapable of detecting signal 
below a certain concentration of protein, showing no signal when less than 5% of total control cell 
lysate was present on the membrane. Therefore, although no signal was seen to indicate the 
presence of phospho-Aurora after 1 µM MLN8054 treatment of HeLa cells, the antibody 
limitations may mean that complete kinase inactivation is not actually achieved at this 
concentration (Figure 3.3C). Therefore, it may be possible to increase the potency of Aurora A 
inhibition, which may enable a more accurate characterisation of the role of Aurora A kinase 
activity within cells. 
7.2 Increasing the concentration of MLN8054 causes more potent Aurora A inhibitory 
effects but also inhibits Aurora B activity  
To increase the potency of Aurora A inhibition achieved by MLN8054, the obvious solution would 
be to simply increase the concentration of the MLN8054 applied to cells. Indeed, analysing the 
polarity of fixed cell samples indicated that increasing the concentration of MLN8054 did cause a 
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reduction in the proportion of bipolar spindles (Figure 7.1A). As Aurora A activity is required for 
bipolar spindle assembly, the reduction in the bipolar index therefore suggested that MLN8054 
could be used at higher concentrations to inhibit Aurora A activity more potently (Glover et al., 
1995, Girdler et al., 2006, Mori et al., 2007). Furthermore, cell cycle profiles revealed that while 1 
µM MLN8054 caused an increase of cells with 4N DNA, treatment with 3 µM MLN8054 caused a 
further accumulation of cells with 4N DNA. This accumulation of cells with 4N DNA may 
represent an extended mitotic delay caused by the higher MLN8054 concentration, which is 
comparable to that seen after Eg5 inhibition (Figure 6.3A).  
MLN8054 has been used in the investigation so far at 1 µM, as I found that higher concentrations 
of MLN8054 caused the inhibition of Aurora B activity as well as Aurora A, as judged by the 
analysis of Western blots (Figure 3.3). To further investigate the effect of high dose MLN8054 
treatment on Aurora B activity however, I observed the ability of the cells to divide, as cytokinesis 
failure is a hallmark of Aurora B inhibition (Bischoff and Plowman, 1999, Adams et al., 2001a, 
Nigg, 2001b). The investigation into Aurora B activity in response to MLN8054 was carried out 
using phase contrast time-lapse imaging of live cells (Figure 7.1C). Interestingly, both control cells 
and the majority of cells treated with 1 µM MLN8054 were observed to divide. Increasing the 
concentration of MLN8054 however, caused a dramatic increase in cells which were unable to 
perform cytokinesis, which was similar to the effects of the Aurora B inhibitor ZM1 that also 
produced cytokinesis failures.  Therefore, the analysis of the ability of cells to perform cytokinesis 
supported the previously described Western blot data that increasing the concentration of 
MLN8054 lead to the dual inhibition of Aurora B as well as Aurora A activity. Importantly, it was 
not possible to identify the effects of Aurora B inhibition from the flow cytometry profiles, as it 
was not possible to distinguish between cells which had overridden the spindle assembly 
checkpoint and failed to divide, from those which were held in mitosis (Figure 7.1B). This 
therefore highlights the danger of using flow cytometry profiles to draw conclusions regarding 
specific cell cycle phases. 
In addition to inhibiting Aurora B activity and causing cytokinesis failure, increasing the 
concentration of MLN8054 from 1 µM to 4 µM also increased the time by which cells were 
delayed in mitosis (Figure 7.1C). On average, exposure of cells to 1 µM MLN8054, caused them to 
spend 117 minutes in mitosis (a 156% increase compared to control samples), while treatment with 
4 µM MLN8054 caused cells to spend an average of 158 minutes in mitosis (a 244% increase 
compared to control cells). This increased mitotic delay seen after treatment with the higher 
concentration of MLN8054, together with the reduction in cell bipolarity, suggested that it may 
indeed be possible to increase the potency of Aurora A inhibition by increasing the concentration 
of MLN8054.  
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Figure 7.1 Increasing the MLN8054 concentration appears to increase the potency
of Aurora A inhibition, however Aurora B inhibitory phenotypes are also detected
(A) HeLa cells were treated with a range of MLN8054 concentrations for 2 hours before
fixing. The cells were then immunostained with antibodies against Aurora A to observe
centrosomes and enable the identification of bipolar spindles. (B) Flow cytometry PI
profiles of HeLa cells treated with 0 µM, 1 µM and 3 µM MLN8054 for 24 hours. (C) DLD-1
cells were treated with the indicated drugs while time-lapse phase contrast microscopy
images were taken every 2 minutes. The resulting movies were analysed and the time
taken for cells to go through mitosis was plotted (determined as being between nuclear
envelope break down and chromosome decondensation). Green circles represent cells
that performed cytokinesis, red circles indicate cells that were unable to do so, and purple
circles denote cells that started blebbing while in mitosis.
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The reduction in bipolar index after MLN8054 treatment, suggested that by increasing the 
concentration of MLN8054 it may be possible to produce spindle defects more comparable to those 
seen after Eg5 inhibition (Figure 4.4). The mitotic delay experienced by the cells treated with 4 µM 
MLN8054 however, was not as pronounced as that reported to occur after Eg5 inhibition (Figure 
6.1). Thus to determine whether the mitotic effects produced my 4 µM MLN8054 were comparable 
to those seen after Eg5 inhibition, with combined Aurora B inhibition, I applied both ZM1 and an 
Eg5 inhibitor to cells and observed the affect on mitotic progression. Interestingly, the average 
mitotic timing of cells treated with both ZM1 and the Eg5 inhibitor 145 minutes, which was highly 
comparable to that seen after 4 µM MLN8054 treatment. This therefore indicated that increasing 
the concentration of MLN8054 resulted in an increased affect on the spindles of cells, which was 
bore close resemblance to those seen after Eg5 inhibition as well as the previously described effects 
of removing Aurora A activity from cells (Mori et al., 2007, Glover et al., 1995, Girdler et al., 
2006). Therefore, it appeared to be possible to increase the potency of Aurora A inhibition by 
increasing the concentration of MLN8054 above 1 µM, although above 1 µM MLN8054, Aurora B 
activity was also affected. Therefore to effectively probe the role of Aurora A activity I required a 
method by which I could increase the concentration of MLN8054 to more potently inhibit Aurora 
A activity, but identify a method by which Aurora B activity was not also inhibited at this higher 
concentration of MLN8054.  
7.3 A drug-resistant cell line can be used to revert the high-dose effects of MLN8054 on 
Aurora B activity  
To enable to use of MLN8054 at higher concentrations without inhibiting Aurora B activity in 
addition to Aurora A, I investigated the use of drug-resistant mutants. A variety of different drug-
resistant cell lines have previously been created in the lab by continuously exposing the colon 
cancer cell line HCT116 to the Aurora B inhibitor ZM1 (Girdler et al., 2008). HCT116 cells were 
chosen as they have defective mismatch repair machinery, which has been shown to cause higher 
levels of spontaneous mutations (Glaab and Tindall, 1997). This hyper-mutation rate enabled 
Girdler and colleagues to produce a greater number of genetic variants within the culture 
population, thus increasing the possibility of selecting for a drug-resistant mutant. Furthermore, 
HCT116 cells have been shown to express a relatively low level of p-glycoprotein, which is 
involved in removing a broad range of harmful substances from the cell (Teraishi et al., 2005). 
Reduced expression of p-glycoprotein therefore reduces the chance of resistancy to ZM1 through 
the expression of drug pumps, and increases the possibility of drug-resistant mutant cells 
developing. 
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The continued exposure of the HCT116 cells to ZM1 produced a variety of resistant mutants, some 
of which were shown by the examination of flow cytometry profiles to revert the Aurora B 
inhibitory effects of MLN8054 (Girdler et al., 2008). To confirm whether this data reflected the 
ability of the mutated cell lines to maintain the activity of Aurora B in the presence of presence of 
high doses of MLN8054, I used Western blotting to observe the activity of Aurora B after 
MLN8054 treatments. 
Before testing the drug-resistancy of the mutant HCT116 cells however, the effect of MLN8054 in 
wild-type HCT116 cells was assessed to determine whether Aurora A activity could be inhibited 
and any effects on Aurora B activity in the wild-type cells. The wild-type HCT116 cells were 
exposed to a range of MLN8054 concentrations, and the analysis of the Western blotted samples 
revealed that both Aurora A and B activity could be inhibited by MLN8054. Interestingly, both 
kinases were inhibited at roughly equivalent concentrations as those in HeLa and DLD-1 cells 
(Figure 3.3). At 0.25 µM MLN8054, Aurora A activity was markedly reduced in the wild-type 
HCT116 cells, as indicated by low phospho-Aurora A (Thr288) and phospho-TACC3 (Ser558) 
signal. Increasing the concentration of MLN8054 to 1 µM, caused the removal of all visible 
phospho-Aurora A signal from the blotted samples, indicating the potent inhibition of the kinase. 
Similarly, a reduction in phospho-Histone H3 (Ser10) indicated a reduction of Aurora B activity 
when samples were treated with only 0.75 µM MLN8054. Phospho-Aurora B (Thr232) signal was 
also reduced in samples treated with 2 µM MLN8054. Therefore, although Aurora A can be 
inhibited by MLN8054 in wild-type HCT116 cells, Aurora B activity is also inhibited at similar 
concentrations.  
To determine whether the mutations produced after the extended exposure to ZM1 were capable of 
inferring resistance to the Aurora B inhibitory effects of MLN8054, I treated the mutant HCT116 
cell lines with a range of MLN8054 concentrations and analysed the effect. One of the HCT116 
cell lines, found to have a Tyrosine residue substituted for a histadine at position 156 in Aurora B 
(referred to as R12 – (Girdler et al., 2008)), showed a high level of resistance against high dose 
MLN8054 effects on Aurora B activity (Figure 7.2B). Indeed, the analysis of the phospho-Histone 
H3 (Ser10) and phospho-Aurora B (Thr232) signal in MLN8054-treated R12 samples, showed no 
reduction even after their treatment with 10 µM MLN8054. Importantly however, Aurora A 
activity was seen to be inhibited by 1 µM MLN8054 in the R12 HCT116 cell line, as determined 
by phospho-Aurora A (Thr288) and phospho-TACC3 (Ser558) signal.  
The Western blot analysis therefore revealed that the mutant R12 HCT116 cell line was resistant to 
the effects of MLN8054 on Aurora B, however to confirm whether this resistance would be capable 
to reverting the cytokinesis defects observed after high does MLN8054 treatments, I compared the  
Figure 7.2 R12 HCT116 cells are resistant to high-dose MLN8054 Aurora B inhibition
Wild-type (A) and R12 (B) HCT116 cells were treated with Nocodazole for 16 hours before
being treated with MG132 and a range of MLN8054 concentrations for a further 2 hours.
The samples were then harvested and assayed for Aurora A and B activity by Western
blot, using antibodies against phospho-Aurora A (Thr288), phopho-TACC3(Ser558),
phospho-Aurora B (Thr232) and phopho-Histone H3 (Ser10). The images displayed
represent results that were consistent over three independent experiments.
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cell cycle flow-cytometry profiles of wild-type and R12 HCT116 cell lines, which had both been 
treated with a range of MLN8054 concentrations for 24 hours (Figure 7.3). Consistent with 
previously reported HeLa data (Figure 6.3A), 1 µM MLN8054 caused the reduction in the 
proportion of cells with 2N DNA in both the wild-type and the mutant cell line and  increased the 
proportion of R12 cells with 4N DNA. This 4N DNA increase most probably represents an 
extension to the time taken for the R12 cells to progress through mitosis after the 1 µM MLN8054 
treatment (Figures 6.1 and 6.2A). Wild-type cells however, did not show a similar increase in the 
population of cells with 4N DNA, and instead exhibited a shortening and widening of the 4N peak. 
The inability of wild-type cells to show the same accumulation of cells with 4N DNA, may be 
indicative of the combined inhibition of Aurora A and B activity, which may be experienced by 
wild-type cells.  
Increasing the concentration of MLN8054 applied to wild-type HCT116 cells to 4 µM and 10 µM, 
produced effects that were very typical of Aurora B inhibition, with most cells observed as having 
either 4N or 8N DNA following the treatments. This finding is indicative of the treated cells being 
unable to perform cytokinesis and separate their genetic material into two cells, a phenomenon that 
has previously been noted following Aurora B inhibition (Ditchfield et al., 2003). In contrast, the 
cycle profiles of R12 HCT116 cells treated 4 µM and 10 µM, were strikingly similar to those of 1 
µM MLN8054-treated R12 cells, indicating that, unlike wild-type cells, the three treatments 
produced very similar cell cycle effects. All three MLN8054 concentrations caused the R12 cell 
line to accumulate a greater population of cells with 4N DNA and decrease the proportion of cells 
with 2N DNA. This phenotype may either demonstrate a delay in mitosis, or indicate the inability 
of cells to perform cytokinesis following the treatments. The presence of only a very small 8N 
DNA population indicates that any cytokinesis defects caused by the MLN8054 treatments are 
unlikely be the result of profound Aurora B inhibition, although mild Aurora B inhibition cannot be 
ruled out, particularly after the treatment of the cells with 10 µM MLN8054, which caused the 
largest 8N DNA peak. Despite the possibility of mild cytokinesis defects at 10 µM MLN8054, the 
argument for the existence of profound cytokinesis failure is further weakened by the observation 
of a relatively large cell population with 2N DNA after MLN8054 treatment in the R12 cell line. 
This population indicates that, unlike wild-type cells, the R12 cells were still able to divide even 
after the high doses of MLN8054 treatment.  
Therefore R12 HCT115 reversion of the Aurora B inhibitory phenotype seen in wild-type cells 
after high dose MLN8054 treatment indicates the possibility of potentially increasing the potency 
of Aurora A inhibition. Whether it is actually possible to more potently increase Aurora A 
inhibition in this way remains to be seen. It is interesting to observe however, that no dramatic 
changes occurred in the cell cycle profiles of R12 HCT116 in response to increases in MLN8054  
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concentration, indicating that potent Aurora A inhibition may be already achieved at 1 µM 
MLN8054. 
7.4 Increasing the potency of Aurora A inhibition in HCT116 cells decreases the inter-
pole distance 
The revelation that increasing the concentration of MLN8054 did not largely appear to cause large 
changes to cell cycle profiles of R12 HCT116 cells or further affect their ability to divide, 
suggested that Aurora A activity may not have been optimally inactivated at 1 µM MLN8054. To 
gain a more accurate understanding of the level of Aurora A inhibition achieved however, I next 
examined the degree of centrosome separation seen in cells treated with a range of MLN8054 
concentrations.  
I have previously shown that 1 µM MLN8054 treatment of HeLa cells caused a shortening of inter-
pole measurements (Figure 4.2). Despite this, the majority of cells were capable of separating their 
centrosomes to form bipolar spindles (Figure 3.4), which is inconsistent with a number of reports 
which described the occurrence of large numbers of monopolar spindles after Aurora A 
inactivation (Glover et al., 1995, Mori et al., 2007, Girdler et al., 2006). I have also described the 
reduction in HeLa cell spindle bipolarity with increasing concentrations of MLN8054 (Figure 
7.1A). Therefore, using fixed and immunostained R12 HCT116 cells, I tested whether these cells 
also experienced a reduction in spindle polarity, in relation to increasing the concentration of 
MLN8054 (Figure 7.4).  
Measurements of control cells R12 HCT116 showed a range of different spindle lengths, 
presumably reflecting the different stages of mitotic progression (Figure 4.2). The most common 
inter-pole length category of the control R12 HCT116 cells was observed to be 9-9.99 microns, and 
the largest inter-pole distance recorded distance as 12.51 microns, both of which are highly 
comparable with the HeLa cell data. Treatment of the R12 cells with 1 µM of MLN8054 however, 
severely shortened the inter-pole distances of the R12 cells, with most recorded as having 
centrosomes less than 1.99 microns apart reflecting the profound monopolarity of the population. 
This finding was in stark contrast to the same treatment in HeLa cells, where the equivalent 
MLN8054 concentration only caused a slight shortening to the majority of spindle lengths (Figure 
4.2). These clear differences in the effects of MLN8054 in HCT116 cells compared to HeLa or 
DLD-1 cells is surprising, as Western blotting showed the cells lines exhibited relatively equivalent 
levels of Aurora A inhibition (Figures 3.3 and 7.2). The observed differences in spindle polarity 
after MLN8054 treatment, may therefore be indicative of cellular differences in response to Aurora 
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A inhibition, or could either be indicative of off-target effects in the HCT116 cells. Interestingly, a 
similar in the differing abilities to form bipolar spindles between HCT116 cells and HeLa cells has 
also seen after Aurora A was down regulated in previous reports in the literature (Marumoto et al., 
2003).  
Although the Rl2 HCT116 cells experienced profound monopolarity after their treatment with 1 
µM MLN8054, a range of larger inter-pole distances were recorded, with the longest spindle length 
being 7.68 microns. Increasing the concentration of MLN8054 to 4 µM caused a slightly higher 
proportion of R12 HCT116 cells to have inter-pole distances of less than 1 micron. Importantly 
however, as with the 1 µM treatment, a proportion of the population were also observed to have a 
range of larger inter-pole distances of up to 10.06 microns.  
Despite occurrence of a large range of spindle lengths after MLN8054 treatment, the occurrence of 
high numbers of monopolar spindles after Aurora A inhibition is more consistent with several 
reports in the literature, which describe a prominent role for Aurora A activity in bipolar spindle 
formation (Glover et al., 1995, Mori et al., 2007, Girdler et al., 2006). The production of a high 
proportion of monopolar spindles is similar to the effect of inhibiting Eg5 activity, which has also 
been shown to cause extended mitotic delays, after which cells were not capable of dividing 
(Figures 4.4A, 4.4B, 6.1 and 6.3A). Despite the similarity in respect to both treatments causing 
profound monopolarity, the cell cycle profiles of R12 HCT116 cells treated with MLN8054 
indicated that they did not experience similar extreme mitotic delays, and were still able to divide 
(Figure 7.3). This interesting discrepancy between the two treatments, despite apparently causing 
the same spindle defects, therefore required further investigation.   
7.5 Increasing the potency of Aurora A inhibition extends the delay in mitosis, although 
cells can still divide 
To address whether the cell cycle profiles of R12 HCT116 cells were correct in indicating that cells 
were still able to divide after potent Aurora A inhibition, despite the prominent presence of 
monopolar spindles, I used phase contrast microscopy and time-lapse imaging to follow the mitotic 
progression of individual cells (Figure 7.5). 
To determine the time cells spent in mitosis in response to various treatments, the duration between 
nuclear envelope breakdown and chromosome decondensation was recorded, as well as whether 
cell division had taken place. Using this methodology, I found untreated wild-type cells to take an 
average of 41 minutes to progress through mitosis, after which they all divided into two daughter  
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Figure 7.5 Increasing the concentration of MLN8054 up to 4 µM increases the time
R12 HCT116 cells spent in mitosis, although they are eventually able to divide
Wild-type (A) and R12 (B) HCT116 cells were treated with the indicated concentrations of
MLN8054, and time-lapse phase contrast microscopy images were taken every 2 minutes.
The resulting movies were analysed and the time taken for cells to go through mitosis was
plotted (determined as between nuclear envelope break down and chromosome
decondensation). Green circles represent cells that performed cytokinesis and red circles
indicate cells that were unable to do so. *** = P<0.001; ns = P>0.01 two-tailed t test.
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cells (Figure 7.5A). In contrast, 1 µM MLN8054 caused the wild-type cells to exhibit a large range 
of different mitotic periods, although all cells spent longer in mitosis than untreated cells, with an 
average mitotic period of 312 minutes. Therefore, consistent with data from both MLN8054-treated 
HeLa and DLD-1 cells, MLN8054 treatment caused a mitotic delay in wild-type HCT116 cells 
(Figures 6.1 and 6.2A). Unlike HeLa or DLD-1 cells however, a large proportion of wild-type 
HCT116 cells were unable to perform cytokinesis after treatment with 1 µM MLN8054 (Figures 
6.1 and 7.1). This could reflect the apparently more severe effect of MLN8054 treatment in the 
HCT116 cells, or alternatively it may be indicative of mild Aurora B inhibition being caused by 
MLN8054 at this concentration. Interestingly, increasing the concentration of MLN8054 to 4 µM, 
did not significantly change the mitotic period compared to cells treated with 1 µM MLN8054, 
however the majority of cells were also prevented from dividing (Figure 7.5A). At 4 µM MLN8054 
however, the level of phospho-Aurora B had previously been shown to be greatly decreased, 
suggesting that MLN8054 was inhibiting Aurora B activity at this concentration (Figure 7.2). This 
could therefore indicate a compromised spindle assembly checkpoint, which may explain the 
increase in cytokinesis defects and the slight decrease in mitotic timings. Increasing the 
concentration of MLN8054 to 10 µM, further reduced the time wild-type HCT116 cells spent in 
mitosis, with an average mitotic period of 189 minutes (Figure 7.5A). Furthermore, all cells were 
prevented from performing cytokinesis, which is consistent with previously described data and 
reports in the published literature which show the Aurora B activity is inhibited following treatment 
with high concentrations of MLN8054 (Manfredi et al., 2007, Hoar et al., 2007). 
To test whether the effects of high dose MLN8054 could be reverted by using the drug-resistant 
cell line, I applied the same range of MLN8054 concentrations to R12 HCT116 cells. Following 
the progression of individual cells through mitosis revealed that, similar to wild-type cells, control 
R12 HCT116 cells spent 42 minutes in mitosis before dividing (Figure 7.5B). Furthermore, treating 
the R12 HCT116 cells with 1 µM MLN8054 extended the time cells spent in mitosis, with an 
average mitotic period being recorded as lasting 160 minutes. Interestingly however, this increase 
was not as profound as that seen in wild-type cells, and unlike wild-type cells, R12 HCT116 cells 
were still able to divide. The ability of the R12 HCT116 cells to revert the cytokinesis defects and 
even reduce the degree of mitotic delay, suggests these phenomena may be derived from Aurora B 
inhibitory effects. The finding that 1 µM MLN8054 may cause Aurora B inhibition in HCT116 
cells has important implications, particularly for  the findings of some reports in the literature, 
which use 1 µM MLN8054 to make assumptions regarding Aurora A activity in HCT116 cells 
(Kaestner et al., 2009). 
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Increasing the concentration of MLN8054 further to 4 µM in R12 HCT116 cells, prolonged mitosis 
still further, causing the average cell to take 248 minutes to exit mitosis. In agreement with the 
HCT116 flow cytometry profiles however, many cells were still able to divide after the extended 
mitotic periods (Figure 7.3). Cells treated with 10 µM though, experienced no significant further 
mitotic delay when compared with cells treated with 4 µM MLN8054. A great increase was 
however observed in the proportion of cells that were unable to divide following treatment with 10 
µM MLN8054. Consequently, in the previously discussed flow cytometry profiles, the slight 
increase to the population of the 4N DNA population of cells treated with 10 µM MLN8054 may 
therefore have been caused by cells that were unable to perform cytokinesis rather than by a great 
extension to the mitotic delay (Figure 7.2).  
Therefore, although it may be possible that a mild Aurora B inhibition is seen in R12 HCT116 cells 
after treatment with 10 µM MLN8054, it was largely possible to revert the Aurora B inhibition 
seen after lower concentrations using the drug-resistant cell line. By exploiting this resistancy for 
MLN8054 effects to Aurora B activity, it was possible to increase the concentration of MLN8054 
without also inhibiting Aurora B, to reveal the effect of potently inhibiting Aurora A activity. 
Interestingly, increasing the concentration of MLN8054 of 1 µM to 4 µM, caused an extension to 
the time R12 cells spent in mitosis, however the vast majority were still able to divide. Although 
this supports the findings of the flow cytometry graphs (Figure 7.3), it is surprising when 
considering that most cells appear to have monopolar spindles after MLN8054 treatment (Figure 
7.4). The ability of cells to divide following Aurora A inhibition suggests that they are eventually 
able to form functional spindles after the extended mitotic delays. Indeed, as well as the prominent 
occurrence of monopolar spindles after both 1 µM and 4 µM MLN8054 treatments, a range of 
longer spindle lengths were also recorded, supporting the assumption that cells are eventually 
capable of forming bipolar spindles.  
An alternative explanation for the ability of cells to exit mitosis despite the profound occurrence of 
monopolar spindles may however be that Aurora A inhibition causes the override of the spindle 
assembly checkpoint. This latter theory would therefore imply that cells were capable of exiting 
mitosis without rectifying their monopolar spindles and satisfying the spindle assembly checkpoint. 
I have previously been unable to identify a prominent role for Aurora A activity in the spindle 
assembly checkpoint, however it was not clear whether such a role could be detected when more 
potently inhibiting Aurora A activity. 
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7.6 Aurora A activity does not have a prominent role in the spindle assembly checkpoint  
The ability of cells to arrest after Aurora A inhibition, and effectively localise spindle checkpoint 
proteins in the absence of Aurora A activity after Nocodazole  treatment, supports the idea that 
Aurora A activity does not have a role in the spindle assembly checkpoint (Figures 6.1, 6.2, 5.3B 
and 5.4B). In addition, increasing the potency of Aurora A inhibition still permitted cells to stay in 
mitosis and divide after extended mitotic delays, indicating the presence of an active spindle 
checkpoint in cells after Aurora A inhibition (Figure 7.7B). However, two recently published 
papers have described a role for Aurora A activity in the proper functioning of the spindle assembly 
checkpoint (Wysong et al., 2009, Kaestner et al., 2009).  
Therefore, to examine whether potent Aurora A inhibition was capable of overriding the spindle 
assembly checkpoint, I inhibited Eg5 activity to cause chromosome misalignments to maintain 
checkpoint activation (Figure 4.4) (Kapoor et al., 2000, Mayer et al., 1999). Consistent with 
sustained checkpoint activation, the flow cytometry profiles of both wild-type and R12 HCT116 
cells treated with an Eg5 inhibitor for 24 hours showed an accumulation of cells with 4N DNA 
(Figure 7.6). By co-treating the cells with MLN8054, I hoped to determine whether Aurora A 
inhibition could cause cells to be driven out of mitosis, despite the chromosome alignment defects 
produced by inhibiting Eg5 activity. If such an effect was seen to occur, it would imply a role for 
Aurora A activity in the spindle assembly checkpoint.  
By following this experimental deign, the resulting flow cytometry profiles of wild-type cells co-
treated with 1 µM MLN8054 for 24 hours showed a slight reduction in the proportion of cells with 
4N DNA when compared to cells treated with just the Eg5 inhibitor. Increasing the concentration 
of MLN8054 to 4 µM and 10 µM however, greatly reduced the 4N population of cells and 
introduced a prominent 8N peak. In comparison to wild-type cells however, the majority of R12 
HCT116 cells were able to maintain 4N DNA after combined Eg5 and potent Aurora A inhibition. 
A small 8N peak could however be detected after the treatment of the cells with 10 µM MLN8054 
and Eg5 inhibitor. This clear difference observed after the co-treatment of MLN8054 in the wild-
type and the drug-resistant HCT116 cells, is likely to result from the ability of MLN8054 to inhibit 
Aurora B activity in wild-type cells, but not in the drug-resistant cell line. Therefore, the inhibition 
of Aurora B by MLN8054 in wild-type cells provides an example of a checkpoint override, where 
the 8N cell population is representative of cells which have been driven out of mitosis (Ditchfield 
et al., 2003, Kapoor et al., 2000). The absence of such a prominent 8N cell population after the 
equivalent treatment in R12 cells indicates that cells were not driven out of mitosis when cells were 
able to resist the Aurora B inhibitory effect of MLN8054. Therefore, the potent inhibition of  
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Figure 7.6 Potent Aurora A inhibition does not noticeably override the spindle
assembly checkpoint
Flow cytometry PI profiles of wild-type and R12 HCT116 cells, which were harvested after
24 hours of treatment with the indicated concentrations of MLN8054 in combination with
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Aurora A activity did not noticeably compromise the spindle assembly checkpoint, indicating that 
Aurora A activity does not play a prominent role in it the checkpoint. 
Whether the Aurora A kinase activity is involved in the maintenance of the checkpoint is however 
still up for debate, as the cell cycle profiles do not allow one to distinguish between cells that were 
held in mitosis, from those which were prematurely forced into G1 after an extended delay (as seen 
in DLD-1 cells in Figure 6.1). Despite this limitation, Aurora A activity clearly is not prominently 
involved in the spindle assembly checkpoint.  
7.7 Summary 
In the previous chapters I inhibited Aurora A activity demonstrating its roles in efficient spindle 
assembly, chromosome alignment, timely mitotic progression and normal cell division. However, 
inconsistencies with the published literature suggested that it may be possible to inhibit Aurora A 
to a greater degree to produce more profound effects on spindle assembly and mitotic progression 
(Glover et al., 1995, Mori et al., 2007, Girdler et al., 2006). While investigating this hypothesis, I 
found that simply increasing its concentration also caused the inhibition of Aurora B activity. 
Despite this, the observation of decreased spindle bipolarity together with the extension of mitotic 
timings, suggested that it might indeed be possible to increase the potency of Aurora A inhibition 
by raising the concentration of MLN8054.  
Through using a drug-resistant HCT116 cell line, I was able to revert the effects of MLN8054 on 
Aurora B activity, thus enabling the characterisation of the effects of potent Aurora A inhibition 
without also inhibiting Aurora B activity. Using this cell line I was able to increase the 
concentration of MLN8054, which produced profound monopolarity in the spindles of mitotic cells 
and extended the time cells spent in mitosis. Despite the monopolarity of their spindles, the cells 
were still able to divide even after the extended mitotic delays. This phenomenon was not 
considered to be derived from a prominent role for Aurora A activity in the functioning of the 
spindle assembly checkpoint, but rather cells were predicted to be capable of forming bipolar 
spindles after extended mitotic periods. Therefore the potent inhibition of Aurora A activity 
confirmed that Aurora A activity was required for the formation of normal bipolar spindles and for 
the timely progression through mitosis. Aurora A activity however was not required for the process 
of cell division as cells were eventually able to form adequate spindles without the kinase activity. 
The accuracy of the cell division in the absence of Aurora A activity is however as yet unknown, 
although cell cycle profiles indicated the existence of a relatively narrow 2N DNA peak after 24 
hours of MLN8054 treatment in HCT116 cells, possibly suggesting even segregation. 
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So far in the investigation, the role of Aurora A activity has only been investigated in cancer cell 
lines. Therefore, in the next chapter I will describe data in which non-transformed cells were tested 
for their dependency on Aurora A activity. This line of investigation may consequently have 
important connotations in developing a more universal understanding of the role of Aurora A 
activity in cells, as well as understanding the effects of Aurora A-directed anti-cancer therapies to 
healthy cells in the human body.  
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8 Investigating the role of Aurora A kinase activity in a non-
transformed cell line 
8.1 Introduction 
Cancerous cell lines are commonly used for research in laboratories as they are typically fast 
growing, have been immortalised, and are relatively robust to life in culture conditions. These 
qualities have meant that many cancer cell lines, such as the ones used in this investigation, have 
been well characterised, making them ideal model systems. It was important however, to examine 
the role of Aurora A activity within non-tumour cells to develop a better understanding of the role 
of Aurora A kinase activity within the normally functioning human body. Furthermore, if any 
differences were observed between the roles of Aurora A activity in non-tumour cell lines and in 
cancer cells, this may have important implications for the effectiveness of the targeting of Aurora A 
kinase activity as an anti-cancer therapy. For these reasons, I therefore decided to expand the 
investigation to examine the role of Aurora A activity in non-transformed cells.   
To enable the practical use of non-transformed cells, it was necessary to select a cell line that had 
been immortalised to prevent the induction of scenescence, in response to telomere shortening 
resulting from a limited proliferation capacity. Despite being immortalised, the cell line could still 
be used as a model to exemplify the role of Aurora A activity in non-transfomed cells as they, 
unlike transformed cells, would not form a tumour if injected into mice and were subject to contact 
inhibition induced senescence (data not shown). It must be noted however, that although non-
transformed cells were used to model the role of Aurora A activity in non-cancer cells, the process 
of isolating and culturing cells has been shown to cause adaptation to culture conditions, and thus 
cultures cells cannot be used synonymously with healthy tissue samples (Engelmann and Valtink, 
2004). To truly investigate the role of Aurora A kinase activity in healthy tissues, in vivo methods 
would have to be emplyed, however in this investigation such techniques were not feasable, and 
non-transformed culture cells were used as an adequate alternative. 
Differences between transformed and non-transformed cell lines in their response to various anti-
mitotic drug treatments have been previously reported (Orth et al., 2008, Brito et al., 2008, Brito 
and Rieder, 2009, Gascoigne and Taylor, 2008). In all these cases, a greater proportion of cell death 
was observed in the cancer cell lines compared to the non-transformed lines when exposed to anti-
mitotic drugs. In light of this data, I set out to determine whether non-transformed cell lines were  
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Figure 8.1 MLN8054 can be used to specifically inhibit Aurora A activity in RPE cells
RPE cells were mitotically enriched with Nocodazole for 16 hours before being treated with
MG132 and a range of concentrations of MLN8054 for a further 2 hours. The samples were
then harvested and lysed, and whole cell lysates were separated using SDS PAGE.
Immunoblotting was used to detect the presence of: Aurora A, Phospho-Aurora A (Thr288),
phospho-Aurora B (Thr232), phospho-TACC (Ser558), Aurora B and phospho-histone H3
(Ser10). HeLa cells were treated identically with 0 µM, 1 µM and 4 µM MLN8054 and run
on the same blot to compare inhibition levels. The images displayed represent results that
were consistent over three independent experiments.
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also more resilient to Aurora A inhibition, as well as addressing whether Aurora A activity played 
an equivalent role in non-transformed cells to that observed in the cancer cell lines tested. 
8.2 Aurora A activity can be inhibited in RPE cells  
Immortalised human retinal pigment epithelial (RPE) cells expressing telomerase reverse 
transcriptase (hTERT) were selected as the non-transformed cell line to be investigated in this 
chapter. The expression of hTERT prolongs cell life by reconstituting telomerase activity, thus 
preventing senescence occurring as a result of telomere shortening. Importantly however, neither 
aneuploidy nor transformation is induced by the expression of hTERT, making it an ideal method 
of immortalisation for the investigation into non-transformed cells (Jiang et al., 2003a, Gascoigne 
and Taylor, 2008, Jiang et al., 2003b).  
After selecting the non-transformed cell line, I next set out determine whether they were responsive 
to the Aurora A inhibitory effects of MLN8054. To do this, I treated the RPE cells with a range of 
MLN8054 concentrations, separated the samples on a SDS PAGE gel, and then used Western 
blotting to observe any changes in activity (Figure 8.1). Encouragingly, the disappearance of bands 
representing phospho-Aurora A indicated that Aurora A activity could indeed be inhibited in RPE 
cells with MLN8054. Furthermore, the level of Aurora A inhibition produced appeared to be 
equivalent to that observed in cancer cells samples (Figures 3.3 and 7.2), where the complete 
disappearance of phospho-Aurora A signal was observed to occur in samples treated with 1 µM 
MLN8054. Interestingly however, in RPE cell samples the phospho-TACC3 signal was not 
reduced to equivalent levels as in HeLa cell samples shown on the same blot. Despite these 
differences, the RPE Western blot data demonstrated that Aurora A activity could be potently be 
inhibited at 1 µM MLN8054.  
As well as inhibiting Aurora A activity however, MLN8054 could also inhibit Aurora B activity in 
the RPE cell line. RPE samples treated with 4 µM MLN8054 showed a reduction in phospho-
Aurora B signal when compared with a control sample, however treatment with 10 µM MLN8054 
appeared to abolish the signal completely. This level of inhibition was consistent with that seen in 
HeLa cells on the same Western blot, however the RPE phospho-histone H3 signal was only 
reduced when RPE cells were treated with 10 µM MLN8054. This differs from the cancer cell lines 
tested, as the level of phospho-Histone H3 signal in HeLa, DLD-1 and HCT116 cells was affected 
by lower concentrations of MLN8054 (Figures 3.3, 7.2 and 8.1). Therefore, although differences 
could be observed between the effects of MLN8054 on the downstream targets of Aurora A and 
Aurora B, the analysis of the phosphorylated forms of Aurora A and B in the Western blots  
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demonstrated that MLN8054 could be used at 1 µM in non-transformed cells to potently and 
specifically inhibit Aurora A activity.  
8.3 Inhibiting Aurora A activity causes mitotic delays in RPE cells, although not to the 
extent seen in the cancer cell lines  
After confirming that it was possible to inhibit Aurora A activity in RPE cells, I next wanted to 
establish if, as seen in cancer cells, Aurora A activity was required for efficient mitotic progression. 
To address this question I used phase-contrast time-lapse microscopy to observe the length of time 
individual cells took to go from nuclear envelope break-down to chromosome decondensation. The 
quantitation of the mitotic timings revealed that control RPE cells took on average 31 minutes to go 
through mitosis before dividing into two cells (Figure 8.2A). Interestingly, this mitotic period is 
slightly shorter than those previously described for the cancer cell lines, with HeLa and R12 
HCT116 cells observed to take an average of 68 and 42 minutes to complete mitosis respectively 
(Figure 8.2B). Treatment of the RPE cells with 1 µM MLN8054 caused them to be retained in 
mitosis for 44 minutes, a 42% increase in mitotic period compared to control cells. This increase is 
strikingly shorter than those seen in HeLa and R12 HCT116 cells after the equivalent treatment, 
which saw average mitotic periods increase by 289% and 281% respectively (Figure 8.2C). Despite 
the differences in severity of MLN8054 treatment on transformed and non-transformed mitoses, as 
with cancer cell lines the majority of the RPE cells were able to divide following their treatment 
with 1 µM MLN8054 (Figures 6.1, 6.2A, 7.1C and 7.5B). 
Raising the concentration of MLN8054 to 4 µM, caused a further extension to the RPE mitotic 
period, with cells taking an average of 168 minutes to exit mitosis, a 443% increase to the mitotic 
timing compared with control cells. Interestingly, unlike previously reported cancer cell data, the 
vast majority of RPE cells were still able to perform cytokinesis after treatment with 4 µM 
MLN8054 (Figures 7.1C and 7.5A). This difference may be due to RPE cells being more resilient 
to the effects of 4 µM MLN8054 on down stream components of the Aurora B signalling pathway 
compared to the cancer cell lines tested, as determined by phospho-Histone H3 levels (Figure 8.1). 
Treating RPE cells with 10 µM MLN8054, caused cells to spend an average of 173 minutes in 
mitosis, a 458% increase compared to control cells. This extended mitotic period suggested that 10 
µM MLN8054 was capable of causing more profound chromosomal alignment defects, possibly 
through an increased potency towards Aurora A activity. Importantly however, all cells analysed 
were incapable of dividing, demonstrating the effects of Aurora B inhibition seen at this MLN8054 
concentration and confirming that MLN8054 cannot be used at 10 µM to specifically inhibit 
Aurora A activity (Figure 8.1). The lower concentrations of MLN8054 however, were capable of 
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specifically inhibiting Aurora A activity, and clearly showed that Aurora A inhibition extended the 
time RPE cells spent in mitosis. Interestingly though, Aurora A inhibition did not produce such 
profound increases to mitotic periods in RPE cells as was seen in cancer cells after the equivalent 
treatments, indicating the existence of integral differences between the cell types.   
8.4 In RPE cells the processes of chromosome alignment and spindle assembly are not as 
severely affected by Aurora A inhibition as in cancer cells 
To explore the reason as for why RPE cells did not experience as acute effects to mitotic 
progression as cancer cell lines, despite apparently equivalent levels of Aurora A inhibition, I 
examined the effect of Aurora A inhibition on the ability of RPE cells to form bipolar spindles and 
align their chromosomes. I had previously shown Aurora A inhibition to reduce the efficiency of 
bipolar spindle assembly and chromosome alignment in cancer cells, consequentially causing 
extended mitotic delays (Figures 5.1 and 6.1). Therefore, consistent with the previously outlined 
identical experiment in HeLa cells, I treated RPE cells with an Eg5 inhibitor to create monopolar 
spindles, then allowed the cells to reorganise their spindles and align their chromosomes in the 
presence of various treatments (Figure 8.3A). The analysis of the fixed cell samples revealed that 
as seen in HeLa cells, maintaining the Eg5 inhibition produced severe chromosomal alignment 
defects in 100% of cells (Figure 8.3B). This treatment also produced monopolar spindles in the 
majority of cells analysed, explaining the source of the chromosome misalignments (Figure 8.3C). 
In contrast, washing out the effects of the Eg5 inhibitor produced the occurrence of bipolar spindles 
and properly aligned chromosomes (Figures 8.3B DMSO and 8.3C DMSO). Replacing the Eg5 
inhibitor with an Aurora B inhibitor however, prevented the re-alignment of the chromosomes in 
98% of cells, despite the reformation of their bipolar spindles (Figures 8.3B-ZM1and 8.3C-ZM1). 
Importantly, all three of the treatments produced phenotype profiles which were consistent with 
previously described HeLa data as well as published reports of similar treatments (Figure 5.1) 
(Mayer et al., 1999, Kapoor et al., 2000, Adams et al., 2001b, Ditchfield et al., 2003).  
Interestingly however, the replacement of the Eg5 inhibitor with 1 µM MLN8054 in the RPE cells 
produced strikingly less severe cellular phenotypes from those described in the cancer cell line. 
Only 23% of HeLa cells were previously reported to be capable of realigning their chromosomes in 
the absence of Aurora A inhibition in the allocated time period (Figure 5.1A), whereas 90% of RPE 
cells were recorded as having completely aligned chromosomes after the same treatment, and 100% 
of cells were observed as having bipolar spindles (Figures 8.3B-MLN8054 and 8.3C-MLN8054). 
Although I had previously also described the majority of HeLa cells to be capable of forming 
bipolar spindles after MLN8054 treatment, the spindles were found to be shorter than in control  
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Figure 8.3 Aurora A inhibition only minimally reduces the efficiency of chromosome
alignment in RPE cells and does not significantly reduce centrosome separation
(A) Protocol used to determine whether Aurora A activity has a role in chromosome
alignment. After following the protocol outlined in (A), RPE cells were fixed and stained
with antibodies against Pericentrin and Tubulin to determine the spindle phenotype, and
Aurora B together with Hoesht to allow the observation of chromosomal alignment.
(B) Quantitation of efficiency of chromosomal alignment. Cells were classified as having
’mild’ misalignment if up to 4 of their chromosomes were unaligned or, if there were more
than 4, the cell was termed as having ’severe’ misalignment. Cells treated with 1 µM
MLN8054 were found to show no significant difference in in their ability to align their
chromosomes (two-tailed t test). (C) Histogram to show spindle phenotypes of the
samples. (D) Measurement of spindle lengths from z-stacked images. The graphs
represent data taken from three independent experiments. ns = P>0.01 two-tailed t-test.
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cells (Figures 5.1C and 5.1D). Therefore to determine whether RPE cells also suffered from 
shortened spindles after Aurora A inhibition, I measured the inter-pole distances of the cells 
exposed to each of the previously described treatments (Figure 8.3A). The measurement of fixed 
cell spindles revealed that sustained Eg5 inhibition produced severely shortened spindle lengths an 
average of 1.9 microns long, reflecting the monopolarity of the spindles (Figure 8.3D). 
Comparatively, cells exposed to DMSO or ZM1 after the removal of the Eg5 inhibitor, showed 
longer average spindle lengths of 9.3 and 9.0 microns respectively. Interestingly, RPE spindles 
formed in the presence of MLN8054, showed similar spindle lengths that were not significantly 
different from those of control cells, with an average spindle length measurement of 8.3 microns. 
This data therefore indicated that RPE cells were more efficiently able to form spindles of a normal 
length and align their chromosomes in the absence of Aurora A inhibition, than the cancer cell line 
tested. This distinction may therefore provide an explanation as to why the cancer cell lines were 
delayed in mitosis for longer periods than the RPE cells.  
To test whether the relatively short mitotic delay caused in RPE cells by Aurora A inhibition was 
related to their superior ability to align their chromosomes compared to cancer cells, I analysed live 
RPE cells which had been transfected with GFP-histone to observe their DNA (Gascoigne and 
Taylor, 2008). The analysis of cellular DNA by fluorescence microscopy time-lapse imaging 
showed that, as with HeLa cell samples (Figure 6.2B(i)), control RPE cells experienced nuclear 
envelope breakdown, before organising their chromosomes into a metaphase plate and proceeded 
into anaphase and dividing into two cells (Figure 8.4A). Consistent with previously described live 
cell data (Figure 8.2A), when treated with MLN8054, RPE cells were delayed in mitosis (Figure 
8.4B). RPE cells were however able to align chromosomes to form a metaphase plate in a shorter 
time period that seen in HeLa cell samples exposed to Aurora A inhibition (Figure 6.2B). 
Furthermore, unlike HeLa cells, no segregation defects were observed in the RPE cells analysed, 
demonstrating the presence of correctly aligned chromosomes (Figures 6.2B (ii) and 6.2B(iii)). The 
ability of RPE cells to more efficiently form bipolar spindles and align their chromosomes after 
Aurora A inhibition can therefore be used to explain why RPE cells only suffer comparatively short 
mitotic delays after the treatment. Alternatively however, Aurora A activity may not be as potently 
inhibited as in the cancer cell lines tested, despite evidence to the contrary (Figure 8.1). Without the 
creation of mutant RPE cells that able to revert the high dose MLN8054 effects on Aurora B 
activity however, it would not be possible to increase the concentration of MLN8054 while 
maintaining specificity towards Aurora A activity. 
72
Figure 8.4 Aurora A inhibition in RPE cells causes the extension of prometaphase,
however they are eventually able to divide after only a relatively short delay
Projected z-section time-lapse images of GFP histone H2B RPE cells treated with 0 µM
MLN8054 (A) and 1 µM MLN8054 (B). Numbers shown in the bottom right-hand corner of
each image indicate the time elapsed in minutes after nuclear envelope breakdown.
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8.5 Long-term Aurora A inhibition causes RPE cells to accumulate with 2N DNA and 
permits the survival of a number of sparsely populated colonies 
The ability of non-transformed cells to more efficiently align their chromosomes compared to 
cancer cells in the absence of Aurora A activity, indicates that the cells may be more resilient to the 
degenerative effects of Aurora A inhibition compared to the cancer cell lines tested. Differences 
between the long-term viability of transformed and non-transformed cells may have important 
implications for the targeting of Aurora A activity as an anti-cancer therapy, since an important 
consideration in determining the effectiveness of a therapeutic agent is whether healthy tissue is 
also damaged during the targeting of the disease.  
I previously described how prolonged exposure to 1 µM MLN8054 caused HeLa cells to 
experience severe chromosomal misalignment, prolonged delay in mitosis, aneuploidy and 
eventually cell death, indicating the toxicity of the treatment (Figures 6.3A(ii), 6.3B and 6.3C). In 
comparison, flow cytometry profiles of RPE cells treated with 1 µM MLN8054 for 24 hours, 
showed only a very slight increase in the proportion of cells with 4N DNA, demonstrating the 
comparatively short mitotic delay experienced by the cells (Figure 8.5A). Interestingly, treatment 
with 1 µM MLN8054 for more than 48 hours caused the proportion of RPE cells with 4N DNA to 
be reduced, suggesting that cells were prevented from progressing normally through the cell cycle. 
Furthermore, the development of a sub-G1 peak after 72 hours of treatment indicated that cells 
were dead or dieing as a result of the inhibitor treatment. Interestingly however, after 96 hours of 
sustained Aurora A inhibition, only a minimal sub-G1 population was detected, with most cells 
instead forming a prominent 2N DNA peak (Figure 8.5A).  
Treating RPE cells with 4 µM MLN8054 produced similar cell cycle profiles to those seen after the 
1 µM treatment, although a slightly larger 4N peak and smaller 2N DNA peak were detected, 
indicating of the longer mitotic delay experienced by the cells (Figure 8.2A).  Despite this, both 
1 µM and 4 µM MLN8054 produced distinct effects to RPE cells than those observed in HeLa 
cells, with the flow cytometry profiles appearing to indicate that RPE cells only experienced a 
comparatively low amount of cell death after extended Aurora A inhibition. 
To assess the long-term viability of the RPE cells exposed sustained Aurora A inhibition, and 
address whether they did indeed suffer only relatively low amounts of cell death, I tested their 
ability to form colonies after prolonged Aurora A inhibition. Following 14 days of the exposure of 
the RPE cells to a range of different treatments, I fixed and stained the samples with crystal violet 
and analysed the samples to detect cell colonies (Figure 8.5B). Previously, HeLa cells had been 
shown to be unable to form colonies after sustained treatment with 1 µM (Figures 6.3B and 6.3C).  
DMSO 1 µM
MLN8054
4 µM
MLN8054
2 µM
ZM1
0
20
40
60
80
100
DMSO 1 µMMLN8054
4 µM
MLN8054
2 µM
ZM1
Dense colonies
Sparse colonies
150
  151 
 
  
In the equivalent experiment in RPE cells, control cells were shown to form a large number of 
densely populated colonies during the growth period. In contrast, treating the cells with ZM1 
completely prevented the formation of colonies, which is consistent with previously described 
HeLa data (Figure 6.3C). RPE cells exposed to sustained 1 µM MLN8054, were unable to form 
colonies that were identical to those of control samples, however surprisingly, smaller and less 
densely populated colonies could be detected. Importantly however, not only was the density of the 
colonies reduced after the 1 µM MLN8054 treatment but also the quantity, with a 41% reduction in 
the number of colonies detected. Interestingly, the sustained treatment of cells with 4 µM 
MLN8054 prevented the growth of almost all colonies, denoting the higher toxicity of the 
treatment. 
Although RPE cells were rendered unviable after their extended exposure to 4 µM MLN8054, the 
observation that 1 µM MLN8054 allowed the formation of a number of sparsely populated colonies 
was in stark contrast the complete loss of HeLa cell viability after the same treatment. Furthermore, 
the finding that long-term Aurora A inhibition caused RPE cells to accumulate with 2N DNA, 
while a profound sub-G1 population was produced in HeLa cells, highlighted some important 
differences in how the transformed and cancer cells responded to the treatment. Supporting these 
observations, a recently published report described how MLN8054 caused a higher proportion of 
cell death in transformed cells compared to non-transformed cell lines (Shang et al., 2009). 
8.6 The effect of Aurora A inhibition on the localisation of RPE proteins 
The data in this chapter so far has outlined some clear differences between the effects of Aurora A 
inhibition on transformed and non-transformed cell lines. To uncover an explanation for these 
differences, I examined changes in the localisation of various proteins in response to Aurora A 
inhibition.  
I have previously described that Aurora A localisation in HeLa cells was not dependent on its 
activity, however its activity was partially required for its stable association to the spindle (Figure 
4.7A). A similar result was also seen in fixed and immunostained RPE cells (Figure 8.6A). When 
RPE cells were not extracted before their fixation, there appeared to be no change to the Aurora A 
antibody localisation after MLN8054 treatment (data not shown). However, when including the 
extraction step in the protocol, Aurora A inhibition caused a reduction of Aurora A to be detected 
on the spindle, although consistent with the HeLa data, its localisation to the centrosome did not 
appear to be affected. 
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Figure 8.6 Aurora A activity is partially required for the stable association of Aurora
A protein to the spindle, however TACC3 and chTOG localisation are not as
affected by Aurora A inhibition as previously described in HeLa cells
RPE cells were treated with 0 µM MLN8054 (control) or 1 µM MLN8054 for 2 hours before
being fixed and stained with the indicated antibodies. Z-stacked images were taken of the
samples to observe the affect of Aurora A inhibition on Aurora A localisation (A), on
TACC3 localisation (B), and chTOG localisation (C). Scale bars = 4 µm.
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The localisation of TACC has been attributed to Aurora A activity, with a recent study even 
suggesting that the mislocalisation of TACC3 seen after MLN8054 treatment could be a 
pharmacodynamic method of measuring Aurora A activity (LeRoy et al., 2007). Furthermore, the 
localisation of chTOG/XMAP215 to the minus-ends of microtubules has been proposed to be 
dependent on TACC (Barros et al., 2005, Giet et al., 2002, Kinoshita et al., 2005, LeRoy et al., 
2007, Deluca et al., 2006, Peset et al., 2005, Lee et al., 2001, Gergely et al., 2003). Consistent with 
these findings, I previously showed that TACC3 was completely mislocalised and chTOG levels 
were reduced after Aurora A inhibition in HeLa cells (Figures 4.7B, 4.7C and 4.7D). Intriguingly 
however, MLN8054 treatment of RPE cells did not cause the same level of TACC3 mislocalisation 
as previously seen in HeLa cells (Figure 8.6B). Instead, its localisation was only slightly reduced 
on spindles after the treatment. This finding is in agreement with the findings of Barros and 
colleagues (2003), which showed that a D-TACC that could not be phosphorylated by Aurora A, 
was still localised to the centrosomes of Drosophila, but its localisation was reduced on 
microtubules. Interestingly, the localisation of chTOG to the centrosomes did not seem to be 
reduced at all, with its localisation instead often appearing to be more intense on some centrosomes 
after the treatment (Figure 8.6C).  
8.7 Summary 
Comparing the effects of Aurora A inhibition in non-transformed cells with cancer lines, revealed 
some interesting differences. One of the most profound of these differences was the ability of RPE 
cells to more efficiently form bipolar spindles and align their chromosomes in the absence of 
Aurora A activity compared to cancer cells despite equivalent levels of Aurora A inhibition. The 
comparative efficiency of these processes in the absence of Aurora A activity meant that non-
transformed cells only suffered relatively minimal mitotic delays after the treatment. Furthermore, 
after extended Aurora A inhibition RPE cells were caused to accumulate with 4N DNA and were 
able to form sparsely populated colonies, while HeLa cells quickly become aneuploid and died 
after the same treatment.  
The ability of RPE cells to maintain relatively efficient cell division after Aurora A inhibition may 
be due to a capacity to either sustain the activity of particular cellular pathways in the absence of 
Aurora A activity or exploit alternatives, where the cancer cells were less able to do so. This ability 
to withstand the effects of Aurora A inhibition was demonstrated through the continued efficient 
localisation of chTOG and TACC3 to centrosomes even after MLN8054 treatment, a phenomenon 
that was not seen in the cancer cell line tested. Interestingly, both chTOG/XMAP215 and TACC3 
have been attributed to the normal growth of spindles (Barros et al., 2005, Giet et al., 2002, 
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Kinoshita et al., 2005, LeRoy et al., 2007, Deluca et al., 2006, Peset et al., 2005, Lee et al., 2001, 
Gergely et al., 2003). The sustained localisation of chTOG and TACC3 after MLN8054 treatment 
could possibly therefore be used to explain how RPE cells are able to form spindles of a normal 
length after the treatment, whereas HeLa cells could not.  
The apparent higher sensitivity to Aurora A inhibition of cancer cell lines compared to RPE cells 
suggests that targeting the kinase activity of Aurora A may be able to effectively target transformed 
cells while leaving the healthy cells comparitivley less effected, a theory that is supported by a 
number of reports (Tomita and Mori 2010, Manfredi et al., 2007, Dees et al., 2010). Despite the 
differences observed between the cancer cell lines and the RPE cells, it is important to highlight 
that RPE cells were the only non-transformed cells to be tested during this investigation. The 
differences observed between the two cell types may therefore simply be the result of inter-cell line 
differences. More work with alternative non-transformed cell lines would need to be undertaken 
before any concrete conclusions could be made regarding the different effects of Aurora A 
inhibition in healthy and cancer cells.  
Furthermore, the process of removing RPE cells from the retinal sample to growing them in culture 
involves a major level of disruption to their normal living conditions, causing the development of a 
degree of continuous adaptation in the cell population (Engelmann and Valtink, 2004). Such 
adaptations make it possible to effectively culture the cells, however the resulting cell population is 
also consequently made integraly different from the sample from which they were derived. Thus, 
although RPE cells have been used during this investigation to represent non-transformed cells, 
they are not truly synonymous with naturally occurring cells of the human body. A true observation 
of the role of Aurora A activity within healthy cells would therefore instead, have to be in the form 
of in vivo experiements, which unfortunately were not possibile during this investigation. 
Desepite the requirement for in vivo studies to make accurate conclusions about the role of Aurora 
A activity in healthy cells, the differences highlighted between transformed and the RPE cell line 
demonstrated the danger of assuming commonality between distinct cell lines, and was thus an 
important part of the investigation.  
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9 Discussion 
9.1 Introduction 
The Aurora kinase family has received much attention in recent years, with investigations revealing 
roles for the kinases throughout mitosis, with links even reported between the expression of the 
kinases and the development and progression of cancer (Zhou et al., 1998, Keen and Taylor, 2004, 
Bischoff et al., 1998, Carmena and Earnshaw, 2003). In the case of Aurora A kinase, much of this 
work comprised of depleting, disabling or mutating endogenous protein, or exogenously expressing 
mutated forms to determine the role of the Aurora A kinase (Marumoto et al., 2002, Marumoto et 
al., 2003, Hannak et al., 2001, Mori et al., 2007, Glover et al., 1995, Motegi et al., 2006). These 
techniques provided important insight into the role of Aurora A kinase, exposing many intriguing 
qualities of the kinase. Despite the elegant use of the experimental techniques, the requirement to 
constitutively express mutated forms of the kinase or induce the expression or depletion of 
proteins, meant that temporal control over the experiments was unachievable. Furthermore, the 
removal or depletion of the protein either by genetic knockouts or nulls or by RNAi obstructs the 
ability to distinguish between the structural functions of the kinase and its catalytic roles within the 
cell. Therefore instead of causing permanent changes to cellular Aurora A or employing methods 
that are characteristically slow to take effect, a technique that permits the intricate and reversible 
manipulation of Aurora A activity, would help to develop a more complete understanding of the 
kinase. Throughout the last decade, small molecule inhibitors have proved to be both efficient anti-
cancer therapies and valuable experimental tools, and have made it possible to specifically and 
potently inhibit Aurora A activity in an efficient and reversible way.  
Using the small molecule inhibition of Aurora A activity, I have been able to reveal some 
interesting features of the kinase, some of which conflict with established perceptions within the 
literature. Throughout this report I have detailed these findings, showing that Aurora A activity is 
involved in the formation of a functional spindle in order to efficiently align chromosomes and 
enable the efficient detection of alignment defects. Therefore when Aurora A activity was 
inhibited, cells displayed segregation errors and the cell population became eventually unviable. 
Despite this prominent role for Aurora A activity in mitosis, I showed that cells can divide and 
activate the spindle assembly checkpoint in its absence, demonstrating that Aurora A activity is not 
required for cytokinesis and does not play a prominent role in the checkpoint. Aurora A activity 
was also not required for cytokinesis or the activation of the spindle checkpoint in the non-
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transformed cells tested, although surprisingly, non-transformed cell spindles were not as 
profoundly affected by Aurora A inhibition as cancer cell lines.  
9.2 The limitations of the study 
The use of small molecules to inhibit Aurora A activity permitted fast, easily controllable, dose-
dependent and reversible kinase inhibition, without directly affecting protein levels. However, the 
specificity of the inhibitors towards Aurora A was an issue (for review see [Taylor and Peters, 
2008]). To determine the ability of MLN8054 to specifically target Aurora A activity, Western 
blotting was used to reveal that MLN8054 was the most specific Aurora A inhibitor out of those 
available (Figure 3.3). At 1 µM MLN8054 inhibited Aurora A activity to more than 95% in HeLa 
cells and to around 95% in DLD-1 cells, and importantly didn’t also show signs of also inhibiting 
Aurora B activity (Figures 3.3C and 3.3D). The specificity of MLN8054 for Aurora A activity over 
the other Aurora family members was further confirmed by the observation that the majority of 
cells did not suffer cytokinesis defects or exhibit stabilised merotelic attachments following 
treatment (Figures 5.5, 6.1 and 6.2A) (Hauf et al., 2003, Ditchfield et al., 2003, Giet and Glover, 
2001, Yang et al., 2010b). 
This data therefore demonstrated that MLN8054 could be used to potently inhibit Aurora A 
activity, over that of the other family members, however it was also important to determine 
whether MLN8054 affected any additional kinases. The specificity of the 1 µM MLN8054 
treatment over the other members of the kinome was investigated by comparing the cellular effects 
of the treatment with those of two other Aurora A inhibitors, through the inspection of 
immunofluorescently-stained cell samples. Encouragingly, similarities between the effects of 
MLN8054 and the Aurora inhibitor ZM3 to cells indicated that both treatments appeared to be have 
no obvious off-target action. This deduction is consistent with published in vitro data, in which 
MLN8054 was found to be more than 40-times more selective for Aurora A activity than for that of 
Aurora B (Manfredi et al., 2007). In the same publication, in vitro data was used to show 
MLN8054 was more potent towards Aurora A activity than a panel of 226 other kinases. A recent 
publication futher highlighted the importance of testing chemical inhibitors on a large panel of 
protein kinases such as this to ensure their specificity, which is of particular importance when 
considering that there are over 500 protein kinases in the human genome (Cohen, 2010). Despite 
the promising result of the comparative immunofluorescence however, it could not be ruled out that 
additional off-target kinases were being inhibited by the MLN8054 treatment, and that this was 
simply not realised by using this technique.  
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To further tackle this issue, I therefore attempted to create a cell line which expressed a form of 
Aurora A that was mutated in a way that rendered it resistant to 1 µM MLN8054. This cell line 
could then be used to identify any off-target effects by treating the cells with MLN8054 and 
observing any differences that occurred between untreated cells. Any differences between the 
treated and untreated mutant cell lines would therefore highlight off-target effects of the inhibitor. 
Despite attempting to introduce a number of different mutations into Aurora A however, none 
conferred sufficient resistance to MLN8054, and thus could not be used to investigate any off-
target effects of the treatment (data not shown). Thus, although immunofluorescence comparison 
experiments and published in vivo data appeared to indicate that MLN8054 was not having off-
target effects when used at 1 µM, I cannot completely rule out the occurrence of such effects 
(Figure 3.4; (Manfredi et al., 2007)). Despite the disappointing inability to produce MLN8054-
resistant Aurora A mutants, this difficulty may have important connotations for the development of 
resistancy in treated patients, and thus the future success of Aurora A inhibitors as anti-cancer 
treatments. 
In addition to being unable to fully investigate off-target MLN8054 effects, a further weakness of 
the investigation was highlighted in that Aurora A activity may not be sufficiently inhibited by 1 
µM MLN8054. Indeed, the application of MLN8054 at 1 µM to HeLa and DLD-1 cells did not 
produce as markedly pronounced spindle effects as those described in may other reports, despite 
the apparent potent inhibition indicated in the Western blot data (Figures 3.3, 3.4, 4.4A and 4.4B) 
(Liu and Ruderman, 2006, Giet and Prigent, 2000, Giet and Prigent, 2001, Roghi et al., 1998, 
Marumoto et al., 2003, Glover et al., 1995, Hannak et al., 2001, Girdler et al., 2006). Therefore, to 
test whether the potency of Aurora A inhibition could be increased, I used a HCT116 line which 
endogenously expressed a mutated drug-resistant form of Aurora B kinase (Girdler et al., 2008). 
This mutant HCT116 cell line was able to suppress the effects of high concentrations of MLN8054 
on Aurora B activity, making it possible to increase the concentration of MLN8054, and therefore 
to investigate whether more potent Aurora A inhibition was possible (Figures 7.2 and 7.3).  
Surprisingly however, treating the mutant HCT116 cells with even 1 µM MLN8054 produced the 
profound occurrence of monopolar spindles in mitotic cells, although raising the concentration still 
further to 4 µM caused a further increase in the proportion of cells with shorter spindles (Figure 
7.4). These observations were extremely similar to those of cells treated with an Eg5 inhibitor, as 
well as previous reports of the effects of removing the activity of Aurora A from cells (Figure 4.4A 
and 4.4B) (Liu and Ruderman, 2006, Giet and Prigent, 2000, Giet and Prigent, 2001, Glover et al., 
1995, Hannak et al., 2001, Girdler et al., 2006). Whether the increased monopolarity of the 
HCT116 cells following MLN8054 treatment represents more potent Aurora A inhibition 
compared to the other cell lines tested however is up for debate, although Western blots indicated 
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that the Aurora A inhibition achieved throughout was equivalent in the cell lines tested (Figure 
7.2). HCT116 cells may simply have a distinct balance of signalling pathways, causing them to be 
more dependent on Aurora A activity for bipolar spindle assembly.   
Finally, although deductions could be made regarding the differing dependencies of non-
transformed and cancer cells on Aurora A activity for the efficient formation of mitotic spindles 
(Chapter 8), no concrete conclusions could be made due to the use of only one non-transformed 
cell line. This limitation leaves the study open to the criticism that the differences observed 
between the two cell types may simply be the result of inter-cell line differences in the effect of 
Aurora A inhibition. Further work with multiple cell lines would have to be completed before any 
firm conclusions could be formed regarding the differences between transformed and non-
transformed cells in response to Aurora A inhibition.  
9.3 Aurora A activity is required for the development of normal mitotic spindle 
structures in cancer cell lines  
Although relatively little was known regarding Aurora A activity at the beginning of this project, 
depletion and mutagenesis experiments had been used to indicate that Aurora A activity was 
required for the formation of a bipolar spindle, and without it mitotic cells were shown to 
predominantly exhibit monopolar spindles (Liu and Ruderman, 2006, Giet and Prigent, 2000, Giet 
and Prigent, 2001, Roghi et al., 1998, Marumoto et al., 2003, Glover et al., 1995, Hannak et al., 
2001, Girdler et al., 2006). By using MLN8054 to potently inhibit Aurora A activity, I was able to 
demonstrate that although Aurora A activity was indeed required for the normal development of a 
mitotic spindle, some interesting differences were observed to occur between my data and the 
published literature.  
9.3.1 Aurora A activity is not required for the formation of bipolar spindles in the majority 
of DLD-1 and HeLa cells 
Western blotting of cell samples treated with 1 µM MLN8054 indicated that the treatment caused 
specific inhibition of Aurora A activity (Figure 3.3). Despite this, the majority of DLD-1 and HeLa 
cells were seen to form bipolar spindles during mitosis (Figure 3.4), which is in contrast with the 
finding that the removal of Aurora A activity produced the prominent occurrence of monopolar 
spindles in mitotic cells (Liu and Ruderman, 2006, Giet and Prigent, 2000, Giet and Prigent, 2001, 
Roghi et al., 1998, Marumoto et al., 2003, Glover et al., 1995, Hannak et al., 2001, Girdler et al., 
  159 
 
  
2006). This intriguing discrepancy provoked the closer inspection of the mitotic spindles formed in 
the absence of Aurora A activity, which revealed some interesting spindle abnormalities.  
9.3.2 Aurora A activity is required to define spindle length  
Although the majority of HeLa and DLD-1 cells appeared to have bipolar spindles following 
Aurora A inhibition, the number of long K-fibres was found to be reduced and the spindles were 
less capable of separating and maintaining centrosome separation (Figures 4.2, 4.3, 4.5 and 5.6). 
This shortening of inter-pole distance in the absence of Aurora A activity is intriguingly similar to 
reports describing shorter spindle lengths in cells where Aurora A is prevented from interacting 
with its activator TPX2 (Bird and Hyman, 2008). Similarly, the depletion of TPX2 in C. elegans 
embryos was also reported to lead to a reduction in spindle lengths, a phenomenon which was 
linked to causing a reduction in TPX2/Aurora A down spindle microtubules (Greenan et al., 2010). 
Indeed TPX2 has previously been determined to be required for both Aurora A localisation to the 
spindle microtubules and for activating and maintaining its Aurora A kinase activity (Eyers et al., 
2003, Tsai et al., 2003, Kufer et al., 2002, Kufer et al., 2003, Bayliss et al., 2003, Gruss et al., 2001, 
Eyers and Maller, 2004). Interestingly, the stable association of Aurora A to the spindle was found 
to be reduced after treatment with MLN8054 (Figure 4.7A). This may indicate a direct role for the 
activity of Aurora A in its stable attachment to spindle microtubules. Alternatively the association 
of MLN8054 to Aurora A may negatively affect the formation of the TPX2/Aurora A complex, 
which may as a result hinder Aurora A recruitment to spindle microtubules in a TPX2-dependent 
way. Thus, both the direct inactivation of Aurora A activity in my experiments or the prevention of 
Aurora A from interacting with TXP2 appears to reduce the length of the mitotic spindle structure, 
highlighting the importance of Aurora A activity in the regulation of spindle formation. 
9.3.3 Aurora A activity regulates the stability of spindle microtubules  
The exact role of Aurora A on the spindle is as yet unknown, however Aurora A activity is required 
for the proper localisation of TACC3 to both the centrosomes and spindle microtubules (Figure 
4.7B), a finding that is supported in the literature (Giet et al., 2002, Kinoshita et al., 2005, LeRoy et 
al., 2007, Peset et al., 2005, Mori et al., 2007). When the Xenopus TACC protein Maskin was 
prevented from localising to the spindle and centrosomes through its depletion in egg extracts, the 
resulting spindles were reported to be on average 30% smaller than control cells with markedly 
reduced microtubule nucleation (O'Brien et al., 2005, Kinoshita et al., 2005, Peset et al., 2005). 
Furthermore, the over-expression of TACC3, D-TACC or Maskin, has been shown to cause the 
increase in the level and length of spindle microtubules (Gergely et al., 2000b, Peset et al., 2005, 
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Lee et al., 2001). These findings therefore suggest that through regulating the localisation of 
TACC3, Aurora A activity may regulate microtubule length, thus providing an explanation as to 
why reduced K-fibre length and inter-pole distances were observed following MLN8054 treatment 
(Figures 4.2 and 4.3 and for model see Figure 9.1). The role for the TACC proteins in maintaining 
microtubule length is not thought to be derived from the increase of microtubule nucleation or 
centrosomal maturation, but by the stabilisation of the microtubules (reviewed in [Peset and 
Vernos, 2008]; (Peset et al., 2005, Bellanger and Gonczy, 2003)). Thus Aurora A activity may 
therefore regulate spindle length by increasing the protection of spindle microtubules from 
depolymerisation.  
This method of microtubule stabilisation may occur through the regulation of the microtubule 
stabilising family of proteins. Indeed, TACC proteins have been found to interact with 
chTOG/XMAP215, and aid its localisation to the centrosome and spindle minus-ends, thus  
countering the effects of the microtubule destabiliser MCAK (Bellanger and Gonczy, 2003, Srayko 
et al., 2003, Sato et al., 2004, Conte et al., 2003, Lee et al., 2001, Gergely et al., 2003, Barros et al., 
2005). Interestingly, the depletion of chTOG/XMAP215 has been shown to shorten the length of 
spindles, thus producing effects similar to those seen after Aurora A inhibition (Figures 4.2 and 
4.3) (Goshima et al., 2005b). Further supporting the link between Aurora A and the regulation of 
chTOG/XMAP215, the phosphorylation of TACC3 by Aurora A has been shown to stabilise 
microtubules by loading chTOG/XMAP215 to the minus-ends of centrosomal spindle fibres (Lee et 
al., 2001, Gergely et al., 2003, Barros et al., 2005, Kinoshita et al., 2001). Consistent with these 
findings, I found chTOG to be reduced at centrosomes after MLN8054 treatment in HeLa cells 
(Figures 4.7C and 4.7D).  This level of regulation over microtubule stability may therefore explain 
why there are less long K-fibres following the inhibition of Aurora A (Figure 4.3 and for model see 
Figure 9.1) 
Therefore Aurora A activity appears to regulate spindle formation through the protection of spindle 
microtubules from depolymerisation. Aurora A activity has however also been implicated in 
regulating microtubule stability by directly controlling the activity and localisation the microtubule 
depolymerisors Kif2a and MCAK. Through the delicate balancing of their action, these two 
microtubule depolymerisors have been shown to work together, enabling the formation of bipolar 
spindles (Ganem and Compton, 2004, Zhang et al., 2008). Indeed the depletion of proteins 
involved in microtubule deploymerisation has previously been reported to increase the length of 
spindles (Goshima et al., 2005b). Furthermore, yeast have has been shown to selectively 
depolymerise long microtubules rather than short ones, highlighting the requirement for 
microtubule depolymerisors to maintain the length of individual spindle fibres (Varga et al., 2006). 
Therefore, by regulating the intricate balancing of depolymerise activity and localisation to  
Aurora A kinase active Aurora A kinase inhibited
Figure 9.1 Model of changes in microtubule stability following Aurora A inhibition
In control cells and those experiencing Aurora A inhibition three major types of spindle
microtubule were observed: 1) long and relatively stable, 2) dynamic, 3) short. Aurora A
activity was found to be required to determine that chromosomes were attached to long
and relatively stable microtubules, while unattached kinetochores were dynamic or
destabilised. Without Aurora A activity, shortened K-fibres were observed, while long and
apparently stable unattached microtubules were often also detected.
These changes observed after Aurora A inhibition were predicted to occur as a result of
the misregulation of the delicate balancing of polymerisation and depolymerisation events
within the cell. When Aurora A kinase activity is inhibited TACC3 is mislocalised from the
centrosome (Figure 4.7B), which reduces the localisation and activity of chTOG/XMAP215
at the minus-ends of microtubules (Figure 4.7C) (Kinoshita et al., 2005). As a conse-
quence, centrosomal microtubule growth and protection from MCAK may be reduced,
causing the shortening of spindle fibres. Furthermore, due to their mislocalisation from the
centrosomal area, TACC3 and chTOG/XMAP215 may become increasingly localised to
the plus-ends of microtubules, and in the case of chTOG/XMAP215, also along the lengths
of microtubules (Spittle et al., 2000; Lee et al., 2001). This may enable inappropriate
microtubule protection and plus-end polymerisation, allowing the growth of abnormally
long non-kinetochore microtubules. In addition, the inhibition of Aurora A may cause the
over-activation of MCAK at early stages of mitosis (Zhang et al., 2008) and an increase of
Kif2a on spindle microtubules (Jang et al., 2009). This misregulation help may also help
explain the problems with bipolar spindle formation as well as the shorter microtubule
length characteristic of cells depleted of Aurora A activity.
K-fibre chTOG TACC3 MCAK orKif2a
dynamic
microtubule
major direction of
microtubule extension
161
  162 
 
  
different areas of the spindle, Aurora A activity may control the length of spindle fibres (for model 
see figure 9.1). Kif2a is also implicated in chromosome congression, a process that was found to be 
disrupted following Aurora A inhibition (Figure 5.1B) (Jang et al., 2008, Jang et al., 2009). The 
requirement for Aurora A to regulate Kif2a function in chromosome congression may therefore 
provide an explanation to the reduced ability of cells to align their chromosomes following Aurora 
A inhibition (Figure 5.1B). During my investigation however, no difference could be detected in 
the localisation of the microtubule destabilisers Kif2a and MCAK following Aurora A inhibition 
(data not shown). I cannot however, rule out the possibility that Aurora A activity does wield some 
form of control, either over the function or localisation of microtubule depolymerases.  
9.3.4 Aurora A activity is required for the proper maturation of the centrosomes 
Aurora A activity may also control the formation of the spindle structure via its role in centrosome 
maturation (Berdnik and Knoblich, 2002, Hannak et al., 2001, Hirota et al., 2003, Terada et al., 
2003, Giet et al., 2002, Barros et al., 2005). This relationship with the regulation of spindle 
formation has been attributed to both the nucleation capacity of the matured centrosomes and the 
determination of microtubule length by contributing to centrosome size (Greenan et al., 2010, Bird 
and Hyman, 2008, Berdnik and Knoblich, 2002, Hannak et al., 2001, Hirota et al., 2003, Terada et 
al., 2003, Giet et al., 2002, Barros et al., 2005). Consistent with the control of centrosome 
maturation by Aurora A activity, I showed that MLN8054 treatment caused a reduction in the 
localisation of various centrosomal components in HeLa cells (Figure 4.7), while also causing a 
slight reduction in centrosomal size (Figures 4.1 and 4.7). Interestingly however, such dramatic 
mislocalisation of centrosomal components was not seen in non-transformed cells, and neither was 
there an obvious reduction in centrosome size following Aurora A inhibition (Figure 8.6). This 
difference in the two cell lines is consistent with their differing abilities to form a bipolar spindles 
capable of efficiently aligning chromosomes, highlighting the importance of proper centrosome 
maturation in proper spindle formation (Figures 5.1 and 8.3).  
Additionally, the role of Aurora A activity in centrosome maturation may also contribute to the 
determination of spindle length through the production of astral microtubules. Aurora A activity 
and its regulation of TACC proteins have been attributed to the efficient nucleation and 
stabilisation of astral microtubules (Giet et al., 2002, Motegi et al., 2006, Srayko et al., 2003). The 
importance of their presence is seen in early mitosis where even before the creation of a spindle 
centrosomes have been shown to move apart, which is proposed to occur through the nucleation of 
astral microtubules (Waters et al., 1993, Rosenblatt et al., 2004). Astral microtubules have also 
been found to act as spindle tethers, contributing to the spindle positioning process with in the cell 
(Thery et al., 2007). The dependency on Aurora A activity for the existence of astral microtubules, 
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may therefore contribute to the reduction inter-pole distances seen after MLN8054 treatment 
(Figure 4.2). 
Aurora A has also been implicated in centriole separation, with the injection of anti-Aurora A 
antibodies or the use of MLN8054 appearing to prevent the separation of centriole pairs (Marumoto 
et al., 2003, Hoar et al., 2007). Despite the reported defects in centriole separation, most cells were 
capable of organising more than one spindle pole, although some spindle poles were observed to be 
lacking NuMA or Centrin 3. This may therefore further demonstrate the role of the Aurora A 
kinase activity in the regulation of centrosome development and function, and may subsequently 
help to explain the abnormal spindle assembly observed following Aurora A inhibition.   
9.3.5 Aurora A activity may regulate microtubule antiparallel sliding 
In addition to controlling spindle formation via centrosomal maturation, Aurora A activity may also 
control spindle length through regulating the antiparallel sliding of its microtubules. Indeed, Aurora 
A has been shown to interact with and phosphorylate the plus-end directed motor protein Eg5, 
which has been reported to be required for bipolar spindle formation (Giet et al., 1999, Giet and 
Prigent, 2000, Koffa et al., 2006, Mayer et al., 1999). The prominent role of Eg5 in bipolar spindle 
formation is highlighted by the observation that Eg5 inhibition causes a severe monopolar spindle 
phenotype (Figures 4.4A and 4.4B). Such a dramatic effect to spindle polarity was however not 
seen in the majority of cells following Aurora A inhibition during this investigation (Figures 3.4, 
8.3C and 8.3D), suggesting that other kinases may also be able to activate Eg5.  Importantly 
however, Aurora A inhibition in HCT116 cells did cause a severe monopolar spindle phenotype 
(Figure 7.4), which could demonstrate the lack of possible alternative Eg5 activating pathways in 
the cell line. Alternatively, HCT116 cells may be the only cell line where complete Aurora A 
inhibition was achieved, therefore residual Aurora A activity in the other cell lines may be 
sufficient to maintain the activity of Eg5. This is however unlikely, as Western blot data indicated 
that equivalent Aurora A inhibition was achieved by MLN8054 in all of the cell lines tested, as 
determined by phosphor-Aurora A signal (Figures 3.3, 7.2 and 8.1). 
9.3.6 Aurora A activity is required for the proper organisation of the spindle  
One of the most notable features of HeLa cell spindles treated with MLN8054 was that they were 
decidedly less organised than those of control cells (Figures 4.1 and 5.3). During late prometaphase 
to metaphase, control cells displayed robust and clearly visible K-fibres, which formed bipolar 
spindles with a canonical structure and neatly aligned chromosomes (Figure 4.1A). In comparison, 
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MLN8054-treated HeLa cells exhibited poorly defined K-fibres which formed an unfocused mass 
of microtubules (Figures 4.1B, 4.1D, 5.3C and 5.3D). Furthermore, although the kinetochores 
within these cells appeared to be attached to spindle microtubules, the chromosomes were often 
misaligned, forming broader metaphase plates with some chromosomes pulled closely into the 
poles. These structural abnormalities formed in the absence of Aurora A activity demonstrate that 
the activity is required not only for spindle length determination, but also for microtubule 
organisation. These roles for Aurora A activity may also stem from its function in bringing about 
the proper maturation of centrosomes, a process which promotes both efficient microtubule 
nucleation and importantly microtubule organisation (Berdnik and Knoblich, 2002, Hannak et al., 
2001, Hirota et al., 2003, Terada et al., 2003, Giet et al., 2002, Barros et al., 2005, Greenan et al., 
2010). 
9.3.7 Aurora A activity regulates the length of non-kinetochore microtubules 
In addition to Aurora A inhibition causing the shortening and disorganisation of spindles, 
abnormally long non-kinetochore microtubules were often observed to protrude from the spindle 
structure of MLN8054-treated HeLa cells (Figures 4.1D and 5.3D). The disruption of the highly 
regulated and delicately balanced action of microtubule stabilisers and depolymerisors may go 
some way in explaining the occurrence of these abnormal fibres. In untreated cells, the balancing of 
these forces usually enables the formation of exceedingly dynamic yet structurally constant mitotic 
spindles. Therefore, the deregulation of this process may lead to the stabilisation of microtubules 
that are normally dynamic, and the reduction in the stability of spindle fibres that are typically 
stable (for model see Figure 9.1). The shortening of the relatively stable K-fibres following Aurora 
A inhibition demonstrates that the latter of these two cases is true (Figure 4.3), with the 
mislocalisation of chTOG also indicating the mislocalisation of microtubule stabilisers (Figures 
4.7C and 4.7D). The mislocalisation of microtubule stabilising factors from the minus-ends of 
microtubules after Aurora A inhibition may produce a more disperse localisation throughout the 
cell allowing the stabilising factors to abnormally localise or increase their localisation to various 
positions throughout the cell. Indeed, both chTOG/XMAP215 and TACC proteins have been found 
to be associated with microtubule plus-ends, a situation which may be heightened after Aurora A 
activity is prevented from targeting them to the centrosomes (Figure 4.7B) (Lee et al., 2001, 
Tournebize et al., 2000, Kinoshita et al., 2001). Furthermore, the role of Aurora A activity in 
regulating MCAK may also contribute to the presence of abnormal long microtubules, as MCAK 
RNAi has been shown to increase the proportion of astral microtubules (Zhang et al., 2008, Rankin 
and Wordeman, 2010). Situations such as these may therefore cause the production and 
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stabilisation of long non-kinetochore microtubules while reducing the length and stability of K-
fibres, similar to the situation seen observed after Aurora A inhibition (Figure 9.1). 
9.4 Aurora A activity is required for the maintenance of genomic stability  
Despite the spindle abnormalities seen after Aurora A inhibition, cells were still capable of 
dividing, although they soon lost viability, highlighting the importance of the kinase in the 
maintenance of genomic stability (Figures 6.1, 6.2 and 6.3). 
9.4.1 The efficient alignment of chromosomes requires active Aurora A  
Although Aurora A inhibition did not create the potent monopolar spindle phenotype as described 
in the literature in the majority of cell lines tested, Aurora A activity was nonetheless found to have 
a prominent role in the formation of a normal spindle (Figure 4.1). Despite the clearly abnormal 
spindles produced by inhibiting Aurora A activity however, the K-fibres within these spindles were 
shown to attach to the kinetochores and generate a degree of force to the chromosomes (Figures 5.3 
and 5.4). This K-fibre attachment was marked by a decrease in Mad2 staining at kinetochores, 
indicating equivalent if not slightly increased microtubule attachment compared to control cells. 
This slight increase may be related to the shortened K-fibres of the cells causing their kinetochores 
to be placed closer towards the microtubule rich centrosomal area, thus making them more 
available for microtubule attachment. Alternatively, the slight increase in microtubule attachment 
may simply be the result of the disorganised nature of spindles produced in the absence of Aurora 
A activity.   
Interestingly however, the centromere stretch of chromosomes within cells exposed to MLN8054 
treatment was greater than those in cells exposed to Nocodazole, but significantly less than 
observed in control cells (Figure 5.4C). This reduction in centromere stretch is most likely to be 
derived from the reduction in length and level of organisation of spindles formed in the absence of 
Aurora A activity (Figures 5.3D and 5.4D). The ability of K-fibres to form apparently stable 
attachments to the kinetochores despite the relatively low levels of centromere stretch, suggests that 
the inter-kinetochore tension applied by the spindle was adequate to prevent microtubule 
destabilisation by tension sensing pathways (for review see [Santaguida and Musacchio, 2009, 
Maresca and Salmon, 2010]; (King and Nicklas, 2000, Kapoor et al., 2000, Waters et al., 1998)). It 
is highly likely that the low levels of force generated by the structurally disorganised spindle 
following the inhibition of Aurora A, prevented the affected cells from efficiently aligning their 
chromosomes (Figure 5.1B).  
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9.4.2 Aurora A activity is required to prevent segregation errors  
The inability of cells to efficiently align their chromosomes in the absence of Aurora A activity was 
found to cause significant delays in mitosis (Figures 6.1, 6.2A, 7.5 and 8.2).  Live cell analysis later 
showed that after prolonged mitotic delay, HeLa cells were observed to suffer from segregation 
errors and decondense their chromatin without first dividing (Figure 6.2B). In light of these 
observations, it was unsurprising to learn that long–term Aurora A inhibition caused the 
development of aneuploidy as well as causing a substantial increase in the sub-G1 peak in flow 
cytometry PI profiles of HeLa cells (Figure 6.3A(ii)). Colony formation assays also demonstrated 
that HeLa cells exposed to long-term Aurora A inhibition eventually lost viability, demonstrating 
the degenerative effect of the segregation errors (Figures 6.3B and 6.3C). The occurrence of such 
segregation defects and the consequential development of aneuploidy have been attributed to the 
dependency on Aurora A activity to maintain the activation of the spindle assembly checkpoint 
(Wysong et al., 2009, Kaestner et al., 2009). This did not however appear to be the case, as cells 
were arrested in mitosis for significant periods after Aurora A inhibition (Figures 6.1, 7.6 and 
8.2C). Therefore cells must instead be able to satisfy the spindle assembly checkpoint despite the 
presence of incorrectly attached and aligned chromosomes. 
This inappropriate satisfaction of the spindle checkpoint despite misaligned chromosomes may be 
derived from the disorganised nature of the spindles formed in the absence of Aurora A activity 
(Figures 4.1B and 5.3D). Their abnormal construction and disorganised nature may permit the 
generation of sufficient tension across kinetochores to satisfy the spindle checkpoint, despite the 
unaligned state of the chromosomes (Li and Nicklas, 1995, Nicklas et al., 1998, Nicklas et al., 
1995, Skoufias et al., 2001, Biggins and Murray, 2001, Stern and Murray, 2001). Alternatively, 
cells may be able to satisfy the spindle checkpoint despite low levels of centromere stretch, relying 
only on the levels of microtubule attachment at kinetochores (Figures 5.4B and 5.4C). The concept 
that a low level of tension does not sustain checkpoint activation has been supported by a range of  
reports, which range from using laser ablation, to exploiting replication defects to support their 
argument (Dewar et al., 2004, O'Connell et al., 2008, Rieder et al., 1995). Despite the compelling 
evidence in support of this theory however, it is difficult to apply it to the situation seen after 
Aurora A inhibition. This difficulty stems from the observation that spindles appear able to 
relatively efficiently attach to kinetochores in the absence of Aurora A activity (Figure 5.4B), 
although the cells still experience extended mitotic delays following the treatment (Figure 8.2C). 
Indeed, the only divergence from the control cell phenotype appears to be the reduced centromere 
stretch, suggesting that this may maintain checkpoint activation, thus causing the extended mitotic 
delays.  
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Despite the abnormal spindles and chromosome alignment defects, the majority of cells were able 
to divide following Aurora A inhibition (Figures 6.1 and 6.2). Indeed, even when a cell population 
was seen to be predominantly monopolar following Aurora A inhibition, unlike with Eg5 
inhibition, cells were still able to divide (Figure 7.5B). This unexpected finding was predicted to be 
due to the cells eventually being capable of forming adequate spindles even in the absence of 
Aurora A activity. Indeed, the observation of live HeLa cell data revealed the sequential collapsing 
and reformation of the mitotic spindle after Aurora A inhibition (data not shown). This observation 
indicates that although bipolar spindle assembly was possible, the weakened spindle structure 
formed in the absence of Aurora A activity may make it impossible for cells to continually 
maintain their bipolarity. If the HCT116 cells observed to be mostly monopolar following Aurora 
A inhibition spent more time with their spindles in the collapsed state, this would explain the 
prominent occurrence of monopolar spindles and relatively few bipolar spindles observed in the 
fixed cell samples (Figure 7.4). The ability to form unstable bipolar spindles would therefore also 
help explain how the cells are able to divide despite spindle defects produced in the absence of 
Aurora A activity.  
9.5 Aurora A activity is not required for regulation of spindle length in non-transformed 
cells  
Cancer cells such as HeLa and HCT116 lines are commonly used in laboratories, due to their ease 
of use and extensively studied profiles. However, to build a more universal understanding of the 
role of Aurora A kinase activity, I used a non-transformed RPE cell line that had been immortalised 
through the expression of hTERT. The requirement to investigate the role of Aurora A in non-
transformed cells was further supported by the observation that they responded differently to anti-
mitotic drugs compared to transformed cell lines, indicating the same may be true for the effects of 
inhibiting Aurora A activity (Orth et al., 2008, Brito et al., 2008, Gascoigne and Taylor, 2008). 
Indeed, comparing Aurora A inhibition in non-transformed cells and cancer lines revealed some 
interesting differences. One of the most profound differences observed was the ability of RPE cells 
to form bipolar spindles which were not significantly reduced in length when compared with 
control cells (Figures 8.3C and 8.3D). Furthermore, the non-transformed cell line was also more 
able to align its chromosomes in the absence of Aurora A activity compared to cancer cells 
(Figures 8.3B and 8.4). The comparative efficiency of these processes in the absence of Aurora A 
activity meant that non-transformed cells only suffered relatively small mitotic delays after the 
treatment (Figure 8.2). Furthermore, after extended Aurora A inhibition, RPE cells accumulated 
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with 2N DNA and were able to form sparsely populated colonies (Figure 8.5). In contrast, HeLa 
cells quickly became aneuploid and lost viability following the same treatment (Figure 6.3).  
9.5.1 Non-transformed RPE cells may be able to maintain signalling pathways down-
stream of Aurora A in the absence of Aurora A activity  
The ability of RPE cells to maintain bipolar spindle formation after the same level of Aurora A 
inhibition experienced as the cancer lines may be due to their capacity to either sustain the activity 
of particular cellular pathways in the absence of Aurora A activity, or exploit alternatives, whereas 
the cancer cells may be less able to do so. The existence of such a system may be demonstrated by 
the presence of phospho-TACC3 even in RPE cells treated with 10 µM MLN8054, despite the loss 
of phospho-Aurora A (Figure 8.1).  Interestingly, this situation was not observed in HeLa or DLD-
1 cells (Figures 3.3 and 8.1), and may indicate a method by which RPE cells retain the activation of 
TACC3 even after Aurora A inhibition. Similarly, although Aurora B activity appeared to be 
inhibited to equivalent levels by 1 µM MLN8054 in both the transformed and non-transformed cell 
lines, as judged by the reduction of phospho-Aurora B signal, the phospho-histone H3 signal was 
only reduced at much higher concentrations in the non-transformed cells. The ability of RPE cells 
to retain the activation of downstream kinases even in the absence of the upstream Aurora kinase 
activity, could therefore demonstrate the presence of redundant pathways which may not be present 
in the cancer cell lines tested.  
Furthermore, in RPE cells chTOG and TACC3 were efficiently localised to centrosomes, and 
TACC3 maintained a relatively high degree of spindle localisation after MLN8054 treatment, 
which is in contrast to HeLa cells which were completely unable to localise TACC3 and showed 
reduced localisation of chTOG (Figures 4.7 and 8.6). Both chTOG/XMAP215 and TACC3 have 
been linked with the normal growth of spindles, and their sustained localisation after Aurora A 
inhibition in RPE cells could therefore explain how RPE cells are able to form spindles of a 
relatively normal length and organisation after the MLN8054 treatment (Barros et al., 2005, Giet et 
al., 2002, Kinoshita et al., 2005, Peset et al., 2005, Lee et al., 2001, Gergely et al., 2003). HeLa 
cells which may not be able to retain the activation of Aurora A-driven signalling pathways may 
not consequently be able to sustain the localisation of cellular components that are essential for the 
development of normal spindles, such as TACC3 and chTOG. 
Although both chTOG and TACC3 maintained a relatively constant localisation after Aurora A 
inhibition in RPE cells, the stable localisation of Aurora A to the spindle microtubules appeared to 
be reduced after the treatment in a similar way to that seen in HeLa cells (Figures 4.7A and 8.6A). 
This similarity in the effect of MLN8054 on Aurora A localisation, together with the equivalent 
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loss of the phospho-Aurora A in Western blot samples (Figure 8.1), indicates that Aurora A activity 
was indeed inhibited to a comparable levels by the MLN8054 in HeLa and RPE cells. Despite the 
Western blot evidence, it could however be argued that RPE cells are somehow more resistant to 
the inhibitory effects of MLN8054, thus providing an alternative theory as to how RPE cells were 
able to more efficiently form functional bipolar spindles than the cancer cells tested. 
9.5.2 In the absence of Aurora A activity RPE cells show signs of senescence 
In addition to showing a differing ability to form bipolar spindles following Aurora A inhibition, 
RPE cells exposed to long-term Aurora A inhibition did not develop a sub-G1 population (Figure 
8.5A). Instead they accumulated with a 2N DNA content and formed sparsely populated colonies 
(Figures 8.5B and 8.5C). In contrast, HeLa cells quickly became aneuploid and became unviable 
following the treatment (Figure 6.3). Consistent with these observations, MLN8054 has recently 
been shown to cause a higher proportion of cell death in transformed cells compared to non-
transformed cell lines (Shang et al., 2009). 
The tendency of RPE cells to accumulate with 2N DNA in response to long-term Aurora A 
inhibition, may indicate that senescence is triggered. Senescence is a state in which cells are no 
longer permitted to proliferate, and are instead usually held in G0 (for review see [Reddel, 2010]). 
The induction of senescence is a stress response, and has been found to be triggered by a range of 
situations including (Chen et al., 2009, Collado et al., 2007, Collado and Serrano, 2010, Mo et al., 
2007, Young et al., 2008, Courtois-Cox et al., 2006). Interestingly, Aurora A over-expression has 
been suggested to extend the life-span of cells by increasing the expression of the human 
telomerase reverse transcriptase (hTERT) and activating telomerase activity (Yang et al., 2004). It 
may therefore be a possibility that the inhibition of Aurora A has the reverse effect, and causes the 
shorting of telomeres, thus providing a mechanism by which senescence may be triggered after 
Aurora A inhibition. The exact conditions by which senescence is triggered, is however dependent 
on the cell type and the culture conditions. Factors which cause increased senescence in some cell 
lines lead to increased apoptosis in others, and it may therefore be possible for MLN8054 treatment 
to have alternate effects in different cell lines (Ventura et al., 2007, Xue et al., 2007).  
Senescent cells are prevented from further proliferation and can be cleared from the body by the 
immune system, which can result in the regression of tumours (Xue et al., 2007, Braig et al., 2005, 
Collado and Serrano, 2010). Indeed, senescence is widely regarded as a barrier to tumour 
formation, as markers for it are often found on pre-malignant tumours, but are absent in their 
malignant states, and senescence markers in biopsies are linked with the success of chemotherapy 
treatment (Chen et al., 2005b, Collado and Serrano, 2006, Gray-Schopfer et al., 2006, Roberson et 
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al., 2005, te Poele et al., 2002). Chemotherapies designed to induce senescence when used may 
even represent a valuable therapy, either on their own or in combination with additional treatments 
(Schmitt et al., 2002). Therefore, the observation of possible senescence in the immortalised RPE 
cells following Aurora A inhibition may indicate a method of targeting the abnormally cycling cells 
and removing them from the body. Indeed, although RPE cells are a non-transformed cell line, their 
immortalisation may mimic benign tumour growth. The ability of MLN8054 to induce a senescent 
response may therefore indicate an important method of anti-cancer therapy.   
The differences highlighted between transformed and non-transformed cells, as well as the 
observed variations in response between the cancer lines, demonstrate the danger of assuming 
commonality between distinct cell lines. However, the high occurrence of cell death in cancer cell 
lines in response to MLN8054 treatment is encouraging. Consistent with in vivo reports, it suggests 
that targeting the kinase activity of Aurora A could be a successful anti-cancer therapy (Shang et 
al., 2009, LeRoy et al., 2007, Manfredi et al., 2007, Kaestner et al., 2009, Dar et al., 2008, Hoar et 
al., 2007).  
9.6 Conclusion and the future targeting of Aurora A  
Throughout this thesis I have shown that in HeLa, DLD-1 and HCT116 cells, Aurora A activity is 
required for the formation of a functional spindle able to efficiently align its chromosomes and the 
effective detection of alignment defects. As a consequence, when Aurora A is inhibited, 
segregation errors are produced in the cancer cell line tested causing the cell population to 
eventually become unviable. Despite this prominent role for Aurora A activity in mitosis, I have 
shown that cells can divide and activate the spindle assembly checkpoint in its absence, showing 
that Aurora A activity is not required for cytokinesis and does not play a prominent role in the 
checkpoint. Interestingly however, the effects of Aurora A inhibition on non-transformed cells 
were not as profound as those observed in the cancer cell lines, with cells being able to retain their 
ability to form spindles and align their chromosomes relatively efficiently when compared to 
cancer cell lines.  
Therefore, in addition to highlighting the importance of Aurora A activity in the regulation of 
spindle formation in many cell lines, this work also demonstrates the existence of important inter-
cell line differences, not just between non-transformed cells and cancer lines, but also between all 
the cell lines tested. This observation has important connotations with regards to making broad 
generalisations from the characteristics of just one cell type. Furthermore, the observation that 
cancer cells became aneuploid after Aurora A inhibition, while non-transformed cells were able to 
sustain relatively efficient chromosome alignment, indicate that inhibiting Aurora A activity may 
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be an efficient method of specifically targeting cancer cells within patients. Indeed, early success in 
both laboratory tests and clinical trials indicates that Aurora A activity is a promising anti-cancer 
target (Shang et al., 2009, LeRoy et al., 2007, Manfredi et al., 2007, Kaestner et al., 2009, Dar et 
al., 2008, Hoar et al., 2007). Despite these promising results, the success of therapies such as 
Aurora A inhibition will rely on the proper appreciation of their effects in a patient and tumour-
specific basis, so as to enable the intelligent application of the appropriate therapy or combination 
of treatments. Therefore, clinical approaches to treating cancer in patients will be increasingly 
reliant on findings such as those detailed in this report in order to determine the most efficient 
methods of cancer treatment. 
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